UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K
(Mark One)
 
[X]ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended May 31, 20082011
 
[_]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to _______________

Commission File Number 0-22182

PATRIOT SCIENTIFIC CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)
84-1070278
(I.R.S. Employer Identification No.)

6183 Paseo Del Norte,701 Palomar Airport Road, Suite 180,170, Carlsbad, California
(Address of principal executive offices)
92011
(Zip Code)

(Registrant’s telephone number, including area code): (760) 547-2700

Securities registered pursuant to Section 12(b) of the Act: NONE

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $.00001$0.00001 par value
___________________

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES [  ][_]  NO [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES [  ][_]  NO [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES [X ]   NO [  ][_]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [_]  NO [_]
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [  ][_]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
 
Large accelerated filer [  ][_]          Accelerated filer [X][_]          Non-accelerated filer [  ][_]          (do not check if smaller reporting company)
   Smaller reporting company [  ][X]
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES [  ][_]  NO [X]

AggregateApproximate aggregate market value of voting and non-votingthe registrant’s common equitystock held by non-affiliates of the registrant on November 30, 20072010 was $238,797,982$40,376,945 based on a closing price of $0.61$0.10 as reported on the OTC Electronic Bulletin Board system.  For purposes of this calculation, it has been assumed that all shares of the registrant's common stock held by directors, executive officers and shareholders beneficially owning five percent or more of the registrant's common stock are held by affiliates. The treatment of these persons as affiliates for purposes of this calculation is not conclusive as to whether such persons are, in fact, affiliates of the registrant.

On August 8, 2008, 387,448,75512, 2011, 406,972,710 shares of common stock, par value $.00001$0.00001 per share (the issuer’s only class of voting stock) were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain information required to be disclosed in Part III of this report is incorporated by reference from the registrant’s definitive Proxy Statement for the 2008 annual meeting of shareholders, which will be held in October 2008 and which proxy statement will be filed not later than 120 days after the end of the fiscal year covered by this report.None



Table of Contents
 
PART I 4
    
 ITEM 1.Business4
 ITEM 1A.Risk Factors810
 ITEM 1B.Unresolved Staff Comments1113
 ITEM 2.Properties1113
 ITEM 3.Legal Proceedings1113
 ITEM 4.Submission of Matters to a Vote of Security Holders[Removed and Reserved]1114
    
PART II  1214
    
 ITEM 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities12
ITEM 6.Selected Financial Data14
 ITEM 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations15
ITEM 7A.Quantitative and Qualitative Disclosures About Market Risk2316
 ITEM 8.Financial Statements and Supplementary Data2425
 ITEM 9.Changes in and Disagreements withWith Accountants on Accounting and Financial Disclosure2425
 ITEM 9A.Controls and Procedures2425
 ITEM 9B.Other Information2926
    
PART III 2926
    
 ITEM 10.Directors, Executive Officers and Corporate Governance2926
 ITEM 11.Executive Compensation29
 ITEM 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters2932
 ITEM 13.Certain Relationships and Related Transactions, and Director Independence2932
 ITEM 14.Principal AccountingAccountant Fees and Services2933
    
PART IV 3034
    
 ITEM 15.EXHIBITS, AND FINANCIAL STATEMENT SCHEDULES3034
SIGNATURES


2


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K, including all documents incorporated by reference herein, includes certain statements constituting “forward-looking” statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995, including statements concerning our beliefs, plans, objectives, goals, expectations, anticipations, estimates, intentions, operations, future results and prospects, and we rely on the “safe harbor” provisions in those laws. Therefore, weWe are including this statement for the express purpose of availing ourselves of the protections of such safe harborharbors with respect to all of such forward-looking statements. The forward-looking statements in this report reflect our current views with respect to future events and financial performance.  These forward-looking statements are subject to certain risks and uncertainties, including specifically: the uncertainty of the effect of pending legislation, the uncertainty of patent and proprietary rights, uncertainty as to royalty payments and indemnification risks, trading risks of low-priced stocks and those other risks and uncertainties discussed herein that could cause our actual results to differ materially from our historical results or those we anticipate. In this report, the words “anticipates,” “believes,” “expects,” “intends,” “future”“future,” “estimates,” “may,” “could,” “should,” “would,” “will,” “shall,” “propose,” “continue,” “predict,” “plan” and similar expressions are generally intended to identify certain of the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.  WeAny forward-looking statement is not a guarantee of future performance.

These forward-looking statements are subject to certain risks and uncertainties, and actual results may differ materially from those in the forward-looking statements as a result of various factors, including, but not limited to those items shown under “Item 1A. Risk Factors.”  You should read this report completely with the understanding that our actual results may differ materially from what we expect.  Unless required by law, we undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events.

 



3


PART I

ITEM 1                 BUSINESS

The Company

Patriot Scientific Corporation (“Patriot Scientific”(the “Company”, “Patriot”“PTSC”, “we”, “us”, or “the Company”“our”) has developed a number of innovative technologies throughout its 20-year history. Wepursues two distinct technology enabled business strategies.  First, through our joint venture, Phoenix Digital Solutions, LLC (“PDS”) we are primarily an intellectual-property licensing company with several patents (described below) covering the design of microprocessor chips. Chips with our patented technology are used throughout the world in products ranging from computers and cameras to printers, automotiveautomobiles and industrial devices.

Our current business strategy is to commercialize  We pursue the commercialization of our patented microprocessor technologies through broad and open licensing and to litigateby litigating against those who may be infringing on our patents.  WithSecondly, through our wholly-owned subsidiary Patriot Data Solutions Group, Inc. formerly known as Crossflo Systems, Inc. (“PDSG”), we provide data sharing and secure data solutions to address the proceeds generated by these licensing efforts, we are undertaking to make investments in technologies,critical data/information sharing needs of federal, state, and acquisitions of companies, operating in the electronics technology market sector. local public safety and law enforcement agencies.

Our business address is 6183 Paseo del Norte,701 Palomar Airport Road, Suite 180,170, Carlsbad, California 92011; our main telephone number is (760) 547-2700. Our internet website page is located at http://www.ptsc.com. All of our reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are available free of charge on our internet website.  The information on, or that can be accessed through, our website is not part of this Annual Report.

Incorporation History. Patriot Scientific Corporation wasPTSC is a corporation organized under Delaware law on March 24, 1992, and is the successor by merger to Patriot Financial Corporation, a Colorado corporation, incorporated on June 10, 1987. In June 2005, we entered into a joint venture agreement with Technology Properties Limited, Inc. (“TPL”) to form Phoenix Digital Solutions, LLC (“PDS”).PDS. During February 2007, we acquired the preferred stock of Holocom, Inc. formerly known as Scripps Secured Data, Inc. (“SSDI”Holocom”), a Carlsbad company located in San Diego, California that develops and manufactures network-security hardware to government, military, and other high-security facilities.  During May 2008, we acquired a 15% shareminority ownership interest in Talis Data Systems, LLC (“Talis”), a Delaware LLC that produces multi-domain computer networking hardware.  During the third quarter of fiscal 2010, Talis was dissolved.  In AugustSeptember 2008, we increasedacquired PDSG which engages in data-sharing services and products primarily in the public safety/government sector.  During the fiscal year 2009, we acquired preferred shares of Avot Media, Inc. (“Avot”) an innovator of video transcoding and near real-time streaming to web-enabled mobile devices.  During March 2010, Avot sold substantially all of its assets.

PDSG is a segment of our investment in Talisbusiness, and Holocom was a segment of our business until April 30, 2009.  Refer to 37.4%.footnote 15 of our consolidated financial statements for more information regarding these segments.

Our Technology

General Background. Throughout our history, Patriot Scientific haswe have developed a number of innovative technologies for a variety of industries. We’re best known for our microprocessors, including the ShBoom, Ignite, and PSC-1000 families of chips, and for the Moore Microprocessor Patent (MMP)(“MMP”) portfolio of intellectual property surrounding them. These chips and their underlying innovations were created through a combination of in-house development and acquired technology.


4


Industry Background. The global semiconductor (or silicon “chip”) market has many segments and categories. The best-known - and most profitable - of these is the microprocessor segment. Microprocessor chips are the “brains” of nearly everymost electronic and electrical devicedevices throughout the world. Although microprocessors are often closely associated with personal computers (“PCs”), PCs account for only about 2% of the microprocessor chips made and sold every year. The vast majority of microprocessors are used in everyday items like automobiles, digital cameras, cell phones, video game players, data
networks, industrial flow-control valves, sensors, medical devices, weapons, home appliances, robots, security systems, televisions, and much more. These “embedded microprocessors” (so called because they’re embedded into another product) are far more ubiquitous than the chips inside personal computers. ItThis is this huge and growingthe market that Patriot Scientific’sour technology serves.

Patent Description. Over the years we’ve developed a number of innovative technologies that have been embodied in our own products and, through licensing, into other companies’ products. Many of these patented technologies are available under the MMP portfolio. The MMP portfolio includes several U.S. patents as well as their European and Japanese counterparts.patents. Some highlights of the patent portfolio are:
 
 US 5,809,336.5,809,336 (the “’336 patent”).  The ’336 patent covers an early and seminal approach to making microprocessor chips go faster. It allows the “core” of the microprocessor to run at a different speed (usually faster) than the rest of the chip. There are many advantages to this, including higher performance, lower power consumption, and simpler manufacturing.

 US 5,784,584.5,784,584 (the “’584 patent”).  The ’584 patent covers an important method for a microprocessor chip to fetch multiple instructions at once. Like speed reading, multiple-instruction fetch allows a chip to get more done in less time - a valuable technique.
 
4

 US 6,598,148.6,598,148 (the “’148 patent). The ’148 patent describes on-chip oscillators (clocks) and covers multi-core and multi-processor implementations - important factors in today’s high-end microprocessor chips.

Our Partners and Affiliates

Phoenix Digital Solutions, LLC. On June 7, 2005, we entered into a Master Agreement (the “Master Agreement”) with TPL,Technology Properties Limited, Inc. (“TPL”), and Charles H. Moore, an individual (“Moore” and together with us and TPL, the “Parties”). We, TPL and Moore were parties to certain lawsuits filed by us alleging infringement (the “Infringement Litigation”) of the seven U.S. patents issued dating back to 1989 on our Microprocessor Patentsmicroprocessor technology (the “Microprocessor Patents”) and a lawsuit also filed by us alleging claims for declaratory judgment for determination and correction of inventorship of the Microprocessor Patents (the “Inventorship Litigation”). The transactions described in the Master Agreement and related agreements (the “Transactions”) included the settlement or dismissal of the Inventorship Litigation.

Pursuant to the Master Agreement we agreed with TPL and Moore as follows:
 
 
We entered into a patent license agreement (the “Intel License”) with Intel Corporation (“Intel”) pursuant to which we licensed certain rights in the Microprocessor Patents to Intel.
  
We entered into an Escrow Agreement along with TPL (the “Escrow Agreement”) pursuant to which the proceeds arising from the Intel License were allocated for the benefit of us and TPL. Pursuant to the Escrow Agreement, the proceeds were allocable equally to PTSC and TPL.  Accordingly, when the initial capitalization obligations of PTSC and those of TPL with regard to PDS (defined below) were satisfied, and when our payment obligations and those of TPL with regard to the Rights Holders (defined below) were made, we received $6,672,349, and the remaining proceeds were allocated to or for the benefit of TPL.
  
We caused certain of our respective interests in the Microprocessor Patents to be licensed to PDS, a limited liability company owned 50% by us and 50% by TPL.

 
PDS engaged TPL to commercialize the Microprocessor Patents pursuant to a Commercialization Agreement among PDS, TPL and us (the “Commercialization Agreement”).

5


 We paid $1,327,651 and TPL paid $1,000,000 to certain holders of rights in the Microprocessor Patents (“Rights Holders”) in exchange for the release of such Rights Holders toin connection with the Transactions.
 We agreed with TPL and Moore to settle or cause to be dismissed all litigation involving the Microprocessor Patents, pursuant to a stipulated final judgment, including the Inventorship Litigation.

 We issued warrants to TPL which were exercised by TPL in September 2007, to acquire shares of our common stock.stock, $0.00001 par value (“Common Stock”). 1,400,000 warrants were exercisable upon issue; 700,000 warrants werebecame exercisable when our common stockCommon Stock traded at $0.50 per share; an additional 700,000 warrants werebecame exercisable when our common stockCommon Stock traded at $0.75 per share; and an additional 700,000 warrants werebecame exercisable when our common stockCommon Stock traded at $1.00 per share. Asshare, all such vesting having been achieved as of the date of this filing, all of the common stock trading prices have been met, causing TPL to be fully vested in all 3,500,000 of the above warrants.filing.
 
 We agreed with TPL and Moore to indemnify each other for, among other things, any inaccuracy or misrepresentation toin any representation or warranty contained in the Master Agreement, any breach of the Master Agreement, certain liabilities relating to the respective interests of each of us in the Microprocessor Patents and the Transactions, and certain tax liabilities.

Pursuant to the Commercialization Agreement, PDS granted to TPL the exclusive right to grant licenses and sub-licenses of the Microprocessor Patents and to pursue claims against violators of the Microprocessor Patents, in each case, on behalf of PDS, us, TPL and Moore, and TPL agreed to use reasonable best efforts to commercialize the Microprocessor Patents in accordance with a mutually agreed business plan. Pursuant to the Commercialization Agreement, PDS agreed to reimbursea reimbursement policy with regard to TPL’s expenses incurred in connection with the commercialization of the Microprocessor Patents. All proceeds generated by TPL in connection with the commercialization of the Microprocessor Patents will beare paid directly to PDS.  From the inception of the Commercialization Agreement to May 31, 20082011, gross license revenues to PDS totaled $230,161,956.$284,923,235.

5

Pursuant to the Master Agreement, we and TPL have entered into the Limited Liability Company Operating Agreement of PDS (“LLC Agreement”). We and TPL each own 50% of the membership interests of PDS, and each have the right to appoint one member of the not to exceed three (3) member management committee. The two (2) current appointees are required to select a mutually acceptable third member of the management committee. Pursuant to the LLC Agreement, we and TPL must each contribute to the working capital of PDS (in addition to the Microprocessor Patent licenses described above), and areat the discretion of PDS’ management committee we may be obligated to make future contributions in equal amounts in order to maintain a working capital fund. The LLC Agreement provides that PDS shall indemnify its members, managers, officers and employees, to the fullest extent permitted by applicable law, for any liabilities incurred as a result of their involvement with PDS, if the person seeking indemnification acted in good faith and in a manner reasonably believed to be in the best interest of PDS.

In April 2010, we filed actions against TPL in San Diego County for default on their note receivable with us and in Santa Clara County for breach of the Commercialization Agreement.  See Part 1, Item 3. “Legal Proceedings” in this Annual Report for more information.

Holocom, Inc. (formerly known as Scripps Secured Data, Inc.Inc). On March 27, 2007, we entered into a revolving line of credit with SSDI,Holocom, a company that manufactures products that protect information and data transmitted over secured networks. Previously, we maintained an unconsolidated equity investment in SSDI.Holocom. We determined that the line of credit transaction caused us to become the primary beneficiary under the Financial Accounting Standards Board’s (“FASB”) authoritative guidance in Interpretation No. 46for consolidation of variable interest entities and as amended (“FIN46(R)”), Consolidation of Variable Interest Entities. Under FIN46(R)such we arewere required to consolidate variable interest entities for which we are deemed to be the primary beneficiary.  On August 29, 2008 Holocom paid us $75,000, the remaining balance due on the line of credit and provided us notice effectively terminating the line of credit on August 29, 2008.

SSDI isDuring July 2008, Holocom obtained a credit facility for up to $300,000 from a third party, the credit facility term extended to May 1, 2009, and was guaranteed by us.  As a result of our guarantee on the third party credit facility, we maintained a variable interest in Holocom.  Upon expiration of the credit facility on May 1, 2009 we deconsolidated Holocom as we were no longer deemed to be the primary beneficiary.
6

Management has determined that the inability of Holocom to meet its business plan, raise capital, and the general economic environment are indicators of impairment on our investment.  Accordingly, at May 31, 2010, we wrote-off our investment in the preferred stock of Holocom, amounting to a $435,182 write-off.  We continue to hold 100% of the preferred stock in Holocom.

Holocom was an operating segment of our business. Referbusiness for the periods in which we were required to footnote 16 of our consolidated financial statements for disclosures about this operating segment.consolidate (March 27, 2007 through April 30, 2009).

Talis Data Systems, LLC.  On May 16, 2008 we acquired a 15.09% equity share in Talis, a company that producesproduced multi-domain computer and network security products for sale to government, military, and enterprise customers. customers. Talis developsdeveloped and marketsmarketed PCs incorporating its Datagent security device, a patented, hardware based data security solution that avoidsavoided the vulnerability of software–based approaches.

On August 1, 2008,Throughout fiscal 2009 and during the first quarter of fiscal 2010, we increased our equity investment in Talis to 37.4%39.4% as a result of purchasing additional sharesmembership units offered by Talis, as well as acquiring sharesmembership units from minority shareholdersmembers which included the acquisition of all Talis sharesmembership units previously held by SSDI.Holocom. The acquisition of Talis sharesmembership units previously owned by SSDIHolocom was made for $100,000 in cash and a reduction on their outstanding line of credit of $219,000.

The inability of Talis to meet its business plan, raise capital, and the general economic environment were indicators of impairment on our investment.  Accordingly at August 31, 2009, management determined that our investment in Talis was impaired by approximately $680,000.  During the third quarter of fiscal 2010 Talis was dissolved.

Avot Media, Inc.  Avot was an innovator of video transcoding and near real-time streaming to web-enabled mobile devices.  During the quarter ended August 31, 2008, we invested an aggregate of $1,300,000, including conversion of a note receivable in the amount of $250,000, to obtain 14,444,444 shares of Series B preferred stock issued by Avot, representing 53.3% of the Series B preferred stock and 37.1% of all Avot’s preferred shares issued and outstanding.  On March 12, 2009, we entered into a secured revolving loan note with Avot for $500,000.  The note bore interest at a rate of 8% and was due December 12, 2009.  During fiscal 2009 and 2010 we wrote-off our investment in Avot as management determined that our investment was impaired due to Avot’s inability to meet its business plan, to raise capital, and the general economic environment. During March 2010, Avot sold substantially all of its assets and we collected our $500,000 note.

Licenses, Patents, Trade Secrets and Other Proprietary Rights

We rely on a combination of patents, copyright and trademark laws, trade secrets, software security measures, license agreements and nondisclosure agreements to protect our proprietary technologies. Our policy is to seek the issuance of patents that we consider important to our business to protect inventions and technology that support our microprocessor technology.technology and other lines of business.

We have sevensix unexpired U.S. patents issued dating back to 1989 on our microprocessor technology (the “Microprocessor Patents”).technology. We have one unexpired microprocessor technology patent issued in fivetwo European countries and one unexpired patent issued in Japan. These patents in the U.S and overseas are currently set to expire between 2012 and 2016.  We may file additional applications under international treaties depending on an evaluation of the costs and anticipated benefits that may be obtained by expanding possible patent coverage. In addition, we have one U.S. patent issued on ground-penetrating radar technology and one U.S. patent issued on one of the communications products.

In addition to such factors as innovation, technological expertise and experienced personnel, we believe that a strong patent position is becoming increasingly important to compete effectively in the semiconductor industry. It may become necessary or desirable in the future for us to obtain patent and technology licenses from other companies relating to certain technology that may be employed in future products or processes. To date, we have not received notices of claimed infringement of patents based on our existing processes or products but, due to the nature of the industry, we may receive such claims in the future.

We have one U.S. patent on our ground-penetrating radar technology.technology, which is currently set to expire in 2011. No foreign application has been made. There are a large number of patents owned by others in the radar field generally and in the field of ground-penetrating radar specifically. Accordingly, although we are not aware of any possible infringement and have not received any notices of claimed infringement, we may receive such claims in the future.

67

In November, 2004, we filed a patent application for “Remote Power Charging of Electronic Devices”.

During fiscal 2009, we finalized an agreement with NuPower Semiconductor whereby we became co-assignees of a total of seven U.S. patents (five of which had issued and two of which had notices of allowance) related to power management for microprocessor based systems.  The agreement was effective until November 30, 2010.  The assignment was final in fiscal 2010 with the United States Patent and Trademark Office (“USPTO”) following the final issuance of the remaining two patents.  These patents are currently set to Patriot Scientific Corporation.expire between 2026 and 2029.

There can be no assurance that any patents will be issued from pending or future applications or that any patents that are issued will provide meaningful protection or other commercial advantages to us. Although we intend to protect our rights vigorously, there can be no assurance that these measures will be successful.

We generally require all of our employees and consultants, including our management, to sign a non-disclosure and invention assignment agreement upon employment with us.

MarketingResearch and DistributionDevelopment

We doDuring fiscal years 2011 and 2010, we incurred $753,017 and $1,503,724, respectively, of research and development expenses related to PDSG technologies.

Products and Services

The following technologies comprise the PDSG family of products:
Crossflo DataExchange® Our technology, Crossflo DataExchange® (“CDX”), was developed to exchange data between a customer’s application or database and an XML schema such as NIEM, Universal Core (U-CORE), CAP, GJXDM, or HL7. CDX can use any XML schema or even create a new schema specific to a customer’s needs. Whether the system is a source of data, a target for data, or both, it is “mapped” to the designated XML schema, and the subsequent exchange of data follows this common schema. This loosely coupled approach is easy to implement and maintain and can be accomplished with personnel who are not currently actively marketIT experts. Data exchange can begin in a matter of days or weeks, versus the microprocessor chipsmonths or even years that may be required using other solutions. Of particular significance is that this approach makes sharing data invisible to the end users by eliminating operational change and disturbance while utilizing existing infrastructure.
CDX is accessed via a web-based interface used to define publications (sources) and subscriptions (targets), and includes a powerful data-transformation mapper. The mapper offers an intuitive "drag and drop" interface, a rich set of transformation objects, and the ability to connect to web services. It also possesses powerful features for exporting data in the appropriate form to be used immediately by other applications including Geospatial Information System (GIS) programs, intelligence analysis programs, emergency management applications, and case management systems. Further, CDX handles complex schema constructs with ease and supports federated, scheduled, and triggered message exchanges.
CDX was designed and built using the latest standards-based technologies resulting in flexibility and cost savings. For example, because our Ignite product line, although we continuesoftware is written in JAVA/J2EE, it runs on virtually any platform and operating system. It incorporates Service Oriented Architecture and Web Services so it is easy to sellaccess and modify. CDX eliminates the need to make any changes to existing applications, procedures, and databases. Designed and developed in the US by US citizens with deep and targeted domain expertise, strong security measures have been integrated into the technology.
Information exchanges utilizing CDX can easily be implemented in a limited numberstaged manner in virtually any environment regardless of chips from our remaining inventory. future technological or infrastructure unknowns, enabling quick and early wins to build confidence and momentum. CDX provides a rapidly deployable, scalable, effective, and affordable means to enable the immediate sharing, integration, and/or aggregation of appropriate data assets across virtually all enterprises, platforms, vendors, and locations. In addition, CDX is compatible with other middleware products and can be implemented using an existing customer-provided Enterprise Service Bus (ESB).
8


In March 2010 a re-architected version of CDX was completed (CDX 4).  Significant additions include the CDX ExchangeBuilder, which is designed to generate National Information Exchange Model (NIEM) conforming Information Exchange Package Documents (IEPDs), significantly reducing the cost and time it takes to specify and deploy standards-based data exchanges.  CDX 4 includes the CDX Portal, a secure, end-user interface designed for justice personnel.  Built on the Global Federated Identity and Privilege Management (GFIPM) framework, the CDX Portal enables agencies to control and manage access to an exchange’s applications and data services. These data services can include federated queries of information residing in disparate data sources integrated by CDX, or services hosted by third party applications already owned by agencies.   The Crossflo DataExchange® is a fully integrated suite of tools, but customers can decide if and when they wish to add individual modules, so an affordable solution can be configured for each client’s specific needs. This will enable agencies of different sizes, with different resources, to choose between a tool such as CDX ExchangeBuilder to design IEPDs, a CDX DataExchange base package for a standard exchange, or a CDX DataExchange enterprise solution to enable large scale exchanges incorporating CDX Portal and multiple data services.

Sales and Marketing

All of ourPDSG’s sales for the fiscal years ended May 31, 2008, 20072011 and 20062010 were to domestic customers.customers with the exception of one CDX hosting arrangement with a customer in Japan.

PDSG markets its products and services to domestic federal, state, and local governmental agencies through direct contracts and via partnerships with prime contractors.

All of our operating assets are located within the United States. While sales to certain geographic areas generally vary from year to year, we do not expect that changes in the geographic composition of sales will materially affect our operations.

Business Development

We are in the process of evaluating investments in technologies, and acquisitions of companies, operating in the technology market sector. In March 2008 we hired a Vice-President of Business Development to work as part of the senior management team to identify investment and acquisition candidates.  In this area we are utilizing a multi-faceted approach, with a focus on i) selective expansion of our IP portfolio, ii) pursuit of strategic minority investments in certain early-stage revenue or technology ventures that represent a technology or capability of interest to us, and iii) full M&A transactions.

Dependence Upon Single Customers

Ten percent (10%) or more of our consolidated product saleslicense and service revenues were derived from shipmentssales to the following PDSG customers for the fiscal years ended May 31 as follows:

  2008  2007  2006 
Space and Naval Warfare Systems  -----   -----   $262,500 
Anixter  $1,354,494   $461,494   ----- 
Graybar Electric Company, Inc.  $889,724   -----   ----- 
Victory Global Solutions  $370,301   -----   ----- 
  2011  2010 
Customer A $136,229  $281,141 
Customer B  -  $106,064 
Customer C $81,642   - 
Customer D $151,323   - 

We had no backlog orders asAs of May 31, 2008, 2007 or 2006.2011 and 2010, our backlog is $834,485 and $268,103, respectively, which consists of revenues from contracts executed with customers which have yet to be recognized as of the applicable fiscal years then ended.

MostAll of our net incomeequity in the earnings of affiliates for the years ended May 31, 2008, 20072011 and 2006,2010 was attributable to our equity in the earnings of our unconsolidated affiliate, PDS.PDS, except for $21,707 in losses from our investment in Talis for the year ended May 31, 2010.

Government Regulation and Environmental Compliance

We believe our products are not subject to governmental regulation by any federal, state or local agencies that would materially affect the manufacture, sale or use of our products, other than occupational health and safety laws and labor laws which are generally applicable to most companies. We do not know what sort of regulations of this type may be imposed in the future, but we do not anticipate any unusual difficulties in complying with governmental regulations which may be adopted in the future.

We have not incurred any material costs associated with compliance with environmental laws and do not anticipate such laws will have any material effect on our future business.


7

Research and Development

We did not incur research and development expenditures for our fiscal years ended May 31, 2008 and 2007. We incurred research and development expenditures of $225,565 for our fiscal year ended May 31, 2006. The majority of these expenditures have been devoted to our microprocessor technology. As our primary business strategy has been to enforce our intellectual property patents through licensing, we are not currently making expenditures relating to research and development, although future research and development costs may be incurred as a result of our merger and acquisition activities.

Employees

We currentlyAt May 31, 2011, we have eighteen employees, five of which are Patriot Scientific Corporationtwelve employees. All Patriot employees are full time and are employed in general and administrative activities.time. We also engage additional consultants and part-time persons, as needed.
9


Our future success depends in significant part upon the continued services of our key technical and senior management personnel. The competition for highly qualified personnel is intense, and there can be no assurance that we will be able to retain our key managerial and technical employees or that we will be able to attract and retain additional highly qualified technical and managerial personnel in the future. None of our employees are represented by a labor union, and we consider our relations with our employees to be good. None of our employees are covered by key man life insurance policies.

Available Information

We file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission (“SEC”). Materials filed with the SEC can be read and copied at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet web site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. Our filings are available to the public at the website maintained by the SEC, http://www.sec.gov. We also make available, free of charge, through our web site at www.ptsc.com, our reports on Forms 10-K, 10-Q, and 8-K, and amendments to those reports, as soon as reasonably practicable after they are filed with or furnished to the SEC.  The information on, or that can be accessed through, our website is not part of this Annual Report.

ITEM 1A.             RISK FACTORS

We urge you to carefully consider the following discussion of risks as well as other information contained in this Form 10-K. We believe the following to be our most significant risk factors as of the date this report is being filed. The risks and uncertainties described below are not the only ones we face.

We Have Initiated Legal Proceedings Against Our Joint Venture Partner Which Could Adversely Affect Our Relationship With Them And Our Receipt Of Licensing Revenues.
Under our joint venture arrangement with TPL, TPL is responsible for the licensing and enforcement of our microprocessor patent portfolio.  In April 2010 we filed two actions against TPL (and with respect to one action, Alliacense, LLC) alleging breach of a $1 million promissory note issued to us by TPL and other causes of action.  Because we are wholly dependent on TPL to secure licensing revenues with respect to our microprocessor patent portfolio, which revenues have represented substantially all of our income since June 2005, the commencement of these adversarial proceedings against TPL has had, and will likely continue to have, an adverse affect on our continued relationship with TPL and its ability to effectively negotiate licenses or enforce our rights with respect to our microprocessor patent portfolio, which in turn has adversely affected, and is likely to continue to adversely affect our revenues and financial condition.  On January 19, 2011 upon receiving payment in full, we settled one of the actions regarding breach of the $1 million promissory note; however, the other action is still pending.  On August 3, 2011, we announced that protracted discussions with TPL had not resulted in settlement and that we intend to pursue a resolution through litigation.

We Have Reported SubstantialLicensing Income In 2008, 2007 and 2006Prior Fiscal Years Which May Not Be Indicative Of Our Future IncomeIncome.

During fiscal 2008, 2007 and 2006, weWe have entered into license agreements directly and through our joint venture with TPL.TPL and have reported licensing income as a result of this activity for the fiscal years 2006 to 2011. Because of the uncertain nature of the negotiations that lead to license revenues, pending litigation with companies which we allege have infringed on our patent portfolio, the possibility of legislative action regarding patent rights, petitionspotential adverse outcomes associated with the U. S. Patent and Trademark Office to re-examine certain(“USPTO”) re-examinations, our litigation with TPL, the litigation initiated by an inventor of our patents,the microprocessor portfolio with TPL, and the possible effect of new judicial interpretationinterpretations of patent laws, we cannot predict the amount of futuremay not receive revenues from such agreements or whether there will bein the future consistent with amounts received in the past, and we may not receive future revenues from license agreements at all.

Our Joint Venture Is At Risk For Going Concern.

PDS, our joint venture with TPL, has experienced significant declines in revenues while at the same time incurring significant legal costs associated with pending litigation with companies which we allege have infringed on our patent portfolio.  Currently, there are no commitments by us or TPL to provide additional working capital to PDS.  PDS has cash resources available to continue as a going concern at least through September 30, 2011.

10


We Are Dependent Upon A Joint Venture In Which We AreOur Role Is Of A Passive PartnerNature For Substantially All Of Our IncomeIncome.

In June of 2005, we entered into a joint venture with TPL, pursuant to which TPL is responsible for the licensing and enforcement of our microprocessor patent portfolio. This joint venture has been the source of virtuallysubstantially all of our income since June of 2005. Therefore, in light of the absence of significant revenue from other sources, we should be regarded as entirely dependent on the success or failure of the licensing and prosecution efforts of TPL on behalf of the joint venture. Sales of our microprocessor products and data security products have resulted in limited revenues. Our microprocessor product lines are no longer being actively marketed, and only generate limited and sporadic sales.

We May Not Be Successful In Identifying Acquisition Candidates And If We Undertake Acquisitions, They Could Increase Our Costs Or Liabilities And Impair Our Revenue And Operating Results.
One of our strategies is to pursue growth through acquisitions. We may not be able to identify suitable acquisition candidates at prices that we consider appropriate. If we do identify an appropriate acquisition candidate, we may not be able to successfully negotiate the terms of the acquisition or finance the acquisition on terms that are satisfactory to us. Negotiations of potential acquisitionsventure, and the integrationability of acquired business operations could disrupt our businessTPL to obtain capital when necessary to fund its operations.  In December 2009 and January 2010, we provided operational funding by diverting management attentionloaning TPL $950,000 and $1,000,000, respectively.  The $1,000,000 note which was due to be repaid by February 28, 2010 went into default; however, on January 19, 2011 we received $1,098, 903 consisting of principal and accrued interest in settlement of this note.  On July 15, 2010, we received $1,003,095 from day-to-day operations. Acquisitions of businesses or other material operations may require debt or equity financing, resulting in leverage or dilution of ownership. We may encounter increased competitionPDS for acquisitions, which may increasepayment on the price of our acquisitions.
8

Integration of acquisitions requires significant management time and financial resources. Any failure to properly integrate and manage businesses we acquire could seriously harm our operating results. In addition, acquired companies may not perform as well as we expect, and we may fail to realize anticipated benefits. In connection with acquisitions, we may issue common stock that would dilute our current stockholders’ ownership and incur debt and other costs which may cause our quarterly operating results to vary significantly. The dilution of our current stockholders’ ownership may be exacerbated if our per share stock price is depressed and common stock is$950,000 note issued in connection with acquisitions.
If we are unable to successfully integrate companies we may acquire, our revenue and operating results could suffer. The integration of such businesses into our operations may result in unforeseen operating difficulties, may absorb significant management attention and may require significant financial resources that would otherwise be available for other business purposes. These difficulties of integration may require us to coordinate geographically dispersed organizations, integrate personnel with disparate business backgrounds and reconcile different corporate cultures. In addition, we may not be successful in achieving anticipated synergies from these acquisitions.December 2009 plus accrued interest. We may experience increased attrition, including, but not limited to, key employees of the acquired companies, during and following the integration of acquired companies that could reduce our future revenue.
In addition, we may need to record write-downs from future impairments of identified intangible assets and goodwill, which could reduce our future reported earnings. Acquired companies may have liabilities or adverse operating issues that we fail to discover through due diligence prior to the acquisition. In particular, to the extent that prior owners of any acquired businesses or properties failed to comply with or otherwise violated applicable laws or regulations, or failed to fulfill their contractual obligations to their customers or clients, we, as the successor owner, may be financially responsible for these violations and failures and may suffer reputational harm or otherwise be adversely affected. The discovery of any material liabilities associated with our acquisitions could cause us to incur additional expenses and cause a reduction in our operating profits.

Changes In Our Relationships With Companies In Which We Hold Less Than A Majority Interest Could Change The Way We Account For Such Interests In The Future.

We hold a minority interest in SSDI to which we provide financing. Under the applicable provisions of accounting principles generally accepted in the United States of America, including FIN 46(R), we currently consolidate the financial statements and results of operations of this company into our consolidated financial statements and results of operations, and record the equity interest that we do not own as a minority interest. For ouranticipate making additional loans to TPL, and its ability to access liquidity from other investments (PDS and Talis) accounted for under the equity method, we record as part of other income or expense our share of the increase or decrease in the equity of these companies in which we have invested. Itsources is possible that, in the future, our relationships and/or our interests in or with this consolidated entity and equity method investees could change. Such potential future changes could result in deconsolidation or consolidation of such entities, as the case may be, which could result in changes in our reported results.not certain.

A Successful Challenge To Our Intellectual Property Rights WouldCould Have A Significant And Adverse Effect On UsUs.

A successful challenge to our ownership of our technology or the proprietary nature of our intellectual property wouldcould materially damage our business prospects. We rely on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. WeWith respect to our core technologies, we currently have seven U.S. patents, one European patent, and one Japanese patent issued. Any issued patent may be challenged and invalidated. Patents may not be issued for any of our pending applications. Any claims allowed from existing or pending patents may not be of sufficient scope or strength to provide significant protection for our products. Patents may not be issued in all countries where our products can be sold so as to provide meaningful protection or any commercial advantage to us. Our competitors may also be able to design around our patents.

Vigorous protection and pursuit of intellectual property rights or positions characterize the fiercely competitive semiconductor industry, which has resulted in significant and often protracted and expensive litigation. Therefore, our competitors and others may assert that our technologies or products infringe on their patents or proprietary rights. Persons we believe are infringing our patents are likely to vigorously defend their actions and assert that our patents are invalid. Problems with patents or other rights could result in significant costs, limit future license revenue, and impair or hinder our acquisition strategy. If infringement claims against us are deemed valid or if our infringement claims are successfully opposed, we may not be able to obtain appropriate licenses on acceptable terms or at all. Litigation could be costly and time-consuming but may be necessary to protect our future patent and/or technology license positions or to defend against infringement claims.  PartiesFrom time to time parties have petitioned the U. S. Patent and Trademark OfficeUSPTO to re-examine certain of our patents. An adverse decision in litigation or in the re-examination process wouldcould have a very significant and adverse effect on our business.
On December 18, 2007 we announced that a resolution was reached in two patent infringement lawsuits in the U.S. District Courts in the Eastern District of Texas and the Northern District of California.  There are no assurances that the resolution will favorably impact, or that it will not impair, our ability to assert our technology rights in the future.

9

During the quarter ended February 29, 2008, we wereWe have been named as co-defendants in three separatemultiple lawsuits regarding the MMP Portfolio.  See footnote 1514 to our consolidated financial statements and Part I, Item 3. Legal Proceedings“Legal Proceedings” in this Report on Form 10-K.10-K for more information.

Our Wholly-Owned Subsidiary Cannot Operate Without Our Continued Support.

Since the acquisition of our wholly-owned subsidiary PDSG in September 2008, we have provided 100% of PDSG’s operational funding amounting to approximately $8,200,000 through May 31, 2011.  After restructuring measures initiated in October 2009 and continued through 2010, PDSG continues to remain unable to generate sufficient revenues to support its operations and remains entirely dependent on our funding.  Should a sale of PDSG occur, it may be on distressed terms with only minimal consideration realized.

Disruptions In The Debt And Equity Markets Will Have An Adverse Affect On Our Ability To Obtain Funding.

The debt and equity markets have been experiencing volatility and disruption for several years.  These issues, along with significant write-offs in the financial services sector, the re-pricing of credit risk, and the current weak economic conditions have made, and will likely continue to make, it difficult to obtain funding.  The cost of accessing the credit markets has increased as many lenders and institutional investors have increased interest rates, enacted tighter lending standards, and reduced or ceased to provide funding to borrowers.  Adverse changes in the economy could limit our ability to obtain financing from debt or equity sources or could adversely affect the terms on which we may be able to obtain any such financing for our operating activities See Part II – Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources-Liquidity.” in this report on Form 10-K for more information.

11


Unstable Market And Economic Conditions May Have Serious Adverse Consequences On Our Business.

Our general business strategy may be adversely affected by the economic downturn and volatile business environment and continued unpredictable and unstable market conditions. A prolonged or profound economic downturn may result in adverse changes to our sales and pricing, which would harm our operating results. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon development plans. There is also a possibility that our stock price may decline further, due in part to the volatility of the stock market and the general economic downturn.

Changes In Our Relationships With Companies In Which We Hold Less Than A Majority Interest Could Change The Way We Account For Such Interests In The Future.

For our investment accounted for under the equity method (PDS), we record as part of other income or expense our share of the increase or decrease in the equity of this company in which we have invested.  Prior to the impairment, we accounted for our investment in Holocom on the cost basis.  It is possible that, in the future, our relationships and/or our interests in or with this equity method investee and our cost basis investee could change. Such potential future changes could result in deconsolidation or consolidation of such entities, as the case may be, which could result in changes in our reported results.

Exercise Of Options May Have A Substantial Dilutive Effect On Our Common Stock.

If the current per share market price of our Common Stock at the time of exercise of any stock options is in excess of the various exercise prices of such securities, exercise of such securities would have a dilutive effect on our Common Stock. As of May 31, 2011, holders of our outstanding exercisable options would receive 2,792,612 shares of our Common Stock, absent any cashless exercise, at a weighted average exercise price of $0.34 per share. Any additional financing that we secure likely will require that we grant rights senior to those of our Common Stock which may result in substantial dilution of the existing ownership interests of our common stockholders.

We May Issue Preferred Stock, And The Terms Of Such Preferred Stock May Reduce The Value Of Our Common Stock.

We are authorized to issue up to a total of 5,000,000 shares of preferred stock in one or more series. Our Board of Directors may determine whether to issue shares of preferred stock without further action by holders of our Common Stock. If we issue shares of preferred stock, it could affect the rights or reduce the value of our Common Stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with or sell our assets to a third party. These terms may include voting rights, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions. We continue to seek capital for our business, and this additional capital may be raised through the issuance of additional preferred stock.

If A Large Number Of Our Shares Are Sold All At Once Or In Blocks, The Market Price Of Our Shares Would Most Likely DeclineMostLikely Decline.

Shareholders who acquired common stock through the exercise of warrantsOur shareholders are not restricted in the price at which they can sell their shares. Shares sold at a price below the current market price at which the common stockour Common Stock is trading may cause the market price of our Common Stock to decline.

A Significant Portion Of Our Investments Are Currently Illiquid Which May Impact Our Acquisition Strategy And/Or Operating Results

Our long-term investment in marketable securities balance consists of auction rate securities with a par value of $12.9 million, which at present are highly illiquid. In the event we need immediate access to these funds, we will not be able to sell these investments at par value. These instruments are expected to remain illiquid until a future auction of these investments is successful, buyers are found outside of the auction process, or they are redeemed by the issuing agencies. We have partially offset the consequences of this illiquidity by securing a line of credit collateralized by the auction rates securities. In the event these securities are deemed to be permanently impaired, we will be required to take a charge to operations in recognition of this impairment.

The Market For Our Stock Is Subject To Rules Relating To Low-Priced Stock (“Penny Stock”) Which May Limit Our Ability To Raise CapitalCapital.

Our common stockCommon Stock is currently listed for trading in the National Association of Securities Dealers (“NASD”) Over-The-Counter Bulletin (“OTC”) Board MarketOTCQB operated by OTC Markets, Inc. and is subject to the “penny stock rules” adopted pursuant to Section 15(g) of the Exchange Act. In general, the penny stock rules apply to non-NASDAQ or non-national stock exchange companies whose common stock trades at less than $5.00 per share or which have tangible net worth of less than $5,000,000 ($2,000,000 if the company has been operating for three or more years). Such rules require, among other things, that brokers who trade “penny stock” on behalf of persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document, quote information, broker’s commission information and rights and remedies available to investors in penny stocks. Many brokers have decided not to trade “penny stock” because of the requirements of the penny stock rules, and as a result, the number of broker-dealers willing to act as market makers in such securities is limited. The “penny stock rules,” therefore, may have an adverse impact on the market for our common stockCommon Stock and may affect our ability to raise additional capital if we decide to do so.

12

Our Share Price Could Decline As A Result Of Short Sales
Sales.
When an investor sells stock that he does not own, it is known as a short sale. The seller, anticipating that the price of the stock will go down, intends to buy stock to cover his sale at a later date. If the price of the stock goes down, the seller will profit to the extent of the difference between the price at which he originally sold it less his later purchase price. Short sales enable the seller to profit in a down market. Short sales could place significant downward pressure on the price of our common stock.Common Stock. Penny stocks which do not trade on an exchange, such as our common stock,Common Stock, are particularly susceptible to short sales.

Our Future Success Depends In Significant Part Upon The Continued Services Of Our Key Senior ManagementManagement.

Our future success depends in significant part upon the continued services of our key senior management personnel. The competition for highly qualified personnel is intense, and we may not be able to retain our key managerial employees or attract and retain additional highly qualified technical and managerial personnel in the future. None of our employees are represented by a labor union, and we consider our relations with our employees to be good. None of our employees are covered by key man life insurance policies.policies

10

ITEM 1B.             UNRESOLVED STAFF COMMENTS

None.

ITEM 2.                PROPERTIES

We have one 3,289currently lease 1,371 square footfeet of office space located at 6183 Paseo Del Norte,701 Palomar Airport Road, Suite 180,170, Carlsbad, California. The facility is leased under a non-cancelable lease expires December 31, 2012.

PDSG currently subleases offices located at 11260 El Camino Real, Suites 100 (3,676 square feet) and 102 (2,592 square feet), San Diego, California.  These facilities are subleased through February 2009. December 2011.

The current floor space provides adequate and suitable facilities for all of our corporate functions.

SSDI has one 3,364 square foot office located at 2386 Faraday Avenue, Suite 200, Carlsbad, California. The facility is subleased from an unrelated party with a month-to-month option until no later than December 2008.

SSDI maintains one 16,500 square foot warehouse facility in Anaheim, California. The warehouse is leased under a cancelable lease until November 2009.

SSDI subleases office space in San Diego, CA under a lease agreement expiring in August 2008.

ITEM 3.                LEGAL PROCEEDINGS

Litigation

Patent Litigation

On February 8, 2008, the Company,we, TPL and Alliacense Ltd. were named as defendants in three separate lawsuits filed in the United States District Court for the Northern District of California by Asustek Computer, Inc., HTC Corporation, and Acer, Inc., and affiliated entities of each of them. On February 13, 2008, the Asustek claims were amended to include claims against MCM Portfolio, LLC (Alliacense and MCM Portfolio are TPL-related entities), which do not involve the Company.

The AsustekAcer case seeks declaratory relief that its products do not infringe enforceable claims of ourthe '336, '584‘749, '148 patents and '749 patents.  The Asustek case also seeks a similar declaration with respect to two patents owned by TPL that are not a part of the MMP Portfolio, and as such the Company is not engaged in this aspect of the litigation and defense.  The Acer case seeks declaratory relief that its products do not infringe enforceable claims of our '336, '584 and '749 patents.US 5,530,890 (the “890 patent”). The HTCcase similarly seeks declaratory relief that its products do not infringe enforceable claims of those threepatents.  We allege counterclaims for patent infringement of the '336, '749, '148 and '890 patents against Acer and our '148 patent.HTC.  On June 16, 2009, District Court Judge Jeremy Fogel stayed the HTC and Acer actions until September 18, 2009.  The stay has been lifted and the cases are in the discovery and claims construction phase.  A claims construction hearing is expected to be scheduled in late 2011.

On April 25,December 1, 2008, the Companywe, TPL and TPLAlliacense, Ltd. were named as defendants in a lawsuit filed five patent infringement lawsuits in the EasternUnited States District of Texas against HTC, Acer and Asustek.  These suits allege infringement by HTC and Acer with respect to our '336 '749 '584 and '148 patents; and by Asustek with respect to our '336, '749 and '584 patents.  On June 4, 2008, the Company and TPL filed patent infringement lawsuits against those parties in the Eastern District of Texas with respect to our '890 patent of the MMP Portfolio.  Motions to dismiss or transferCourt for the Northern District of California actionsby Barco, N.V.  The Barco case seeks declaratory relief that its products do not infringe enforceable claims of the '749 and '890 patents.  We allege counterclaims for patent infringement of our '749, '890 and '336 patents.  On June 22, 2009, Judge Fogel also stayed the Barco case until September 18, 2009.  That stay has been lifted and the case is deemed related to the Eastern District of Texas are currently pending with hearings set for August 29, 2008Acer and HTC cases.  The case is now in the Acer casediscovery and September 19, 2008claims construction phase.  Barco moved for the HTC and Asustek cases.  At that point we expect to learn where the T-3 (“Acer, Asustek and HTC”) litigation will proceed.  Responsive pleadings in those cases are due at varying times in mid-August and early September 2008.  Similar to the actions in the Northern District of California, the Asustek action in the Eastern District of Texas is inclusive of mattersSummary Judgment with respect to twoallegations that it has infringed on the '336 patent on grounds independent of claims construction.  That Motion was denied on February 25, 2011.  A claims construction hearing is expected to be scheduled in late 2011.

13


Crossflo Systems, Inc. Litigation

Under the terms of our Agreement and Plan of Merger (the "Merger Agreement") with Crossflo, and certain of its principal officers, an escrow account was established to hold back approximately 10% of the merger consideration payable to the shareholders of Crossflo (the "Escrow Merger Consideration").  We contend that certain representations and warranties made by Crossflo and certain of its principal officers in the Merger Agreement were false when made, and were false as of the closing of the merger.  We submitted a demand to the escrow agent on August 31, 2009 not to release the Escrow Merger Consideration to the Crossflo shareholders and to instead return it to us.  A sufficient number of Crossflo shareholders have opposed our demand that the escrow consideration has not been released to either side.

On August 31, 2009, we initiated an arbitration proceeding before the American Arbitration Association against the three Crossflo principal officers who were signatories to the Merger Agreement alleging they provided false representations and warranties in the Merger Agreement and alleging nondisclosure of information about Crossflo during the due diligence process leading up to the merger.  Those three principal officers deny our claims and have filed counterclaims.  The arbitration is scheduled to begin November 8, 2011.

TPL Litigation

On April 22, 2010, we filed an action against TPL and Alliacense LLC in Santa Clara Superior Court alleging claims for breach of contract, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and interference with contract, constructive fraud, for preliminary and permanent injunctions and for an accounting.  The Action stemmed from TPL's notification of a license written in April 2010 which included a license of the MMP patents and other patent to use portfolios and technologies co-owned and potentially owned by TPL that are notin the future.  We objected to the amount of license consideration allocated to the MMP patent license as too low relative to the other license components.

On April 26, 2010, the Court granted our application for a partTemporary Restraining Order ("TRO") precluding TPL from executing any license of the MMP Portfolio,patents without providing us five business days' notice of the proposed MMP license and as suchany other proposed license with the licensor, in order to allow us time to seek redress if we are not engaged in this aspectdissatisfied by the proposed licenses.  At that time, TPL filed motions to seal the file and to bar press releases commenting on the contents of the litigationcourt file, and defense.
ITEM 4.            SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERSa motion to compel private arbitration of the dispute.

None.TPL stipulated on August 3, 2010 that the TRO already in place would become a Preliminary Injunction.  On August 12, 2010, the Court considered defendants’ request to seal the file indefinitely and to compel private arbitration of the dispute and denied both Motions.  On September 30, 2010, the Court agreed to redaction of the court file at TPL’s request for commercially sensitive data such as dollar amounts of licenses, percentage allocation to MMP licenses and other such confidential data.  TPL has appealed the denial of its Motion to Compel Arbitration which appeal stays the Superior Court proceeding.  The appeal is in the briefing stage and expected to be decided in late 2011 or early 2012.  If the Appeal is unsuccessful then the Superior Court action will be activated.  If it is successful, some or all of the case would proceed to arbitration.

11

ITEM 4.REMOVED AND RESERVED
 
PART II

ITEM 5.       
ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stockCommon Stock is tradedcurrently listed for trading in the over-the-counter market and is quoted on the NASDOTCQB operated by OTC Bulletin Board system maintained by the National Association of Securities Dealers,Markets, Inc. under the symbol PTSC.  Prices reported represent prices between dealers, do not include markups, markdowns or commissions and do not necessarily represent actual transactions. The market for our shares has been sporadic and at times very limited.

14

The following table sets forth the high and low closing bid quotations for our common stockCommon Stock for the fiscal years ended May 31, 20082011 and 2007.2010.

  BID QUOTATIONS
  HIGHLOW
 Fiscal Year Ended May 31, 2008  
 First Quarter$0.59$0.45
 Second Quarter$0.62$0.38
 Third Quarter$0.80$0.36
 Fourth Quarter$0.59$0.27
    
 Fiscal Year Ended May 31, 2007  
 First Quarter$1.37$0.79
 Second Quarter$1.18$0.61
 Third Quarter$0.77$0.46
 Fourth Quarter$0.70$0.45
   BID QUOTATIONS
  HIGHLOW
 Fiscal Year Ended May 31, 2011  
 First Quarter$0.21$0.08
 Second Quarter$0.14$0.09
 Third Quarter$0.14$0.08
 Fourth Quarter$0.13$0.08
    
  HIGHLOW
 Fiscal Year Ended May 31, 2010  
 First Quarter$0.18$0.11
 Second Quarter$0.36$0.14
 Third Quarter$0.19$0.12
 Fourth Quarter$0.15$0.09

On August 8, 200812, 2011 the closing price of our stock was $0.28$0.06 and we had approximately 601 shareholders690 stockholders of record. Because most of our common stockCommon Stock is held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial owners represented by these record holders.

Dividend Policy

During the fiscal year ended May 31, 2006, we paid a $0.02 per common share dividend on March 22, 2006 and paid a $0.04 per common share dividend on April 24, 2006. During the fiscal year ended May 31, 2007 we paid a $0.02 per common share dividend on April 9, 2007.  We paid no dividends during the fiscal year ended May 31, 2008. On February 22, 2007, our Board of Directors adopted a semi-annual dividend payment policy, subject to determination by our Board of Directors in light of our financial condition, other possible applications of our available resources, and relevant business considerations.  We paid no dividends during the fiscal years ended May 31, 2011 and 2010.

Equity Compensation Plan Information

Our stockholders previously approved each of the Company’s 1992, 1996, 2001,our 2003 and 2006 Stock Option Plans. The following table sets forth certain information concerning aggregate stock options authorized for issuance under our 1996, 2001, 2003 and 2006 Stock Option Plans as of May 31, 2008.2011. For a narrative description of the material features of the plans, refer to footnote 1312 of our consolidated financial statements.

On March 11, 2008, we amended
 
Plan Category
 
Number of securities
to be issued
upon exercise of outstanding
options
  
Weighted-average
exercise price of outstanding
options
  Number of securities remaining available for future issuance under equity compensation plans 
Equity compensation plans approved by security holders  3,010,000  $0.33   10,703,404 

The number of securities available for future issuance under our stock option plans is as follows at May 31, 2011: 2003 Stock Option Plan 3,473,404 shares, 2006 Stock Option Plan to increase the total number of shares of our common stock issuable under the plan from 5,000,000 to 7,000,000.  Shareholders will be asked to ratify the amendment to the plan at our next annual meeting.

12

Shares of common stock issuable on the exercise of warrants have not been approved by our stockholders. This item has been segregated in the table below under the item “Equity compensation plan not approved by security holders”.

 
Plan Category
 
Number of securities
to be issued
upon exercise of outstanding
options and warrants
  
Weighted-average
exercise price of outstanding
options and warrants
  Number of securities remaining available for future issuance under equity compensation plans 
Equity compensation plans approved by security holders  8,195,000  $0.44   3,352,404 
Equity compensation plan not approved by security holders  300,000  $0.57    
Total  8,495,000       3,352,404 
7,230,000 shares.

Recent Sale of Unregistered Securities
None.
Unless otherwise noted, the issuance noted below is considered exempt from registration by reason on Section 4(2) of the Securities Act of 1933, as amended.

15
The exercise listed below was performed on a cashless basis. By exercising on a cashless basis, the warrant holder authorizes us to withhold from issuance shares of common stock that would otherwise be issuable upon exercise of the warrant which when multiplied by the market price of the common stock as of the date of exercise is equal to the aggregate exercise price. The market price, as defined in the warrant, is the average closing price of our common stock during the 5 trading days prior to the date of exercise, less the exercise price of the warrant, this product is then divided by the 5 day average closing price and the result is multiplied by the number of shares in the warrant to arrive at the net number of shares to issue.

On May 1, 2008 warrants to purchase 200,000 shares of our common stock at an exercise price of $0.06 were exercised by an investor on a cashless basis. The number of shares of common stock that would otherwise have been issuable upon the exercise of such warrants was reduced by 34,286, an aggregate value of $28,408, based on the average closing price of our common stock during the 5 trading days prior to date of exercise of $0.35. Accordingly, we issued 165,714 shares of our common stock upon the exercise.

Issuer Purchases of Equity Securities

On April 28, 2006 our Board of Directors authorized a stock repurchase program. We commenced the program in July 2006 and plan to repurchase outstanding shares of our common stockCommon Stock on the open market from time to time. We repurchased common stockCommon Stock during the fourth quarter of fiscal year 20082011 using available cash resources as follows:
 
Period
Total
Number of
Shares
Purchased
 
Average
Price Paid
per Share
 
Total Number of
Shares Purchased as Part of
Publicly
Announced Plans or Programs 
March 1 - 31, 2008- $- -
April 1 - 30, 20081,829,200 $0.37 1,829,200
May 1 - 31, 2008568,700 $0.32 568,700
Total2,397,900 $0.35 2,397,900

Period 
Total
Number of
Shares
Purchased
  
Average
Price Paid
per Share
  
Total Number of
Shares Purchased as
Part of Publicly Announced Plans or Programs
 
March 1 - 31, 2011  -  $-   - 
April 1 - 30, 2011  127,598  $0.10   127,598 
May 1 - 31, 2011  138,385  $0.09   138,385 
Total  265,983  $0.09   265,983 
The repurchase plan has no maximum number of shares and is solely at the discretion of the Board of Directors. The repurchase plan has no set expiration date.

13

ITEM 6.          SELECTED FINANCIAL DATA

The selected consolidated financial data set forth below for the fiscal years ended May 31, 2008, 2007 and 2006, is derived from our audited consolidated financial statements included elsewhere in this report. This information should be read in conjunction with those consolidated financial statements, the notes thereto, and with the section herein entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The selected consolidated financial data set forth below for the fiscal years ended May 31, 2005 and 2004, are derived from our audited consolidated financial statements that are contained in reports previously filed with the Securities and Exchange Commission, not included herein. There are no accounting changes, business combinations or dispositions of business operations, other than the consolidation of SSDI for the fiscal years ended May 31, 2008 and 2007 and the inclusion of Talis in the equity in earnings of affiliated companies for the fiscal year ended May 31, 2008, that materially affect the comparability of the information provided in the charts below.

Summary Consolidated Financial Information
  Fiscal Years Ended May 31, 
Statement of operations data: 2008  2007  2006  2005  2004 
  
Net sales $3,708,218  $638,784  $10,309,709  $2,982,586  $76,417 
Operating income (loss) $(5,603,493) $(14,763,839 $3,911,640  $87,421  $(1,737,370)
Equity in earnings of affiliated companies $19,917,769  $48,965,084  $27,848,363  $  $ 
Net income (loss) $9,388,321  $23,691,187  $28,672,688  $(10,518,704) $(5,760,883)
Basic income (loss) per common share $0.02  $0.06  $0.09  $(0.05) $(0.04)
Diluted income (loss) per common share $0.02  $0.06  $0.07  $(0.05) $(0.04)
Weighted average number of common shares outstanding - basic  390,956,153   378,036,989   316,100,499   222,495,047   139,767,276 
Weighted average number of common shares outstanding - diluted  397,485,699   413,599,373   412,963,173   222,495,047   139,767,276 
Cash dividends declared and paid per share $  $0.02  $0.06  $  $ 


  May 31, 
Balance sheet data: 2008  2007  2006  2005  2004 
  
Cash and cash equivalents $6,424,015  $21,605,428  $3,984,240  $591,426  $355,940 
Total assets $25,431,902  $34,414,629  $12,071,667  $3,724,034  $926,228 
Long-term obligations $1,085,181  $12,222,944  $-  $9,320,654  $6,102,669 
Total liabilities $2,014,719  $14,243,738  $1,244,116  $10,964,418  $6,650,711 
Stockholders’ equity (deficit) $23,301,777  $20,170,891  $10,827,551  $(7,240,384) $(5,724,483)


14

  Fiscal Quarters Ended 
Quarterly statement of operations data for August 31,  November 30,  February 29,  May 31, 
fiscal 2008 (Unaudited): 2007  2007  2008  2008 
Net sales $521,369  $945,830  $801,284  $1,439,735 
Gross profit $369,834  $589,492  $456,200  $782,242 
Net income (loss) $(1,962,386) $2,416,536  $6,292,185  $2,641,986 
Basic income (loss) per common share $( 0.01) $0.01  $0.02  $0.01 
Diluted income (loss) per common share $(0.01) $0.01  $0.02  $0.01 
Weighted average number of common shares outstanding - basic  390,455,132   391,245,755   391,472,101   390,660,391 
Weighted average number of common shares outstanding - diluted  390,455,132   392,627,522   395,666,621   391,717,950 
                 
Cash dividends declared and paid per share $-  $-  $-  $- 
  
 Fiscal Quarters Ended
 
Quarterly statement of operations data for  
August 31, 
  
November 30, 
  
February 28, 
  
May 31, 
 
fiscal 2007 (Unaudited): 
2006
  
2006
  
2007 
  
2007 
 
Net sales $26,375  $18,500  $22,175  $571,734 
Gross profit $26,375  $18,500  $22,175  $252,360 
Net income (loss) $5,990,273  $(1,881,998) $9,617,559  $9,965,353 
Basic income per common share $0.02  $  $0.03  $0.03 
Diluted income per common share $0.01  $  $0.02  $0.02 
Weighted average number of common shares outstanding - basic  368,837,051   378,817,682   381,031,577   387,903,643 
Weighted average number of common shares outstanding - diluted  420,646,769   378,817,682   410,747,949   407,392,062 
Cash dividends declared and paid per share $  $  $0.02  $ 


ITEM 7.                MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THIS ANNUAL REPORT ON FORM 10-K CONTAINS FORWARD-LOOKING STATEMENTS CONCERNING FUTURE EVENTS AND PERFORMANCE OF OUR COMPANY. YOU SHOULD NOT RELY ON THESE FORWARD-LOOKING STATEMENTS, BECAUSE THEY ARE ONLY PREDICTIONS BASED ON OUR CURRENT EXPECTATIONS AND ASSUMPTIONS. MANY FACTORS COULD CAUSE OUR ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE INDICATED IN THESE FORWARD-LOOKING STATEMENTS. YOU SHOULD REVIEW CAREFULLY THE RISK FACTORS IDENTIFIED IN THIS REPORT AS SET FORTH BELOW AND UNDER THE CAPTION “RISK FACTORS.” WE DISCLAIM ANY INTENT TO UPDATE ANY FORWARD-LOOKING STATEMENTS TO REFLECT SUBSEQUENT ACTUAL EVENTS OR DEVELOPMENTS.

Overview

In June 2005, we entered into a series of agreements with TPL and others to facilitate the pursuit of infringersunlicensed users of our intellectual property. We intend to continue our joint venture with TPL to pursue license agreements with infringersunlicensed users of our technology. We believe that utilizing the option of working through TPL, as compared to creating and using a Companyour own licensing team for those activities, avoids a competitive devaluation of our principal assets and is a prudent way to achieve the desired results as we seek to obtain fair value from users of our intellectual property.  In April 2010, we filed an action against TPL regarding TPL’s management of the MMP portfolio.  On August 3, 2011 we issued a press release stating that we cannot come to a settlement with TPL in this matter and are pursuing litigation.

WithDuring fiscal 2010 and through the proceeds generated by these licensing efforts,date of this filing we are undertakingand TPL each contributed $580,000 to make investments in technologies, and acquisitionsfund the working capital of companies operatingPDS.  We expect the contributions to continue in the electronics technology market sectorfuture due to the working capital demands of PDS.  Additionally, we have loaned TPL an aggregate of $1,950,000, evidenced by waya secured note in the principal amount of i) selective expansion$950,000 and an unsecured note in the principal amount of $1,000,000 intended to cover its operating costs including the furtherance of licensing our MMP Portfolio of microprocessor patents.  At February 28, 2010, we reserved $1,013,151 against the unsecured $1,000,000 note receivable which includes accrued interest.  In April 2010, we filed suit against TPL for breach of contract regarding the $1,000,000 note non-payment.  On July 15, 2010, we received $1,003,095 consisting of principal and accrued interest through July 15, 2010 on the $950,000 secured note.  In January 2011, we settled the breach of contract action with respect to the $1,000,000 note and we received $1,098,903 consisting of principal and accrued interest on the unsecured note.

On October 5, 2009, we announced a reorganization of PDSG and our management.  On January 25, 2010, we sold the Iameter assets and during August 2010, we sold the Vigilys business line.  As a result of our IP portfolio, ii) pursuitreorganization and PDSG’s continued inability to meet its business plan, we have incurred impairment charges for our intangibles and goodwill in the PDSG segment of strategic minority investments in certain early-stage revenue or technology ventures that represent a technology or capabilityour business.  We continue to fund the day to day operating costs of interestPDSG while continuing to us,reduce expenses.  Our merger and iii) full M&A transactions.acquisition activities have ceased since our October 2009 reorganization.

1516


Cash shortfalls and liquidity issues currently experienced by PDS and TPL, and continued negative cash flows incurred by PDSG, will have an adverse effect on our liquidity.  Accordingly, we have and may continue to examine alternatives that could allow for the partnering or divestiture of PDSG.  If successful, these measures may provide for a further reduction in expenses and cash use, or additionally in the event of divestiture, cash proceeds, although given the operational history of PDSG to date there can be no guarantee that a divestiture will result in the realization of material consideration.  On July 28, 2011, PDSG announced new business initiatives including Software as a Service offerings aimed at providing alternative methods to drive new revenues.

We are currently in litigation with TPL arising from the April 2010 actions filed for breach of the Commercialization Agreement.  See Part 1, Item 3. “Legal Proceedings” as well as Part 1, Item 1A. “Risk Factors” in this Annual Report for more information.

Critical Accounting Policies and Estimates

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require us to make estimates and judgments that significantly affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods. We believe the following critical accounting policies affect our most significant estimates and judgments used in the preparation of our consolidated financial statements.

1.           Revenue Recognition

Accounting for revenue recognition is complex and affected by interpretations of guidance provided by several sources, including the Financial Accounting Standards Board (“FASB”) and the Securities and Exchange Commission (“SEC”). This guidance is subject to change. We follow the guidance established by the SEC in Staff Accounting Bulletin No. 104, as well as generally accepted criteria for revenue recognition, which require that, before revenue is recorded, there is persuasive evidence of an arrangement, the fee is fixed or determinable, collection is reasonably assured, and delivery to our customer has occurred. Applying these criteria to certain of our revenue arrangements requires us to carefully analyze the terms and conditions of our license agreements. Revenue from our technology license agreements is recognized at the time we enter into a contract determineis entered into, the license modelmethod is determined (paid-in-advance or on-going royalty), and provide ourthe customer is provided with the licensed technology, if applicable. These

PDSG sells software and services to end users primarily through relationships with systems integrators and prime contractors.  PDSG recognizes revenue in accordance with authoritative guidance for the software industry.  PDSG’s revenue is derived primarily from the following sources: (i) software licensing, (ii) related professional services, and (iii) post contract customer support (“PCS”) agreements.  PCS agreements typically include software updates, on a when and if available basis, telephone and Internet access to technical support personnel. Software updates provide customers with rights to unspecified software product upgrades and to maintenance releases and patches released during the term of the support period.

PDSG’s contracts with customers, including systems integrators and prime contractors, are multiple element arrangements which contain professional services that are considered essential to the functionality of the other elements of the arrangement.  PDSG accounts for revenue on these arrangements according to authoritative guidance for contract accounting. Under this guidance, PDSG recognizes revenue based on progress towards contract completion measured by actual hours incurred in relation to the estimate of total expected hours. PDSG measures these revenues by applying the contract-specific estimated percentage of completion to the total contract amount for software and professional services.  PDSG routinely updates the estimates of future hours for agreements in process and reports any cumulative effects of such adjustments in current operations. PDSG immediately recognizes any loss expected on these contracts when it is projected that loss is probable.

On June 1, 2010 we adopted new authoritative guidance on a prospective basis for revenue arrangements containing multiple deliverables.  This guidance requires us to allocate PDSG’s revenues to all deliverables based on their relative selling price using a specific hierarchy.  The hierarchy is as follows:  vendor-specific objective evidence (“VSOE”), third-party evidence of selling price (“TPE”) or best estimate of selling price (“BESP”).

When a sale involves multiple elements, PDSG allocates the entire fee from the arrangement to each respective element based on VSOE of fair value and recognizes revenue when each element’s revenue recognition criteria are generally met duringmet. VSOE of fair value for each element is established based on the fiscal quarter of license announcementprice charged when the same element is sold separately.  PDSG has established VSOE for paid-in-advanceits CDX software licenses and PCS based on historical stand-alone sales to third parties or from the subsequent quarter immediately following. We believe that thisstated renewal rates contained in the customer contracts.  PCS is the point at which we have performed all of our obligations under the agreement; however, this remains a highly interpretive area of accounting and future license agreements may result in a different method of revenue recognition. To date all of our technology licenses have been paid-in-advance, however, on-going royalty license terms may be opted for by future licensees of our technology. Fees for maintenance or support of our licenses are recordedrecognized on a straight-line basis over the underlying period of performance.support period.

Our consolidated variable interest entity recognizes revenue upon shipmentPDSG has not yet demonstrated VSOE for the professional services that are rendered in conjunction with its software license sales.  In accordance with the hierarchy we attempt to establish the selling price of itsprofessional services using TPE.  PDSG’s product and recognizes revenue on its short-term installation contracts as time and materials costs are incurred.contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained.  PDSG is typically not able to obtain TPE for professional services.

When we are unable to establish selling prices using VSOE or TPE, we use BESP.  The objective of BESP is to determine the price at which PDSG would transact a sale if professional services were sold on a stand-alone basis.  BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings which is the case with PDSG’s professional services deliverable.

17


Due to the fact that the majority of PDSG’s contracts require significant customization of software, we are recognizing revenue for the CDX software licenses and professional services over the customization period using contract accounting which reflects continuous release of control of the software to the customer. The adoption of this guidance did not have a material effect on our consolidated financial statements.

2.           
Assessment of Contingent Liabilities

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary course of our business. We accrue for any estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

3.           Stock Options and Warrants

On June 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based Payment,We follow authoritative guidance which establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, primarily focusing on accounting for transactions where an entity obtains employee services in share-based payment transactions. SFAS No. 123(R) requires a public entityWe are required to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.  Stock-based awards to non-employees are accounted for using the fair value method in accordance with SFAS No. 123, Accounting for Stock Based Compensation.   

In November 2005, FASB issued FASB Staff Position No. FAS 123R-3, Transition Election Related to Accounting for Tax Effects of Share-Based Payment Awards (“FAS123R-3”).  We have elected to adopt the alternative transition method provided in FAS 123R-3.  The alternative transition method includes a simplified method to establish the beginning balance of the additional paid-in capital pool (“APIC pool”) related to the tax effects of employee share-based compensation, which is available to absorb tax deficiencies recognized subsequent to the adoption of SFAS No. 123(R).
16

Stock-based compensation expense recognized during the period is based on the grant date fair value of the portion of share-based payment awards that is ultimately expected to vest during the period. Stock-based compensation expense recognized in our consolidated statement of operations for the fiscal year ended May 31, 2007 included compensation expense for share-based payment awards granted prior to, but not yet vested as of May 31, 2006 based on the grant date fair value estimated in accordance with the pro forma provisions of SFAS No. 123 and compensation expense for the share-based payment awards granted subsequent to May 31, 2006 based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123(R)period. Stock-based compensation expense recognized in our consolidated statement of operations for the fiscal year ended May 31, 2008 included compensation expense for share-based payment awards granted subsequent to May 31, 2007 based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123(R). As stock-based compensation expense recognized in the consolidated statements of operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS No. 123(R) requires forfeitures to beForfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The estimated average forfeiture rate for the fiscal year ended May 31, 2008 and 2007, of approximately 5% wasForfeiture rates are based on historical forfeiture experience and estimated future employee forfeitures.

4.           Income Taxes

We must assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that a substantial majority of the deferred tax assets recorded on our balance sheet will ultimately be recovered. However, shouldShould there be a change in our ability to recover the deferred tax assets; the tax provision would increase in the period in which we determined that the recovery was not probable.

Additionally,We follow authoritative guidance to evaluate whether a valuation allowance should be established against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard.  In making such judgments, significant weight is given to evidence that can be objectively verified.  We are assessing our deferred tax assets under more likely than not scenarios in which they may be realized through future income.  Accordingly, our deferred tax assets may be subject to a valuation allowance in an upcoming fiscal period.  We will continue to analyze the more likely than not standard each quarter, and if it is determined that a valuation allowance is necessary, it may have a material impact.

During the quarter ended February 28, 2011, we adopted Financial Accounting Standards Board, (“FASB”) Interpretation No. 48, Accounting for Uncertaintydetermined that all of our deferred tax assets would not be realized in Income Taxes – An Interpretationthe future due to our continuing pre-tax and taxable losses.  As a result of FASB Statement No. 109, or FIN 48, on June 1, 2007, the first daythis determination we have placed a full valuation allowance against our deferred tax assets as of fiscal 2008.  FIN 48 seeksFebruary 28, 2011 and increased our tax provision by approximately $8,107,000.

We follow authoritative guidance to reduce the diversity in practice associated with certain aspects of measurement and recognition in accounting for income taxes.  FIN 48This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.  Under FIN 48this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

5.Investments in Affiliated Companies
18


We follow authoritative guidance to adjust our effective tax rate each quarter to be consistent with the estimated annual effective tax rate. We are also required to record the tax impact of certain discrete items, unusual or infrequently occurring, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur. In addition, jurisdictions with a projected loss for the year or a year-to-date loss where no tax benefit can be recognized are excluded from the estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings or losses versus annual projections.
5.           Investments in Affiliated Companies

We have a 50% interest in PDS.Phoenix Digital Solutions, LLC (“PDS”). We account for our investment using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee and is recognized in the consolidated statementstatements of operations in the caption “Equity in earnings of affiliated companies”.companies.” and also is adjusted by contributions to and distributions from PDS.

We havehad a 15.09%39.4% interest in Talis.  We accountPrior to the write-off of our investment in Talis during the quarter ended August 31, 2009, we were accounting for our investment using the equity method of accounting pursuant to paragraph 8 of AICPA Statement of Position 78-9, Accounting for Investments in Real Estate Ventures (which has applicability to non-Real Estate accounting matters as well) as our membership share of this limited liability company is more than minor.accounting.  Under the equity method of accounting, the investment, originally recorded at cost, iswas adjusted to recognize our share of net earnings or losses of the investee and is recognizedwas presented in the consolidated statementstatements of operations in the caption “Equity in earningsloss of affiliated companies”. In December 2009, Talis was dissolved.

On August 1, 2008,We own 100% of the preferred stock of Holocom. During May 31, 2010 we increasedwrote-off our investment in Talisthe preferred stock of Holocom amounting to 37.4% as a resultapproximately $435,000.  Prior to impairment, this investment was accounted for at cost since we did not have the ability to exercise significant influence over the operating and financial policies of purchasing additional shares offered by Talis, as well as acquiring shares from minority shareholders which included the acquisition of all Talis shares previously held by SSDI. The acquisition of Talis shares previously owned by SSDI was made for $100,000 in cash and a reduction on their outstanding line of credit of $219,000.Holocom.

We review our investments in these affiliated companies to determine whether events or changes in circumstances indicate that the carrying amounts may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of the investees. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.


17

6. Variable Interest Entity

We own 100% of the preferred stock of SSDI. On March 27, 2007 we entered into an 18 month revolving line of credit with SSDI for a maximum amount of $500,000. The line of credit caused us to have a variable interest in SSDI, a variable interest entity,6.           Business Combinations and we have determined that we are the primary beneficiary as we absorb more than half of the variable interest entity’s expected losses. FIN46(R), Consolidation of Variable Interest Entities, requires us to consolidate SSDI as long as we are deemed to be the primary beneficiary.Intangible Assets Including Goodwill 

We reevaluate our primary beneficiary positionaccount for business combinations using the purchase method of accounting and accordingly, the assets and liabilities of the acquired entities are recorded at eachtheir estimated fair values at the acquisition date. Goodwill represents the excess of ourthe purchase price over the fair value of net assets, including the amount assigned to identifiable intangible assets. Due to the time it takes to obtain pertinent information to finalize the acquired company’s balance sheet, dates using the guidance in FIN46(R). Ifit may be several quarters before we are no longer deemedable to finalize the initial fair value estimates. Accordingly, it is not uncommon for the initial estimates to be subsequently revised. The results of operations of acquired businesses are included in our consolidated financial statements from the primary beneficiary of the variable interest entity, we will discontinue consolidation.acquisition date.

Identifiable intangible assets with finite lives are amortized over their estimated useful lives on a straight line basis. Goodwill and intangible assets are tested for impairment on an annual basis, or sooner if an indicator of impairment occurs.
RESULTS OF OPERATIONS

Comparison of fiscal 20082011 and 20072010

19


Consolidated:

Our revenues increased
  May 31, 2011  
May 31, 2010
 
  Dollars  % of Revenue  Dollars  % of Revenue 
Revenue:            
License and service revenue $468,678   100.0% $567,934   100.0% 
Cost of sales:                
License and service revenue  76,242   16.3%  119,568   21.0% 
Amortization of purchased intangibles  252,593   53.9%  551,154   97.0% 
Impairment of purchased intangibles  1,469,629   -%  3,530,263   -% 
Total cost of sales  1,798,464   -%  4,200,985   -% 
 Gross loss $(1,329,786)  -% $(3,633,051)  -% 

PDSG

Revenue consisting of software licenses and associated services relating to PDSG’s CDX product decreased from approximately $639,000$568,000 for the fiscal year ended May 31, 20072010 to approximately $3,708,000$469,000 for the fiscal year ended May 31, 2008. Our2011.  The decrease of approximately $99,000 was primarily due to the fact that revenue amounts do not includeagreements are one time contracts that vary in size and scope depending upon the requirements of the customer.  Cost of sales includes the direct time of PDSG employees on each project. Included in cost of sales is approximately $48,965,000$253,000 and $551,000, respectively, of amortization expense on purchased intangible assets for each of the fiscal years ended May 31, 2011 and 2010.

Management’s plan of restructuring on October 5, 2009 and the continuing inability of PDSG to meet its business plan were indicators of potential impairment on our intangible assets. Accordingly, during the fiscal years ended May 31, 2011 and 2010, management determined that intangibles were impaired by approximately $1,470,000 and $3,530,000, respectively.

Consolidated:
  May 31, 2011  May 31, 2010 
Research and development $753,017  $1,503,724 

PDSG

Research and development costs consist of PDSG’s payroll and related expenses for software engineers as well as outside contractors retained to assist in income resulting from our investmentthe development of PDSG’s software product.  The primary decreases in PDSresearch and development costs for the fiscal year ended May 31, 20072011 as compared to 2010 were approximately $396,000 in outside contractor costs due to completion of CDX4 and approximately $19,918,000$338,000 in income resulting from our investmentssalaries and related costs due to management’s restructuring plan implemented in PDS and Talis forOctober of 2009.  For the fiscal yearyears ended May 31, 2008.  During the 2008 fiscal year we2011 and 2010, approximately $2,000 and $20,000, respectively, of share-based compensation was recorded sales amounting to approximately $3,650,000 by our consolidated variable interest entity, SSDI, with cost of sales amounting to approximately $1,510,000 as compared to the fourth quarter of the 2007 fiscal year during which we recorded SSDI sales amounting to approximately $559,000 with cost of sales amounting to approximately $308,000. During the 2008 and the 2007 fiscal years we recognized maintenance fee revenues totaling approximately $25,000 per year in connection with an agreement with AMD Corporation during the 2005 fiscal year. The agreement called for maintenance fees totaling $100,000 connected with a license agreement for our Ignite technology; the license fee revenue is being recognized as revenue evenly over the four year periodvesting of the license. In addition during the 2008 fiscal year, we recorded sales of approximately $33,000 from the sale of microprocessor chips that we no longer market as compared to approximately $55,000 during the 2007 fiscal year. Inventory associated with the sales of these microprocessor chips is carried at zero value.employee stock options.

Consolidated:
  May 31, 2011  May 31, 2010 
Selling, general and administrative $3,713,240  $6,530,972 

Segment Results:
  May 31, 2011  May 31, 2010 
PDSG:      
Selling, general and administrative $1,162,574  $2,714,965 
PTSC:        
Selling, general and administrative $2,550,666  $3,816,007 
20


PDSG

Selling, general and administrative expenses decreased from approximately $7,559,000$2,715,000 for the fiscal year ended May 31, 20072010 to approximately $6,965,000$1,163,000 for the fiscal year May 31, 2011, due to management’s restructuring plan to reduce expenses.  Decreases consisted primarily of approximately $1,038,000 in salaries and related expenses and approximately $254,000 in marketing expenses.  For fiscal years ended May 31, 2011 and 2010, approximately $18,000 and $49,000, respectively, of share-based compensation was recorded in connection with vesting of employee stock options.

PTSC

Selling, general and administrative expenses decreased from approximately $3,816,000 for the fiscal year ended May 31, 2008. Legal and accounting related expenses decreased by2010 to approximately $668,000$2,551,000 for the fiscal year ended May 31, 2008 compared with2011.  The decrease consisted primarily of approximately $546,000 in payroll and related expenses due to management’s plan of restructuring implemented in October 2009, approximately $250,000 in consulting fees, approximately $155,000 in legal and accounting fees, and approximately $79,000 in public and investor relations expenses.  For the fiscal year ended May 31, 2007 due to settlement2011 and 2010, approximately $56,000 and $153,000, respectively, of legal matters during fiscal year 2008 and reduced accounting expenses in fiscal year 2008.  Fiscal year 2007 included fees related to legal and accounting mattersshare-based compensation was recorded in connection with the restatementvesting of our financial statementsemployee stock options.

Consolidated

Selling, general and administrative expenses decreased from approximately $6,531,000 for the fiscal years 2005, 2004, 2003 and 2002 as well as the quarterly reportsyear ended May 31, 2010 to approximately $3,713,000 for the periodsfiscal year ended AugustMay 31, 20052011 primarily due to management’s plan of restructuring implemented in October 2009.

Consolidated:

  May 31, 2011  May 31, 2010 
Impairment of goodwill $642,981  $1,096,268 

PDSG

Management’s plan of restructuring on October 5, 2009 and February 28, 2006 andthe continuing inability of PDSG to meet its business plan were indicators of potential impairment on our required compliance with Sarbanes-Oxley regulations. Salary costs and related expenses included non-cash expenses associated with the fair value of options grantedgoodwill. Accordingly, during the fiscal years ended May 31, 20082011 and 2007 in accordance with SFAS No. 123(R). Total non-cash compensation for the fiscal year ended 20082010, management determined that goodwill was approximately $502,770 for PTSC as compared to approximately $2,359,036 for PTSC during the fiscal year ended 2007.  The decrease is primarily due to the June 5, 2006 grant of 1,500,000 options to our former chief executive officer resulting in non-cash compensation expense amounting to approximately $1,527,000 during the fiscal year ended 2007. Other salary expenses for PTSC increasedimpaired by approximately $292,000$643,000 and $1,096,000, respectively.

Consolidated:

  May 31, 2011  May 31, 2010 
Operating loss $(6,439,024) $(12,764,015)

Segment Results:

  May 31, 2011  May 31, 2010 
PDSG:      
Operating loss $(3,888,358) $(8,948,008)
PTSC:        
Operating loss $(2,550,666) $(3,816,007)

PDSG

Operating loss decreased from approximately $8,948,000 for the fiscal year ended May 31, 2008 as compared with the fiscal year ended May 31, 2007.  The increase is primarily due to the hire of an additional executive position and severance payments to our past chief executive officers.  Salaries and related expenses for SSDI during the fiscal year ended 2008 were approximately $1,198,000 as compared2010 to approximately $242,538 for the fourth quarter of the 2007 fiscal year. Public and investor relations expenses decreased by approximately $128,000$3,888,000 for the fiscal year ended May 31, 2008 as compared with the 2007 fiscal year2011 primarily due to one-time contracts with investor relations firmsdecreases in impairments of goodwill and intangibles in the current fiscal year 2007.as compared to the prior fiscal year and management’s plan of restructuring implemented in October 2009 which reduced salaries and related expenses.

Settlement and license expenses amounting to
21


PTSC

Operating loss decreased from approximately $7,525,000 were recorded during$3,816,000 for the fiscal year ended May 31, 2007, relating2010 to approximately $2,551,000 for the mediation agreement with Russell H. Fish III (“Fish”).  During fiscal year 2008 we recorded approximately $836,000 relating to royalty paymentsended May 31, 2011 primarily due to the Fish parties.  In January 2008, we made the final payment under the Fish settlement agreement.management’s plan of restructuring implemented in October 2009 which reduced salaries and related expenses.

Consolidated:

  May 31, 2011  May 31, 2010 
 Other income (expense):      
Interest and other income $109,246  $154,482 
Interest expense  (20,810)  (80,567)
Gain on sale of Verras Medical, Inc. assets  -   182,397 
Gain on sale of Vigilys business line  60,000   - 
Recovery of (reserve for) loan losses  1,013,151   (1,013,151)
Impairment of investment in affiliated company  -   (1,548,807)
Realized loss on sale of marketable securities  (600,879)  - 
Equity in earnings of affiliated companies  600,460   4,461,483 
             Total other income, net $1,161,168  $2,155,837 

Segment Results:

  May 31, 2011  
May 31, 2010
 
PDSG:      
Interest and other income $763  $9,579 
Gain on sale of Verras Medical, Inc. assets  -   182,397 
Gain on sale of Vigilys business line  60,000   - 
Total other income, net $60,763  $191,976 
PTSC:        
Interest and other income $108,483  $144,903 
Interest expense  (20,810)  (80,567)
Recovery of (reserve for) loan losses  1,013,151   (1,013,151)
Impairment of investment in affiliated company  -   (1,548,807)
Realized loss on sale of marketable securities  (600,879)  - 
Equity in earnings of affiliated companies  600,460   4,461,483 
Total other income, net $1,100,405  $1,963,861 

Consolidated

Our other income and expenses for the fiscal years ended May 31, 20082011 and 2007 include2010 included equity in the earnings of PDS.  For the fiscal year ended May 31, 2008 our other income and expense also includes our sharePDS consisting of loss in Talis. Our investments are accounted for in accordance with the equity method of accounting. Our investment in PDS for the fiscal year ended May 31, 2008 providednet income after expenses in the amount of approximately $19,926,000 as compared to income after expenses in the amount of$600,000 and approximately $48,965,000 for the fiscal year ended May 31, 2007.  For the fiscal year ended May 31, 2008 our investment in Talis generated a loss of approximately $8,000. Total other income and expense for the fiscal year ended May 31, 2008 amounted to net other income of approximately $21,533,000 compared with total other income and expense for the fiscal year ended May 31, 2007 of net other income amounting to approximately $49,210,000.  Interest income and other income increased from approximately $715,000 for the fiscal year ended May 31, 2007 to approximately $1,470,000 for the fiscal year ended May 31, 2008.$4,462,000, respectively.  The increasedecrease is primarily due to the interest earnedPDS’ lack of license revenues and accrued on our auction rate securities of approximately $363,000 and an increase in other income of approximately $382,000 relating to retainer refunds fromincreased legal firms, settlement of a legal matter and reimbursement items billed to PDS for prior fiscal year legal expenses we incurred. During the fiscal year ended May 31, 2007 we recorded an impairment charge on the value of our note receivable from Holocom Networks, Inc. of approximately $340,000. Also, we recorded an impairment charge of approximately $127,000 on the carrying value of SSDI, the successor company to Holocom Networks, Inc., prior to the March 27, 2007 consolidation of SSDI.  There was no such impairment charges during the fiscal year ended May 31, 2008.

18

Our provision for income taxes was approximately $6,426,000 for the year ended May 31, 2008 as compared to approximately $10,755,000 for the year ended May 31, 2007.  As of May 31, 2008 we have utilized all of our remaining available federal net operating loss carry-forwards of approximately $4,870,000.   At May 31, 2007, we had utilized all of our state net operating loss carry-forwards of approximately $17,822,000.

Comparison of fiscal 2007 and 2006

Our revenues declined from approximately $10,310,000 for the fiscal year ended May 31, 2006 to approximately $639,000 for the fiscal year ended May 31, 2007. Our revenue amounts do not include approximately $27,848,000 and approximately $48,965,000 in income resulting from our investment in Phoenix Digital Solutions, LLC for the fiscal years ended May 31, 2006 and May 31, 2007, respectively. In the first quarter of the 2006 fiscal year we entered into an agreement with Intel Corporation licensing our intellectual property, in connection with which we received a one-time payment of $10,000,000. The license revenue was recognized during the 2006 fiscal year. In addition, product sales amounting to approximately $310,000 were also recorded during the 2006 fiscal year in connection with communications products that we no longer market. Inventory associated with the sales of these communications products was carried at zero value. Cost of sales of approximately $103,000 consisted of payments made to subcontractors for materials and labor in connection with the product sales. During the fourth quarter of the 2007 fiscal year we recorded sales amounting to approximately $559,000 by our consolidated variable interest entity, SSDI with cost of sales amounting to approximately $308,000. Also during the 2007 fiscal year we recognized maintenance fee revenues totaling approximately $25,000HTC, Acer, and Barco cases.  Our investment in connection with an agreement with AMD Corporation during the 2005 fiscal year. The agreement called for maintenance fees totaling $100,000 connected with a license agreement for our Ignite technology; the license fee revenue is being recognized as revenue evenly over the four year period of the license. In addition during the 2007 fiscal year, we recorded sales of approximately $55,000 from the sale of microprocessor chips that we no longer market. Inventory associated with the sales of these microprocessor chips is carried at zero value.

Research and development expenses for the fiscal year ended May 31, 2006 amounted to approximately $226,000. Expenses related to salaries, benefits, training and other employee expenses amounted to approximately $152,000 for the 2006 fiscal year. Consultants related to research and development activities amounted to approximately $64,000 for the 2006 fiscal year and remaining expenses of approximately $10,000 connected with travel and overhead costs supporting research and development activities during the 2006 fiscal year. Research and development activities were terminated during the 2006 fiscal year and no such costs were incurred during the 2007 fiscal year.

Selling, general and administrative expenses increased from approximately $4,151,000 for the fiscal year ended May 31, 2006 to approximately $7,559,000 for the fiscal year ended May 31, 2007. Legal and accounting related expenses increased by approximately $847,000 for the fiscal year ended May 31, 2007 compared with the fiscal year ended May 31, 2006 related to legal and accounting matters in connection with the restatement of our financial statements for the fiscal years 2005, 2004, 2003 and 2002 as well as the quarterly reports for the periods ended August 31, 2005 and February 28, 2006 and our required compliance with Sarbanes-Oxley regulations. Legal expenses related to a dispute with a former officer as well as other legal proceedings involving a co-inventor of a portion of our technology and other legal expenses connected with SSDI contributed to the increase in legal expenses for the 2007 fiscal year. Salary costs and related expenses included non-cash expenses associated with the fair value of options granted during the fiscal year ended May 31, 2007 in accordance with SFAS No. 123(R). On June 5, 2006, 1,500,000 options were granted to our former chief executive officer resulting in non-cash compensation expense amounting to approximately $1,527,000. On October 23, 2006, 230,000 options were granted to employees resulting in non-cash compensation expense of approximately $184,000. On February 9, 2007, 1,070,000 options were granted to employees and directors resulting in non-cash compensation expense of $584,000. Additional non-cash compensation for the fiscal year ended May 31, 2007 amounted to $61,000 for vesting of employee stock options in accordance with SFAS No. 123(R). No such compensation expense was incurred for the 2006 fiscal year. Other salary expenses increased by approximately $398,000 for the fiscal year ended May 31, 2007 as compared with the fiscal year ended May 31, 2006 including approximately $223,000 in salaries and related expenses for SSDI during the fourth quarter of the 2007 fiscal year. Salary expenses for PTSC including expenses connected with bonuses and 401(k) employer matching of salaries increased by approximately $175,000 in the 2007 fiscal year as compared with the 2006 fiscal year. Marketing related expenses decreased by approximately $139,000 for the fiscal year ended May 31, 2007 as compared with the fiscal year ended May 31, 2006 as product marketing activities were largely discontinued. Public and investor relations expenses increased by approximately $165,000 for the fiscal year ended May 31, 2007 as compared with the 2006 fiscal year as a result of a change in our public relations firm and one-time contracts with investor relations consultants. Insurance expense increased by approximately $158,000 for the fiscal year ended May 31, 2007 as compared with the 2006 fiscal year primarily as a result of increased costs of directors and officers insurance coverage. Travel and related expenses for the 2007 fiscal year increased by approximately $44,000 as expenses for SSDI were combined with travel expenses for PTSC which increased due to travel to attend various lawsuit mediations.

19

Settlement and license expenses amounting to approximately $1,918,000 were recorded during the year ended May 31, 2006 in connection with the agreements involving the formation of a joint venture and, separately, a license agreement with Intel Corporation. The expenses consisted of both cash and non-cash elements related to incremental, direct costs of completing the transactions. In connection with the transactions, it was necessary for us to obtain the consent of certain debenture and warrant holders. The necessary consents, together with certain warrants held by the debenture holders and the release of their security interests in our intellectual property, were obtained in exchange for cash, new warrants and repriced warrants. The expenses resulted primarily from cash payments to debt holders of approximately $1,300,000, to co-owners of various intellectual property assets of approximately $960,000 and to a committee of our board of directors of approximately $170,000. Non-cash expenses totaled approximately $82,000 and resulted primarily from the incremental value of the effect of repricing various warrants and granting other warrants in excess of the expense previously recognized for warrants granted to these security holders. Offsetting the non-cash expenses were non-cash benefits from the reconveyance of warrants, amounting to approximately $622,000. During the fiscal year ended May 31, 2007, we recorded $7,525,000 of settlement and license expense relating to the mediation agreement with Russell H. Fish III (“Fish”).

Our other income and expenses for the fiscal year ended May 31, 2007 included equity in the earnings of PDS. The investmentPDS is accounted for in accordance with the equity method of accounting for investments. OurDuring the fiscal year ended May 31, 2010, we recorded an impairment of our investment in Talis of approximately $680,000, an impairment of our investment in Avot of approximately $433,000 and we wrote-off our investment in Holocom of approximately $435,000.  During the joint venturefiscal year May 31, 2011, we recorded a gain on the sale of the Vigilys business line of $60,000.  During the fiscal year ended May 31, 2011, we realized a loss net of partial par value redemptions on our ARS of approximately $601,000 according to terms of our confidential settlement agreement with Deutsche Bank.  During January 2011, we settled our note litigation with TPL and recovered our note receivable balance including principal and interest.  Accordingly, we reversed our allowance for loan loss at the settlement date.

Consolidated:

  May 31, 2011  May 31, 2010 
Loss before income taxes $(5,277,856) $(10,608,178)


22


Segment Results:

  May 31, 2011  May 31, 2010 
PDSG:      
Loss before income taxes $(3,827,595) $(8,756,032)
PTSC:        
Loss before income taxes $(1,450,261) $(1,852,146)

PDSG

Loss before income taxes decreased from approximately $8,756,000 for the fiscal year ended May 31, 2007 provided income after expenses in the amount of2010 to approximately $48,965,000. Our investment in the joint venture provided net income after expenses in the amount of approximately $27,848,000$3,828,000 for the fiscal year ended May 31, 2006. Total other2011 primarily due to decreases in impairments of goodwill and intangibles in the current fiscal year as compared to the prior fiscal year and management’s plan of restructuring implemented in October 2009 which reduced salaries and related expenses.

PTSC

Loss before income and expensetaxes decreased from approximately $1,852,000 for fiscal year ended May 31, 2010 to approximately $1,450,000 for the fiscal year ended May 31, 2007 amounted2011 primarily due to net othermanagement’s plan of restructuring implemented in October 2009 which primarily reduced salaries and related expenses.

Provision (benefit) for income of approximately $49,210,000 compared with total other income and expense for the fiscal year ended May 31, 2006 of net other income amounting to approximately $24,761,000. Changes in the fair value of warrant and derivative liabilities amounted to net other expense for the fiscal year ended May 31, 2006 of approximately $2,457,000 with no corresponding amount for the fiscal year ended May 31, 2007 as all convertible debt had been retired in prior fiscal periods. Non-cash adjustments to interest expense for the 2006 fiscal year amounted to expenses of approximately $471,000 resulting from amortization of debt discount and conversion of the remaining debentures. During the 2006 fiscal year we recorded a loss on debt extinguishment of $445,000 related to the 7,000,000 warrants issued to a debenture holder as consideration for entering into the reset agreements. Interest income and other income increased from approximately $330,000 for the fiscal year ended May 31, 2006 to approximately $715,000 for the fiscal year ended May 31, 2007 as interest bearing account balances increased from cash received as distributions from our investment in PDS. taxes

During the fiscal year ended May 31, 20072011, we recorded an impairment charge on the value of our note receivable from Holocom Networks, Inc. of approximately $340,000. Also, we recorded an impairment charge of approximately $127,000 on the carrying value of SSDI, the successor company to Holocom Networks, Inc., prior to the March 27, 2007 consolidation of the VIE (see Note 8 to our consolidated financial statements for more information).

Oura provision for income taxes wasrelated to federal and California taxes of approximately $10,755,000 for$6,238,000 due to the full valuation allowance placed on our deferred tax assets during the quarter ended February 28, 2011.  We determined that all of our deferred tax assets would not be realized in the future due to our continuing pre-tax and taxable losses.  As a result of this determination we have placed a full valuation allowance against our deferred tax assets as of February 28, 2011 and increased our tax provision by approximately $8,107,000.

During the fiscal year ended May 31, 2007 due to recognition of deferred2010, we recorded a benefit for income taxes of approximately $9,783,000$3,928,000 related to federal and California taxes.

Net loss

We recorded a current tax liability of approximately $972,070. The increase in deferred taxes was due tonet loss for the release of the valuation allowance as we determined that we would utilize our net operating loss carryforwards and other deferred tax assets due to our share of income from PDS. Atfiscal years ended May 31, 2007 we have utilized all2011 and 2010 of our state net operating loss carryforwards of approximately $17,822,000$11,515,390 and utilized approximately $29,090,000 of our federal net operating loss carryforwards.$6,679,821, respectively.


20

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our cash and short-term marketable securities and short-term investment balances decreasedincreased from approximately $25,955,000$10,352,000 as of May 31, 20072010 to approximately $6,722,000$10,661,000 as of May 31, 2008.2011. We also have a restricted cash balancesbalance amounting to approximately $51,000$21,000 as of May 31, 20082011 and approximately $102,000 as of May 31, 2007.2010. Total current assets decreased from approximately $31,399,000$13,417,000 as of May 31, 20072010 to approximately $9,851,000$12,196,000 as of May 31, 2008.2011. Total current liabilities amounted to approximately $930,000$942,000 and approximately $2,021,000$576,000 as of May 31, 20082010 and May 31, 2007,2011, respectively. The change in our current position as of May 31, 20082011 as compared with the previous yearMay 31, 2010 results primarily results from the investmentcollection of idleour note receivable issuance during the fiscal year ended May 31, 2011 and the valuation allowance placed on the current portion of our deferred tax assets during the current fiscal year ended May 31, 2011 .

Current global economic conditions have resulted in increased volatility in the financial markets.  The cost of accessing the credit markets has increased as many lenders and institutional investors have increased interest rates, enacted tighter lending standards, and reduced or ceased to provide funding to borrowers.  Adverse changes in the economy could limit our ability to obtain financing from debt or equity sources or could adversely affect the terms on which we may be able to obtain any such financing.  Currently, we have sufficient resources to fund our operations through at least the next twelve months assuming we do not fund any obligations to PDS.

23


Cash shortfalls currently experienced by PDS and TPL, and continued negative cash flows incurred by PDSG, will have an adverse effect on our liquidity.  Accordingly, we have and may continue to examine alternatives that could allow for the partnering or divestiture of PDSG.  If successful, these measures may provide for a further reduction in expenses and cash use, or additionally in the event of divestiture, cash proceeds, although given the operational history of PDSG to date there can be no guarantee that a divestiture will result in the realization of material consideration.  With respect to PDS and TPL, we do not intend to fund any cash requirements of these entities.

While our current liquid cash resources as of May 31, 2011, are expected to provide the funds necessary to support our operations through at least the next twelve months, the cash flows from our interest in PDS represents our primary significant source of cash generation.  In the event of a continued decrease or interruption in MMP Portfolio licensing we will incur a significant reduction to our cash position as the revenues from our PDSG subsidiary are insufficient to cover the costs of their operations and the costs of Patriot Scientific Corporation as a whole.  While our cash position has been enhanced as a result of our September 2010 auction rate securities which are classified as long-termsettlement with Deutsche Bank, it is highly unlikely that we would be able to obtain any additional sources of financing to supplement our cash and the decrease in distributions received from PDS during fiscal year 2008.short-term investment position of $10,660,674 at May 31, 2011.

Cash Flows From Operating Activities

Cash used in operating activities for the fiscal years ended May 31, 20082011 and 20072010 was approximately $19,260,000$4,321,000 and $14,151,000 as compared with cash provided by operating activities for the fiscal year ended May 31, 2006 of approximately $6,474,000.$7,317,000, respectively. The principal non-cash components of the current fiscal year amount were: deferred taxes of approximately $6,215,000 and impairment of intangibles and goodwill of approximately $2,113,000.  These items were offset by: net loss of approximately $11,515,000, and recovery of loan loss of approximately $1,013,000.

Decreases in our net income of approximately $9,388,000 adjusted for: minority interest in SSDI of approximately $115,000, non-cash charges of approximately $510,000 related to issuance and vesting of stock options and warrants. These increases were partially offset by: the equity in earnings of our investees of approximately $19,918,000, change in deferred taxes of approximately $9,937,000,affiliates for the fiscal years ended May 31, 2011 and a decrease in trade payables and accrued expenses of approximately $1,091,0002010 are primarily due to the decrease in our accrualshare of royalties payable at May 31, 2007 of which we have no obligation at May 31, 2008.  The cash provided by operating activities during fiscal year 2006 was primarily due toearnings in our one-time license of $10,000,000 from Intel Corporation.affiliate PDS.

Cash Flows From Investing Activities

Cash provided by investing activities for the fiscal yearyears ended May 31, 20082011 and 2010 was approximately $10,725,000 as compared$5,698,000 and $11,674,000, respectively.  Decreases were primarily due to cash provided by investing activities of approximately $48,529,000 fordecreases in distributions received from PDS.  Cash used during the fiscal year ended May 31, 2007. The decrease was primarily due to a reduction2011 included approximately $2,205,000 in distributions from PDS of approximately $29,746,000 from fiscal year 2007 as compared to fiscal year 2008.  Additionally we used approximately $8,849,000 of cash in net purchases of investments.

certificates of deposit. Cash provided by investing activities increased to approximately $48,529,000 forduring the current fiscal year ended May 31, 2007 from approximately $21,121,000 for the fiscal year ended May 31, 2006. The increase was primarily due to distributionsconsisted of approximately $50,034,000$4,961,000 which includes proceeds we received from Deutsche Bank in connection with our investmentARS settlement, approximately $808,000 in an affiliate offset by cash useddistributions from PDS and approximately $2,141,000 of approximately $830,000 in net purchases of short-term investments and an issuance of a line of credit of approximately $590,000repayments on our note receivable advances to Holocom Networks, Inc.TPL.

Cash Flows From Financing Activities

Cash used in financing activities for the fiscal yearyears ended May 31, 20082011 and 2010 was approximately $6,647,000 as compared to cash used in financing activities of approximately $16,757,000 for$3,264,000 and $223,000, respectively.   For the fiscal year ended May 31, 2007. Cash used in fiscal year 2008 consisted primarily2011, cash of approximately $2,761,000$3,122,000 was used to repurchase warrants from an investorrepay our line of credit with Wedbush and cash of approximately $3,891,000$138,000 was used to repurchase shares of our common stock for treasury.  The cash used inFor the fiscal year 2008 was partially offset by proceeds receivedended May 31, 2010 cash of approximately $31,000 from the exercise of common stock options and warrants. Cash used in financing activities in fiscal year 2007 consisted primarily of approximately $8,115,000 in cash dividends to common shareholders and approximately $8,832,000$234,000 was used to repurchase shares of our common stock for treasury.

Cash used in financing activities for the fiscal year ended May 31, 2007 was approximately $16,757,000 as compared to approximately $24,202,000 for the fiscal year ended May 31, 2006 primarily due to payments of approximately $8,115,000 in cash dividends to our common shareholders and qualifying warrant holders for fiscal year 2007 as compared to approximately $24,698,000 in cash dividends paid for fiscal year 2006, and approximately $8,832,000 paid to repurchase shares of our common stock for treasury in fiscal year 2007. The cash used in fiscal 2007 was partially offset by cash received of approximately $214,000 from the exercise of common stock options and warrants.


21

Capital Resources

OurWhile our current positionliquid cash resources as of May 31, 2008 is2011, are expected to provide the funds necessary to support our operations through at least the fiscal year ended May 31, 2009.

MANAGEMENT OUTLOOK

During recent yearsnext twelve months, the cash flows from our interest in PDS represents our primary significant source of cash generation.  In the event of a continued decrease or interruption in MMP Portfolio licensing we have relied upon financing activitieswill incur a significant reduction to provideour cash position as the funds necessary forrevenues from our operations. The numberPDSG subsidiary are insufficient to cover the costs of sharestheir operations and the costs of Patriot Scientific Corporation as a whole.  While our common stock outstanding increased from 171,156,363 at May 31, 2004 to 366,199,765 at May 31, 2006, largelycash position has been enhanced as a result of financing activities including sales of common stock, the issuance of convertible debentures and notes payable and related conversions and exercises of common stock warrants. Beginning in fiscal year 2006,our September 2010 auction rate securities settlement with Deutsche Bank, it is highly unlikely that we werewould be able to finance operations utilizing distributions we received from PDS. As we pursueobtain any additional sources of financing to supplement our cash and short-term investment and acquisition strategy, we may use a combinationposition of cash, debt, and common stock to finance these efforts.

CONTRACTUAL OBLIGATIONS AND COMMITMENTS

A summary of our outstanding contractual obligations$10,660,674 at May 31, 2008 is as follows:
Contractual
Cash Obligations
 
Total Amounts
Committed
  
1-3
Years
 
       
Operating leases - facilities $192,423  $192,423 
2011.

24


RECENT ACCOUNTING PRONOUNCEMENTS

In June 2009, the Financial Accounting Standards Board (“FASB”) revised the authoritative guidance for the consolidation of variable interest entities.  The objective of this authoritative guidance is to improve financial reporting by enterprises involved with variable interest entities.  The revised authoritative guidance is effective as of the beginning of each reporting entity’s first annual reporting period that begins after November 15, 2009.  We adopted this guidance on June 1, 2010 and the adoption had no impact on our consolidated financial statements.

In July 2006,2009, the FASB revised the authoritative guidance relating to software revenue recognition to exclude all tangible products containing both software and non-software components that function together to deliver the product’s essential functionality. The revised authoritative guidance is effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, and shall be applied on a prospective basis. Earlier application is permitted as of the beginning of an entity’s fiscal year provided it has not previously issued financial statements for any period within that year. We adopted this guidance on June 1, 2010, and the adoption had no impact on our consolidated financial statements.

In September 2009, the FASB revised the authoritative guidance for revenue arrangements with multiple deliverables.  This revised authoritative guidance requires companies to allocate revenue in arrangements involving multiple deliverables based on the estimated selling price of each deliverable, even though such deliverables are not sold separately either by the company itself or other vendors. This revised authoritative guidance eliminates the requirement that all undelivered elements must have objective and reliable evidence of fair value before a company can recognize the portion of the overall arrangement fee that is attributable to items that already have been delivered. As a result, the new guidance may allow some companies to recognize revenue on transactions that involve multiple deliverables earlier than under previous requirements. This revised authoritative guidance is effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after December 15, 2009. Early adoption is permitted at the beginning of a company’s fiscal year. We adopted this guidance on June 1, 2010, and the adoption had no impact on our consolidated financial statements.

In January 2010, the FASB issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109 (“FIN 48”). This interpretation clarifiesguidance to amend the application of SFAS No. 109, Accounting for Income Taxes, by defining criteria that an individual tax position must meet for any part of the benefit of that position to be recognized in a company’s financial statements and also provides guidance on measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. We adopted FIN 48 on June 1, 2007 and did not record any cumulative effect adjustment to retained earnings as a result of adopting FIN 48.  Interest and penalties, if any,requirements related to unrecognized tax benefits are recorded in income tax expense.  As of June 1, 2007, we are subject to U.S. Federal income tax examinations for the tax years May 31, 1991 through May 31, 2007, and we are subject to state and local income tax examinations for the tax years May 31, 1999 through May 31, 2007 due to the carryover of net operating losses from previous years.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements.  SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principals and expands disclosures about fair value measurements. The statement does not require new fair value measurements, but is applied toguidance requires the extent that other accounting pronouncements require or permit fair value measurements.  The statement emphasizes that fair value is a market-based measurement that should be determined baseddisclosure of roll forward activities on purchases, sales, issuance, and settlements of the assumptions that market participants would use in pricing an asset or liability.  Companies that have assets and liabilities measured atusing significant unobservable inputs (Level 3 fair value measurements). The guidance will be required to disclose information that enables the users of its financial statements to access the inputs used to develop those measurements.  The reporting entity is encouraged, but not required, to combine the fair value information disclosed under this statementbecome effective for us with the fair value information disclosed under other accounting pronouncements.  SFAS No. 157 is effective for fiscal yearsreporting period beginning after November 15, 2007. We expect to adopt SFAS No. 157 on June 1, 2008.  In February 2008, the FASB released FASB Staff Position 157-2, Effective Date of FASB Statement No. 157, which delayed the effective date of SFAS No. 157 for all nonfinancial assets and nonfinancial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually) until the fiscal year beginning May 31, 2009.  We are in the process of evaluating the provisions of the statement, but do not anticipate that2011. Other than requiring additional disclosures, the adoption of SFAS No. 157this new guidance will not have a material impact on our consolidated financial statements.

22

In February 2007,May 2011, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assetsguidance to amend the accounting and Financial Liabilities. SFAS No. 159 permits entities to choose to measure atdisclosure requirements on fair value manymeasurements. The new guidance limits the highest-and-best-use measure to nonfinancial assets, permits certain financial instrumentsassets and certain other items that are not currently requiredliabilities with offsetting positions in market or counterparty credit risks to be measured at fair value. The objective is to improve financial reportinga net basis, and provides guidance on the applicability of premiums and discounts. Additionally, the new guidance expands the disclosures on Level 3 inputs by providing entities with the opportunity to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS No. 159 also establishes presentation andrequiring quantitative disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 does not affect any existing accounting literature that requires certain assets and liabilities to be carried at fair value. SFAS No. 159 does not establish requirements for recognizing and measuring dividend income, interest income, or interest expense. This Statement does not eliminate disclosure requirements included in other accounting standards. SFAS No. 159 is effective in fiscal years beginning after November 15, 2007. We are in the process of evaluating the provisions of the statement, butunobservable inputs and assumptions, as well as description of the valuation processes and the sensitivity of the fair value to changes in unobservable inputs. The new guidance will be effective for us beginning March 1, 2012. We do not anticipate that the adoption of SFAS No. 159 willto have a material impact on our consolidated financial statements.

In December 2007,June 2011, the FASB issued SFAS No. 141(R), Business Combinations. SFAS No. 141(R) requires acquiring entities in a business combinationguidance on presentation of comprehensive income. The new guidance eliminates the current option to recognize the assets acquiredreport other comprehensive income and liabilities assumedits components in the transaction; establishes the acquisition-date fair value as the measurement objectivestatement of changes in equity. Instead, an entity will be required to present either a continuous statement of net income and other comprehensive income or in two separate but consecutive statements. The new guidance will be effective for all assets acquired and liabilities assumed; and requires the acquirer to disclose to investors the information it needs to evaluate and understand the nature and financial effect of the business combination. SFAS No. 141(R) is effective in fiscal yearsus beginning after December 15, 2008. We expect to adopt SFAS No. 141(R) on June 1, 2009.  We are currently assessing the impact the adoption of SFAS No. 141(R)2012 and will have onresult in presentation changes only for our consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements. SFAS No. 160 requires entities to report noncontrolling (minority) interests in subsidiaries as equity in the consolidated financial statements. SFAS No. 160 is effective in fiscal years beginning after December 15, 2008. We expect to adopt SFAS No. 160 on June 1, 2009.  We are currently assessing the impact the adoption of SFAS No. 160 will have on our consolidated financial statements.

ITEM 7A.          QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest rate risk

The primary objective of our investment activities is to maintain surplus cash in accounts that provide a high level of funds accessibility in large, respected financial institutions with asset safety as a primary consideration. Accordingly, we maintain our cash and cash equivalents with high quality financial institutions. Amounts deposited with these institutions may exceed federal depository insurance limits.

Cash and Cash Equivalents

We maintain cash and cash equivalents in institutional money market accounts. In general, money market funds are not subject to interest rate risk because the interest paid on these funds fluctuates with the prevailing interest rate.

Our commercial checking account is linked to a sweep account. This sweep account is maintained by our financial institution in an offshore account located in the Cayman Islands. This sweep account is a deposit liability of our financial institution, the funds are not insured by the Federal Deposit Insurance Corporation (“FDIC”), in liquidation the funds have a lesser preference than deposits held in the United States, and the funds are subject to cross-border risks.

Auction Rate Securities

Our exposure to market risk for changes in interest rates relates primarily to our auction rate securities.  During the quarter ended February 29, 2008, investment banks were reporting an inability to successfully obtain subscribers for high credit quality auction rate securities.  As of May 31, 2008, we held such auction rate securities with a par value totaling $12.9 million that failed to sell at auction. In the event we need to access funds invested in these auction rate securities we will not be able to liquidate these securities until: a future auction of these securities is successful, they are refinanced and redeemed by the issuers, or a buyer is found outside of the auction process.  The investments consist of student loan auction rate instruments issued by various state agencies pursuant to the Federal Family Educational Loan Program (“FFELP”).  These investments are of high credit quality and the AAA credit ratings of the investments have been reaffirmed since May 2008.  These instruments are collateralized in excess of the underlying obligations, are insured by the various state educational agencies, and are guaranteed by the Department of Education as an insurer of last resort.

23

At May 31, 2008, the fair value of our auction rate securities was estimated at $12.5 million based on a valuation by Houlihan Smith & Company, Inc.  We recorded the net temporary valuation adjustment of $220,617 in other comprehensive income, which represents the gross valuation adjustment of $372,325, net of the related tax benefit of $151,708.  We have concluded that the unrealized losses on these investments are temporary because (i) we believe that the decline in market value and absence of liquidity that has occurred is due to general market conditions, (ii) the auction rate securities continue to be of a high credit quality and interest is paid as due and (iii) we have the intent and ability to hold these investments until a recovery in market value occurs.  Since this valuation adjustment is deemed to be temporary, it did not affect our earnings for the fiscal year ended May 31, 2008.

We are not currently able to predict how long these investments will remain illiquid, and as such, they have been classified as long-term investments in marketable securities in the accompanying consolidated balance sheet at May 31, 2008.

The fair value of our long-term investments in marketable securities could change significantly in the future and we may be required to record other-than-temporary impairment charges or additional unrealized losses in future periods.

We do not believe that the illiquidity of these investments will materially impact our ability to fund our working capital needs, capital expenditures or other business requirements.

During June 2008 we obtained a credit facility which provides for financing up to 50% of the par value balance of our outstanding auction rate securities. The facility is collateralized by the full value of the outstanding auction rate securities, required no origination fee, and if drawn upon will bear interest at the federal funds rate plus 3%.

ITEM 8.                FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and supplementary data required by this item are included in Part IV, Item 15 of this Report and begin on page F-1 with the index to consolidated financial statements.

ITEM 9.                CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.             CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting, as defined in Exchange Act Rules 13a-15(f). We have designed and maintain disclosure controls and procedures to ensure that information required to be disclosed in the our reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating these controls and procedures, our management recognizes that any system of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives and necessarily applies judgment in evaluating the cost-benefit relationship of other possible controls and procedures. In addition, we consolidate SSDI, a variable interest entity as defined in Financial Accounting Standards Board Interpretation (“FIN”) No. 46(R), Consolidation of Variable Interest Entities, an interpretation of ARB No. 51 (“FIN 46(R)”), that we do not control or manage and consequently, our disclosure controls and procedures with respect to this entity are necessarily limited to oversight or monitoring controls that we have implemented to provide reasonable assurance that the objectives of our disclosure controls and procedures as described above are met.

25
As of the end of the period covered by this report, we carried out an evaluation, under
Under the supervision and with the participation of our management, including our Interim Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operationwe conducted an evaluation of our disclosure controls and procedures, (asas such term is defined in Rule 13(a)-15(e)13a-15(e) of the Exchange Act).Act, as of the end of the period covered by this report. Based on thatthis evaluation, our Interim Chief Executive Officer and Chief Financial Officer concluded that as of May 31, 2008 our disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file andor submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’sSEC’s rules and forms, and is accumulated and communicated to our management, including our Interim Chief Executive Officer and Chief Financial Officer, as a result of the material weakness identified and discussed below.
24

Changes in Internal Controls over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during our fourth fiscal quarter ended May 31, 2008, that has materially affected, or is reasonably likelyappropriate to materially affect our internal control over financial reporting.allow timely decisions regarding required disclosures.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act RulesRule 13a-15(f) and 15d-15(f).

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our principal executive officerInterim Chief Executive Officer and principal financial officer,Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of May 31, 2011 based on the frameworkcriteria set forth in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).Commission. Based on ourthis evaluation, under the framework in Internal Control — Integrated Framework , our management concluded that our internal control over financial reporting was not effective as of May 31, 2008.2011.

A material weakness is a deficiency, or a combinationThis Annual Report does not include an attestation report of control deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

As discussed above, we consolidate SSDI, a variable interest entity as defined in FIN No. 46(R) that we do not control or manage and consequently, our disclosure controls and procedures with respect to this entity are necessarily limited to oversight or monitoring controls that we have implemented to provide reasonable assurance that the objectives of the our disclosure controls and procedures are met.  In connection with our assessment of internal control over financial reporting, we identified the following material weakness in our internal control over financial reporting:

As of May 31, 2008, a material weakness existed relating to SSDI’s information technology general controls, including ineffective controls relating to following:

·There is no IT security policy,
·There is no change management policy,
·There is no evidence of changes which have been performed,
·There is no physical security over servers, firewall, router and switches,
·There is no documentation of the granting of user access rights process,
·There is no documentation of the user access termination process,
·The firewall configuration does not reflect SSDI’s current usage,
·Remote access is not well controlled,
·Two of five systems did not have recent antivirus signature files,
·The antivirus software is not installed on the server,
·All named users, plus the CIO using the administrator account, have full access to all areas of QuickBooks,
·All authenticated users are allowed full access to the files in the Finance directory,
·The domain administrator list is not limited to the minimum appropriate personnel,
·Passwords are only required to be five characters which is deemed insufficient for good security,
·There is no evidence of the CIO’s weekly backup review occurring, and management is not being notified of failures,
·There are no stored backup tapes off-site or in a media safe, and
·There are no regularly run test restorations.

Because of the material weakness described above, we concluded that we did not maintain effective internal control over financial reporting as of May 31, 2008.

25

Our internal controls over financial reporting as of May 31, 2008 have been audited by KMJ Corbin & Company LLP, our independent registered public accounting firm as stated in their report which appears herein.

Plans for Remediation of Material Weakness

We are in the process of developing and implementing remediation plans to address our material weakness.  Our remediation plans include many actions that are in various stages of completion and designed to strengthen ourregarding internal controlscontrol over financial reporting. They includeManagement's report was not subject to attestation by our independent registered public accounting firm pursuant to the following:rules of the SEC that permit us to provide only management's report in this Annual Report.

Changes in Internal Controls over Financial Reporting
As of May 31, 2008, there
There were multiple control deficiencies which when combined constituted a material weaknessno changes in our internal control over financial reporting relating to our consolidated variable interest entity, Scripps Secured Data, Inc.  These deficiencies centered onthat occurred during the information technology control environment, with many of these controls incomplete and under development or in the process of implementation atfourth fiscal quarter ended May 31, 2008.  Accordingly, we expect2011, that by the close of our first fiscal quarter of 2009, the majority of the deficiencies will have been either remediatedmaterially affected, or satisfactorily mitigated.
Through these steps, we believe we are addressing the deficiencies that affectedreasonably likely to materially affect, our internal control over financial reporting as of May 31, 2008, and we intend to continue to evaluate and strengthen our systems of internal control over financial reporting.



26

 
Report of Independent Registered Public Accounting FirmInherent Limitations on Internal Control

ToA control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the Boardobjectives of Directorsthe control system are met. Further, the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and Stockholdersinstances of Patriot Scientific Corporation:fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

We have audited the internal control over financial reporting of Patriot Scientific Corporation and subsidiaries, and Scripps Secured Data, Inc., a consolidated variable interest entity. (collectively, the "Company") as of May 31, 2008, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting , included in the accompanying Management's Report on Internal Control over Financial Reporting included in Item 9A. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.



A material weakness is a control deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.  The following material weakness has been identified and included in management’s assessment:

Information Technology Control Environment at Scripps Secured Data, Inc.

As of May 31, 2008, a material weakness existed relating to SSDI’s information technology general controls, including ineffective controls relating to following:

·There is no IT security policy,
·There is no change management policy,
·There is no evidence of changes which have been performed,
·There is no physical security over servers, firewall, router and switches,
·There is no documentation of the granting of user access rights process,
·There is no documentation of the user access termination process,
·The firewall configuration does not reflect SSDI’s current usage,
·Remote access is not well controlled,
·Two of five systems did not have recent antivirus signature files,
·The antivirus software is not installed on the server,
·All named users, plus the CIO using the administrator account, have full access to all areas of QuickBooks,
·All authenticated users are allowed full access to the files in the Finance directory,
·The domain administrator list is not limited to the minimum appropriate personnel,
·Passwords are only required to be five characters which is deemed insufficient for good security,
·There is no evidence of the CIO’s weekly backup review occurring, and management is not being notified of failures,
·There are no stored backup tapes off-site or in a media safe, and
·There are no regularly run test restorations.

27

In our opinion, because of the effect of the material weakness described above on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of May 31, 2008, based on the COSO criteria.


The material weakness described above was considered in determining the nature, timing, and extent of audit tests applied in our audit the 2008 consolidated financial statements, and this report does not affect our report dated August 14, 2008 on those consolidated financial statements.


/s/ KMJ Corbin & Company LLP
Irvine, California
August 14, 2008
28

ITEM 9B.             OTHER INFORMATION

None.

PART III

ITEM 10.              DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Director Qualifications – We believe that individuals who serve on our Board should possess the requisite education and experience to make a significant contribution to the Board and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and should have the highest ethical standards, a strong sense of professionalism and dedication to serving the interests of our stockholders.  The following are qualifications, experience and skills for Board members which are important to our business:
26


·
Leadership Experience – We seek directors who demonstrate extraordinary leadership qualities.  Strong leaders bring vision, diverse perspectives, and broad business insight to the company.  They demonstrate practical management experience, skills for managing change, and knowledge of industries, geographies and risk management strategies relevant to the company.

·
Finance Experience – We believe that all directors should possess an understanding of finance and related reporting processes.  We also seek directors who qualify as “audit committee financial experts” as defined in rules of the Securities and Exchange Commission for service on the Audit Committee.

·
Industry Experience – We seek directors who have relevant industry experience including: existing and new technologies, new or expanding businesses and a deep understanding of the company’s business environments.

The following table and biographical summaries set forth information, regardingincluding principal occupation, business experience, other directorships and director qualifications concerning the members of our Board of Directors and our executive officer as of May 31, 2011. There is no blood or other familial relationship between or among our directors or executive officer.  At our annual shareholder meeting in January 2011, we reduced our board seats to three as Helmut Falk Jr., Donald Schrock and Dharmesh Mistry were not re-elected to our board.
NAMEAGEPOSITION and TERM
Carlton M. Johnson, Jr.51Director (since August 2001)
Gloria H. Felcyn64Director (since October 2002)
Clifford L. Flowers53
Chief Financial Officer/Secretary (since September 17, 2007)
Interim CEO (since October 5, 2009)
Director (since January 19, 2011)

CARLTON M. JOHNSON, JR. Carlton Johnson has served as a director of the Company since 2001, and is Chairman of the Executive Officers, PromotersCommittee of the Board of Directors. Mr. Johnson is in-house legal counsel for Roswell Capital Partners, LLC, a position he has held since June 1996. Mr. Johnson has been admitted to the practice of law in Alabama since 1986, Florida since 1982 and Control Persons,Georgia since 1997. He has been a shareholder in the Pensacola, Florida AV- rated law firm of Smith, Sauer, DeMaria Johnson and was President-Elect of the 500 member Escambia-Santa Rosa Bar Association. He also served on the Florida Bar Young Lawyers Division Board of Governors. Mr. Johnson earned a degree in History/Political Science at Auburn University and Juris Doctor at Samford University - Cumberland School of Law. Since 1999, Mr. Johnson has served on the board of directors of Peregrine Pharmaceuticals, Inc., a publicly held emerging bio-tech company.  Mr. Johnson serves as chairman of Peregrine’s audit committee and is a member of Peregrine’s compensation and nominating committees. Since May 2009, Mr. Johnson has served on the board of directors of CryoPort, Inc. a publicly held company providing cost-efficient frozen shipping to biopharmaceutical and biotechnology industries.  Mr. Johnson serves as chairman of CryoPort’s compensation committee and as a member of its audit committee and nomination and governance committee.  Since November 2009, Mr. Johnson has served on the board of directors of ECOtality, Inc. a leader in clean electric transportation and storage technologies.  Mr. Johnson serves on the audit committee and compensation committee of ECOtality.

The Board of Directors concluded that Mr. Johnson should serve as a director in light of the extensive public company finance and corporate governance experience that he has obtained through serving on the boards and audit committees of Peregrine Pharmaceuticals, Inc., CryoPort, Inc., and ECOtality, Inc.

GLORIA H. FELCYN. Gloria Felcyn has served as a director of the Company since October, 2002 and is the Chairman of the Audit Committee of the Board of Directors.  Since 1982, Ms. Felcyn has been the principal in her own certified public accounting firm, during which time she represented Helmut Falk Sr. and nanoTronics, along with other major individual and corporate clients in Silicon Valley.  Following Mr. Falk’s death, Ms. Felcyn represented his estate and family trust as Executrix and Trustee of the Falk Estate and The Falk Trust.  Prior to establishing her firm, Ms. Felcyn worked for the national accounting firm of Hurdman and Cranston from 1969 through 1970 and Price Waterhouse & Co. in San Francisco and New York City from 1970 through 1976, during which period, she represented major Fortune 500 companies. Subsequent to that, Ms. Felcyn worked in the field of international tax planning with a major real estate syndication company in Los Angeles until 1982 when she decided to start her own practice in Northern California.  A major portion of Ms. Felcyn’s current practice is “Forensic Accounting”, which involves valuation of business entities and investigation of assets. Ms. Felcyn has published tax articles for “The Tax Advisor” and co-authored a book published in 1982, “International Tax Planning”.  Ms. Felcyn has a degree in Business Economics from Trinity University and is a member of the American Institute of CPA’s.

27


The Board of Directors concluded that Ms. Felcyn should serve as a director and the chairperson of the Audit Committee in light of the extensive financial and accounting experience that she has obtained over her career.

CLIFFORD L. FLOWERS. Cliff Flowers became our Chief Financial Officer and Secretary on September 17, 2007.  On October 5, 2009 Mr. Flowers was named Interim CEO and was elected a director of the Company on January 19, 2011.  From May 2007 to September 17, 2007, Mr. Flowers was the interim CFO for BakBone Software Inc., working as a consultant on behalf of Resources Global Professionals, Inc.  From June 2004 through December 2006, Mr. Flowers was the senior vice president of finance and operations and CFO for Financial Profiles, Inc. a developer and marketer of software for the financial planning industry.  Prior to joining Financial Profiles, Mr. Flowers served as CFO of Xifin, Inc., a provider of hosted software services to the commercial laboratory marketplace.  Prior to Xifin, Mr. Flowers served for nine years in positions of increasing responsibility at Previo, Inc., a developer and marketer of various PC and server-based products, including back up and business continuity offerings.  As CFO of Previo, Mr. Flowers’ global responsibilities included all financial operations and legal affairs.  He earlier served as an audit manager with Price Waterhouse, LLP.  Mr. Flowers is a graduate of San Diego State University with a B.S. summa cum laude in Business Administration with an emphasis in accounting.

The Board of Directors concluded that Mr. Flowers should serve as a director due to his leadership and financial experience combined with the perspective and experience he brings as our current Chief Financial Officer and interim Chief Executive Officer.

Board Leadership Structure

Our bylaws provide that the Chairman of the Board shall preside over all meetings of the Board of Directors.  Our bylaws also state that the Chairman of the Board shall serve as the Chief Executive Officer unless determined otherwise by our Board.  Since October 5, 2009 our Chief Financial Officer has served as our interim CEO and our Board has not appointed a Chairman of the Board.  On January 19, 2011, our Chief Financial Officer who also serves as our interim CEO was elected to the Board of Directors.  During meetings of our Board of Directors, Mr. Johnson, an independent director, serves as Chairman of the Board.

Our independent directors meet in executive sessions without management present to evaluate whether management is performing its responsibilities in a manner consistent with the direction of the Board.  Additionally, all Board committee members are independent directors.  The committee chairs have authority to hold executive sessions without management present.  The Board has determined that its current structure is in the best interests of the Company and its stockholders.  We believe the independent nature of the Audit Committee and the Compensation Committee as well as the practice of the independent directors regularly meeting in executive session without Mr. Flowers present ensures that the Board maintains a level of independent oversight of management that is appropriate for the Company.

Board Risk Oversight

Our Board oversees and maintains our governance and compliance processes and procedures to promote the conduct of our business in accordance with applicable laws and regulations and with the highest standards of responsibility, ethics and integrity.  As part of its oversight responsibility, our Board is responsible for the oversight of risks facing the Company and seeks to provide guidance with respect to the management and mitigation of those risks.  Our board also delegates specific areas of risk to the Audit Committee which is responsible for the oversight of risk policies and processes relating to our financial statements and financial reporting processes.  The Audit Committee reviews and discusses with management and the independent auditors significant risks and exposures to the company and steps management has taken or plans to take to minimize or manage such risks.  The Audit Committee meets in executive session with our Chief Financial Officer and our independent auditor at each regular meeting of the Audit Committee.

Section 16(a) Beneficial Ownership Reporting Compliance with

Section 16(a) of the Exchange Act requires our directors, executive officers and Corporate Governance is incorporatedpersons who beneficially own 10% or more of a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial ownership with SEC. Directors, executive officers and greater than 10% stockholders are required by referencethe rules and regulations of the SEC to furnish us with copies of all reports filed by them in compliance with Section 16(a).
Based solely on our review of the information contained incopies of such forms received by us, or written representations from reporting persons, we believe that our definitive proxy statement which will be filedinsiders complied with the Securities and Exchange Commission in connection with our 2008 Annual Meetingall applicable Section 16(a) filing requirements during fiscal year 2011.

28


Code of Shareholders.Ethics

CODE OF ETHICS

We have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.  Our Code of Ethics is available on our website at www.ptsc.com.www.ptsc.com under the link “Investors” and “Management Team”.

Audit Committee
We have an audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act, currently comprised of: Gloria H. Felcyn (Committee Chair) and Carlton M. Johnson, Jr. Each member of our Audit Committee (the “Audit Committee”) is independent as defined under the applicable rules of the SEC and NASDAQ Stock Market LLC (“NASDAQ”) listing standards.  The Board of Directors has determined that Gloria H. Felcyn, who serves on the Audit Committee, is an “audit committee financial expert” as defined in applicable SEC rules.

Director Legal Proceedings
During the past ten years, no director, executive officer or nominee for our Board of Directors has been involved in any legal proceedings that are material to an evaluation of their ability or integrity to become our director or executive officer.
ITEM 11.              EXECUTIVE COMPENSATION

The information regarding Director Compensation, Reportfollowing table summarizes the compensation of the named executive officers for the fiscal years ended May 31, 2011 and 2010.  For fiscal 2011, the named executive officers are our Chief Executive Officer and our Chief Financial Officer.  For fiscal 2010, the named executive officers are our Chief Executive Officer, Chief Financial Officer and Vice President of Business Development.

Summary Compensation Committee,Table
For Fiscal Years Ended May 31, 2011 and 2010
Name and Principal PositionYear Salary ($)  Bonus ($)  Option Awards ($)(1)  
All Other
Compensation
($) (2)
  
Total
Compensation ($)
 
Frederick C. Goerner, CEO(a)2010 $95,731  $-  $-  $168,236  $263,967 
                      
Clifford L. Flowers, Interim2011  292,872   -   12,000   8,455   313,327 
CEO and CFO                     
Clifford L. Flowers, Interim2010  272,103   208,375(3)  -   8,095   488,573 
CEO and CFO                     
                      
Paul R. Bibeau,2010  85,354   -   -   18,655   104,009 
V.P. Business Development                     

1.Represents the aggregate grant date fair value of grants awarded in fiscal 2011 and 2010 computed in accordance with authoritative guidance issued by the Financial Accounting Standards Board.  For the fiscal year ended May 31, 2010, Mr. Goerner forfeited 2,000,000 options due to vesting criteria not being met upon our October 5, 2009 restructuring.
2.See the All Other Compensation Table below for details of the total amounts represented.

3.Mr. Flowers was paid a $62,500 discretionary bonus in July 2009 per his employment contract.  At May 31, 2010 $145,875 was accrued for his interim CEO bonus which was paid to him in fiscal 2011.

(a)Mr. Goerner served as CEO until October 5, 2009.  Mr. Flowers is currently serving as Interim CEO.


29


All Other Compensation DiscussionTable
For Fiscal Years Ended May 31, 2011 and Analysis2010

Name and Principal PositionYear 
Vacation
Payout On Termination ($)
  401(k) Company Match ($)  
Severance
($) (1)
  Other ($) (2)  Total ($) 
Frederick C. Goerner, CEO2010 $7,267  $3,023  $145,833  $12,113  $168,236 
                      
Clifford L. Flowers, Interim2011  -   8,455   -   -   8,455 
CEO and CFO                     
Clifford L. Flowers, Interim2010  -   8,095   -   -   8,095 
CEO and CFO                     
                      
Paul R. Bibeau,2010  3,050   2,624   12,981   -   18,655 
V.P. Business Development                     
1.Severance for both Mr. Goerner and Mr. Bibeau was paid entirely in fiscal 2010.

2.Consists of $3,500 in outplacement services and $8,613 in health and dental insurance premium reimbursement payments to Mr. Goerner in connection with his Separation Agreement.

The following table shows the number of shares covered by exercisable and Executive Compensation is incorporatedun-exercisable options held by referenceour named executive officers as of May 31, 2011.

 Outstanding Equity Awards
As of May 31, 2011
Name Number of Securities Underlying Options (#)Exercisable  Number of Securities Underlying Unexercised Options (#) Unexercisable  Option Exercise Price($) 
Option
Expiration Date
Clifford L. Flowers  750,000(1)  -   0.45 9/17/2012
   150,000   -   0.10 6/3/2015

1.On October 5, 2009, in connection with Mr. Flowers’ appointment as Interim CEO, the Compensation Committee authorized his unvested options to immediately vest.

Employment Contracts
In connection with Mr. Flowers’ appointment as Chief Financial Officer on September 17, 2007, we entered into an Employment Agreement (the “Flowers Agreement”) with Mr. Flowers for an initial 120-day term if not terminated pursuant to the information containedFlowers Agreement, with an extension period of one year and on a day-to-day basis thereafter.  Pursuant to the Flowers Agreement, Mr. Flowers’ initial base salary was $225,000 per year and he is eligible to receive an annual merit bonus of up to 50% of his base salary, as determined in the sole discretion of the Board of Directors.  Effective October 1, 2008 and October 5, 2009, Mr. Flowers’ base salary was increased to $231,750 and $291,750, respectively.  Also pursuant to the Flowers Agreement and on the date of the Flowers Agreement, Mr. Flowers received a grant of non-qualified stock options to purchase 150,000 shares of our 2008 definitive proxy statement.Common Stock and a grant of non-qualified stock options to purchase 600,000 shares of our Common Stock.  Mr. Flowers’ right to exercise the foregoing stock options became fully vested on October 9, 2009, in connection with his appointment as Interim CEO.  The Flowers Agreement also provides for Mr. Flowers to receive customary employee benefits, including health, life and disability insurance.

30


Pursuant to the Flowers Agreement, if Mr. Flowers is terminated without cause or resigns with good reason any time after two years of continuous employment, he is entitled to receive an amount equal to 12 months of his annual base salary.  Mr. Flowers is also entitled to certain payments upon a change of control of the Company if the surviving corporation does not retain him.  All such payments are conditional upon the execution of a general release.

We had an employment agreement with Mr. Goerner.  Under terms his Separation Agreement, Mr. Goerner was paid outplacement assistance of $3,500 and a severance payment of $145,833.  The severance payment was paid in bi-weekly installments over a seven month period that ended May 2010.  We also reimbursed Mr. Goerner for a portion of his health and dental insurance premiums totaling $8,613 during the seven month period ended May 2010 according to provisions in his Separation Agreement.

Director Compensation
As described more fully below, this table summarizes the annual cash compensation for our non-employee directors during the fiscal year ended May 31, 2011.
Director Compensation
For Fiscal Year Ended May 31, 2011
Name 
Fees Earned or
Paid in Cash
($)
  
Option Awards
($)
  
All
Other
Compensation
  
Total
Compensation
($)
 
Carlton M. Johnson, Jr. $122,400(1) $20,000   --  $142,400 
Gloria H. Felcyn  96,000(2)  20,000   --   116,000 
Helmut Falk, Jr.  24,000(3)  -   --   24,000 
Donald E. Schrock  38,400(4)  -   --   38,400 
Dharmesh Mistry  56,000(5)  -   --   56,000 

1.Consists of $28,800 board fee, $36,000 Phoenix Digital Solutions, LLC management committee fee, $28,800 Compensation Committee Chair fee and $28,800 Executive Committee Chair fee.
2.Consists of $28,800 board fee and $67,200 Audit Committee Chair fee.
3.Mr. Falk was paid board fees through January 2011.  Mr. Falk was not nominated to be reelected at our annual meeting of stockholders in January 2011.

4.Consists of $19,200 board fee and $19,200 Corporate Development, M & A Committee Chair fee through January 2011.  Mr. Schrock was not nominated to be reelected at our annual meeting of stockholders in January 2011.
5.Consists of $24,000 board fee and $32,000 Technology Committee Chair fee through January 2011.  Mr. Mistry was not nominated to be reelected at our annual meeting of stockholders in January 2011.

At May 31, 2011, the aggregate number of options outstanding was:  Mr. Johnson – 450,000 shares and Ms. Felcyn – 450,000 shares.
Directors who are not our employees are compensated for their service as a director as shown in the table below:
31


Schedule of Director Fees
May 31, 2011
Compensation ItemAmount
Board$36,000/28,800(1)
Corporate Development, M & A Committee Chair28,800
Audit Committee Chair67,200
Compensation Committee Chair28,800
Executive Committee Chair28,800
Technology Committee Chair48,000
Phoenix Digital Solutions, LLC Management Committee Board Member36,000

1.Mr. Johnson, Ms. Felcyn and Mr. Schrock receive the lesser amount in conjunction with their fee reductions implemented in May 2009.

All retainers are paid in monthly installments.

Other
We reimburse all directors for travel and other necessary business expenses incurred in the performance of their services for us. 

ITEM 12.             
ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth, as of August 12, 2011, the stock ownership of each of our officers and directors, of all our officers and directors as a group, and of each person known to us to be a beneficial owner of 5% or more of our Common Stock. The number of shares of Common Stock outstanding as of August 12, 2011, was 406,972,710.  Except as otherwise noted, each person listed below is the sole beneficial owner of the shares and has sole investment and voting power over such shares. Each individual’s address is 701 Palomar Airport Road, Suite 170, Carlsbad, California 92011-1045.
Name 
Amount & Nature of
Beneficial Ownership
 Percent of Class 
Gloria H. Felcyn, CPA  1,259,700(1)  * 
Carlton M. Johnson, Jr.  975,000(2)  * 
Clifford L. Flowers  900,000(3)  * 
All directors & officers as a group (3 persons)  3,134,700(4)  0.77% 

*Less than 1%
(1)Includes 450,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of August 12, 2011.
(2)Includes 450,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of August 12, 2011.
(3)Represents shares issuable upon the exercise of outstanding stock options exercisable within 60 days of August 12, 2011.
(4)Includes 1,800,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of August 12, 2011.

The information regarding Security Ownership of Certain Beneficial Owners and Management and Equity Compensation Plan Information is incorporated by reference to the information contained in our 2008 definitive proxy statement.

ITEM 13.             
ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information regarding Certain RelationshipsTransactions With Directors, Executive Officers and Related TransactionsPrincipal Stockholders

32


There were no transactions, or series of transactions during the fiscal year ended May 31, 2011, nor are there any currently proposed transactions, or series of transactions, to which we are a party, in which the amount exceeds $120,000, and Corporate Governancein which to our knowledge any director, executive officer, nominee, five percent or greater stockholder, or any member of the immediate family of any of the foregoing persons, has or will have any direct or indirect material interest other than as described below.
Director Independence
Our Board of Directors has determined that a majority of the members of, and nominees to, our Board of Directors qualify as “independent,” as defined by the listing standards of NASDAQ.  Consistent with these considerations, after review of all relevant transactions and relationships between each director and nominee, or any of his or her family members, and us, our senior executive management and our independent auditors, the Board of Directors has determined further that all of our directors and nominees are independent under the listing standards of NASDAQ.  In making this determination, the Board of Directors considered that there were no new transactions or relationships between its current independent directors and the Company, its senior management and its independent auditors since last making this determination.  Each member of our Audit Committee, and each member of the Compensation Committee of our Board of Directors, is incorporatedindependent as defined by reference to the information contained in our 2008 definitive proxy statement.listing standards of NASDAQ.

ITEM 14.             PRINCIPAL ACCOUNTINGACCOUNTANT FEES AND SERVICES

Pursuant to the Policy on Engagement of Independent Auditor, the Audit Committee is directly responsible for the appointment, compensation and oversight of the independent auditor. The Audit Committee pre-approves all audit services and non-audit services to be provided by the independent auditor and has approved 100% of the audit, audit-related and tax fees listed below. The Audit Committee may delegate to one or more of its members the authority to grant the required approvals, provided that any exercise of such authority is presented at the next Audit Committee meeting for ratification.
Each audit, non-audit and tax service that is approved by the Audit Committee will be reflected in a written engagement letter or writing specifying the services to be performed and the cost of such services, which will be signed by either a member of the Audit Committee or by one of our officers authorized by the Audit Committee to sign on our behalf.
The information regarding Principal AccountingAudit Committee will not approve any prohibited non-audit service or any non-audit service that individually or in the aggregate may impair, in the Audit Committee’s opinion, the independence of the independent auditor.
In addition, since January 1, 2003, our independent auditor may not provide any services to our officers or Audit Committee members, including financial counseling or tax services.
Audit Fees
During the fiscal years ended May 31, 2011 and Services is incorporated2010, the aggregate fees billed by reference toour principal accountants for professional services rendered for the information containedaudit of our annual financial statements, audits of effectiveness of internal control over financial reporting for fiscal 2010 only, and reviews of quarterly financial statements included in our 2008 definitive proxy statement.reports on Form 10-Q, and audit services provided in connection with other statutory or regulatory filings were $166,650 and $229,900, respectively.
Audit-Related Fees
None.

Tax Fees
During the fiscal years ended May 31, 2011 and 2010, the aggregate fees billed by our principal accountant for tax compliance, tax advice and tax planning rendered on our behalf were $13,708 and $18,934, respectively, which related to the preparation of federal and state income tax returns.
All Other Fees
Our principal accountant billed no other fees for the fiscal years ended May 31, 2011 and 2010, except as disclosed above.


2933


PART IV

ITEM 15.             EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)    The following documents are filed as a part of this Report:report:
 
 1.
Financial Statements. The following consolidated financial statements and Report of Independent Registered Public Accounting Firm are included starting on page F-1 of this Report:

Patriot Scientific Corporation

Report of KMJ Corbin & Company LLP, Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of May 31, 2008 and 2007

Consolidated Statements of Income for the Years Ended May 31, 2008, 2007 and 2006

Consolidated Statements of Stockholders’ Equity and Comprehensive Income for the Years Ended May 31, 2008, 2007 and 2006

Consolidated Statements of Cash Flows for the Years Ended May 31, 2008, 2007 and 2006

Notes to Consolidated Financial Statements

Phoenix Digital Solutions, LLC

Report of KMJ Corbin & Company LLP, Independent Registered Public Accounting Firm

Balance Sheets as of May 31, 2008 and 2007

Statements of Income for the Years Ended May 31, 2008, 2007 and 2006

Statement of Members’ Equity for the Years Ended May 31, 2008, 2007 and 2006

Statements of Cash Flows for the Years Ended May 31, 2008, 2007 and 2006
Patriot Scientific Corporation

Report of KMJ Corbin & Company LLP, Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of May 31, 2011 and 2010
Consolidated Statements of Operations for the Years Ended May 31, 2011 and 2010
Consolidated Statements of Stockholders’ Equity and Comprehensive Loss for the Years Ended May 31, 2011 and 2010
Consolidated Statements of Cash Flows for the Years Ended May 31, 2011 and 2010
Notes to Consolidated Financial Statements

Phoenix Digital Solutions, LLC

Report of KMJ Corbin & Company LLP, Independent Registered Public Accounting Firm
Balance Sheets as of May 31, 2011 and 2010
Statements of Income for the Years Ended May 31, 2011 and 2010
Statement of Members’ Equity for the Years Ended May 31, 2011 and 2010
Statements of Cash Flows for the Years Ended May 31, 2011 and 2010
Notes to Financial Statements
 
 2.
Financial Statement Schedules. All financial statement schedules have been omitted since the information is either not applicable or required or is included in the financial statements or notes thereof.
 
 3.
Exhibits. Those exhibits marked with a (*) refer to exhibits filed herewith. The other exhibits are incorporated herein by reference, as indicated in the following list. Those exhibits marked with a (†) refer to management contracts or compensatory plans or arrangements.
 

3034



Exhibit No.
Document
2.1
 
Agreement to Exchange Technology for Stock in the Company, incorporated by reference to Exhibit 2.1 to Form 8-K dated August 10, 1989 (Commission file No. 33-23143-FW)
 
2.2
Assets Purchase Agreement and Plan of Reorganization dated June 22, 1994, among the Company, nanoTronics Corporation and Helmut Falk, incorporated by reference to Exhibit 10.4 to Form 8-K dated July 6, 1994 (Commission file No. 000-22182)
2.2.1
 
Amendment to Development Agreement dated April 23, 1996 between the Company and Sierra Systems, incorporated by reference to Exhibit 2.2.1 to Pre-Effective Amendment No. 1 to Registration Statement on Form SB-2 filed April 29, 1996 (Commission file No. 333-01765)
 
2.3
 
Form of Exchange Offer dated December 4, 1996 between the Company and certain shareholders of Metacomp, Inc., incorporated by reference to Exhibit 2.3 to Form 8-K filed January 9, 1997 (Commission file No. 000-22182)
 
2.4
 
Letter of Transmittal to Accompany Shares of Common Stock of Metacomp, Inc. Tendered Pursuant to the Exchange Offer Dated December 4, 1996, incorporated by reference to Exhibit 2.4 to Form 8-K filed January 9, 1997 (Commission file No. 000-22182)
 
2.5
Agreement and Plan of Merger dated August 4, 2008, among the Company, PTSC Acquisition 1 Corp, Crossflo Systems, Inc. and the Crossflo principal officers, incorporated by reference to Exhibit 99.1 to Form 8-K filed August 11, 2008 (Commission file No. 000-22182)
3.1
 
Original Articles of incorporation of the Company’s predecessor, Patriot Financial Corporation, incorporated by reference to Exhibit 3.1 to registration statement on Form S-18, (Commission file No. 33-23143-FW)
 
3.2
 
Articles of Amendment of Patriot Financial Corporation, as filed with the Colorado Secretary of State on July 21, 1988, incorporated by reference to Exhibit 3.2 to registration statement on Form S-18, (Commission file No. 33-23143-FW)
 
3.3
 
Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on March 24, 1992, incorporated by reference to Exhibit 3.3 to Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)
 
3.3.1
 
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on April 18, 1995, incorporated by reference to Exhibit 3.3.1 to Form 10-KSB for the fiscal year ended May 31, 1995 (Commission file No. 000-22182)
 
3.3.2
 
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on June 24, 1997, incorporated by reference to Exhibit 3.3.2 to Form 10-KSB for the fiscal year ended May 31, 1997, filed July 18, 1997 (Commission file No. 000-22182)
 
3.3.3
 
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on April 28, 2000, incorporated by reference to Exhibit 3.3.3 to Registration Statement on Form S-3 filed May 5, 2000 (Commission file No. 333-36418)
 
3.3.4
 
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on May 6, 2002, incorporated by reference to Exhibit 3.3.4 to Registration Statement on Form S-310-Q for the quarterly period ended February 28, 2009, filed June 27, 2002April 9, 2009 (Commission file No. 333-91352)000-22182)
 
3.3.5
 
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on October 16, 2003, incorporated by reference to Exhibit 3.3.5 to Registration Statement on Form SB-2 filed May 21, 2004 (Commission file No. 333-115752)
 
3.3.6
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on April 29, 2005, incorporated by reference to Exhibit 3.3.6 to Form 10-Q for the quarterly period ended February 28, 2009, filed April 9, 2009 (Commission file No. 000-22182)
3.3.7
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on November 14, 2005, incorporated by reference to Exhibit 3.3.7 to Form 10-Q for the quarterly period ended February 28, 2009, filed April 9, 2009 (Commission file No. 000-22182)


3135



3.3.8
Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on March 18, 2009, incorporated by reference to Exhibit 3.3.8 to Form 10-K for the fiscal year ended May 31, 2009, filed August 14, 2009 (Commission file No. 000-22182)
3.4
Articles and Certificate of Merger of Patriot Financial Corporation into the Company dated May 1, 1992, with Agreement and Plan of Merger attached thereto as Exhibit A, incorporated by reference to Exhibit 3.4 to Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)
 
3.5
Certificate of Merger issued by the Delaware Secretary of State on May 8, 1992, incorporated by reference to Exhibit 3.5 to Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)
3.6
Certificate of Merger issued by the Colorado Secretary of State on May 12, 1992, incorporated by reference to Exhibit 3.6 to Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)
3.7
Bylaws of the Company, incorporated by reference to Exhibit 3.7 to Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)
4.1
Specimen common stock certificate, incorporated by reference to Exhibit 4.1 Form 8-K dated May 12, 1992 (Commission file No. 33-23143-FW)

4.2†
1996 Stock Option Plan of the Company dated March 25, 1996 and approved by the Shareholders on May 17, 1996, incorporated by reference to Exhibit 10.13 to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996 (Commission file No. 333-01765)
 
4.3†4.2†2001 Stock Option Plan of the Company dated February 21, 2001 incorporated by reference to Exhibit 4.19 to Registration Statement on Form S-8 filed March 26, 2001 (Commission file No. 333-57602)
4.4†
2003 Stock Option Plan of the Company dated July 2, 2003 incorporated by reference to Exhibit 4.27 to Registration Statement on Form S-8 filed September 4, 2003 (Commission file No. 333-108489)
4.3†
4.5†
2006 Stock Option Plan of the Company dated March 31, 2006as amended and restated, incorporated by reference to Exhibit 4.19Appendix C to Registrationthe Company Proxy Statement on Form S-8 filed June 20, 2006September 22, 2008 (Commission file No. 333-135156)
4.6Approval Rights Agreement and Termination of Antidilution Agreement and Addendum to Warrants dated October 10, 2006, incorporated by reference to Exhibit 4.29 to Form 10-KSB for the fiscal year ended May 31, 2006, filed on October 13, 2006 (Commission file No. 000-22182)
10.1IGNITE License Agreement with Advanced Micro Devices, Inc., dated February 21, 2005, incorporated by reference to Exhibit 10.38 to Form 10-KSB for the fiscal year ended May 31, 2006, filed on October 13, 2006 (Commission file No. 000-22182)
10.2Patent Portfolio License Agreement with Advanced Micro Devices, Inc., dated February 21, 2005, incorporated by reference to Exhibit 10.39 to Form 10-KSB for the fiscal year ended May 31, 2006, filed on October 13, 2006 (Commission file No. 000-22182)
10.3
Master Agreement, dated as of June 7, 2005, by and among the Company, Technology Properties Limited Inc., a California corporation and Charles H. Moore, an individual, incorporated by reference to Exhibit 10.40 to Form 8-K filed June 15, 2005 (Commission file No. 000-22182)
10.2
10.4
Commercialization Agreement dated as of June 7, 2005 by and among the JV LLC, Technology Properties Limited Inc., a California corporation, and the Company, incorporated by reference to Exhibit 10.41 to Form 8-K filed June 15, 2005 (Commission file No. 000-22182)
10.510.3
Limited Liability Company Operating Agreement of JV LLC, a Delaware limited liability company, dated as of June 7, 2005, incorporated by reference to Exhibit 10.42 to Form 8-K filed June 15, 2005 (Commission file No. 000-22182)
 
10.6†
10.4†
Agreement for Part-Time Employment dated August 3, 2005 between the Company and Thomas J. Sweeney, incorporated by reference to Exhibit 99.3 to Form 8-K filed August 9, 2005 (Commission file No. 000-22182)
10.7Settlement Agreement dated February 13, 2007 by and among the Company, Russell H. Fish, III and Robert C. Anderson as trustee of the Fish Family Trust incorporated by reference to Exhibit 10.45 to Registration Statement en Form SB-2 filed March 21, 2007 (Commission file No. 333-134362)
32

10.8†Employment Agreement dated June 5, 2007 by and between the Company and James Turley, incorporated by reference to Exhibit 10.1 to Form 8-K filed June 8, 2007 (Commission file No. 000-22182)
10.9†Employment Agreement dated September 17, 2007 by and between the Company and Clifford L. Flowers, incorporated by reference to Exhibit 10.1 to Form 8-K filed September 19, 2007 (Commission file No. 000-22182)
10.5†
10.10†
Employment Agreement dated February 29, 2008 by and between the Company and Frederick C. Goerner, incorporated by reference to Exhibit 99.1 to Form 8-K filed May 20, 2008 (Commission file No. 000-22182)
10.6*
Form of Indemnification Agreement by and between the Company and the Board of Directors
14.1
 
Code of Ethics for Senior Financial Officers incorporated by reference to Exhibit 14.1 to Form 10-K for the fiscal year ended May 31, 2003, filed August 29, 2003 (Commission file No. 000-22182)
21.121*
 
List of subsidiaries of the Company incorporated by reference to Exhibit 21.1 of the Company’s annual report on Form 10-KSB filed October 13, 2006 (Commission file No. 000-22182)
23.1*
 
Consent of Independent Registered Public Accounting Firm
23.2*


36



Consent of Independent Valuation Firm
31.1*
 
Certification of Frederick C. Goerner,Clifford L. Flowers, Interim CEO, pursuant to Rule 13a-14(a)/15d-14(a)13a-15(e) or Rule 15d-15(e)
31.2*
 
Certification of Clifford L. Flowers, CFO, pursuant to Rule 13a-14(a)/15d-14(a)13a-15(e) or Rule 15d-15(e)
32.1*
 
Certification of Frederick C. Goerner,Clifford L. Flowers, Interim CEO and CFO, pursuant to 18 U.S.C. Section 1350
32.2*
Certification of Clifford L. Flowers, CFO, pursuant to Section 1350
99.1
Form of ISO Plan Option (Gaspar) dated May 29, 1992, incorporated by reference to Exhibit 28.2 to registration statement on Form SB-2, 1996 (Commission file No. 33-57858)
99.2
Form of NSO Plan Option (Berlin) dated May 29, 1992, incorporated by reference to Exhibit 28.3 to registration statement on Form SB-2, 1996 (Commission file No. 33-57858)
99.3
Form of Incentive Stock Option Agreement to the Company’s 1996 stock Option Plan (individual agreements differ as to number of shares, dates, prices and vesting), incorporated by reference to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996 (Commission file No. 333-01765)
99.4
Form of Non-Qualified Stock Option Agreement to the Company’s 1996 Stock Option Plan (individual agreement differ as to number of shares, date, prices and vesting), incorporated by reference to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996 (Commission file No. 333-01765)
99.5
Press Release of the Company dated November 4, 1996 incorporated by reference to Exhibit 99.5 to Form 8-K filed January 9, 1997 (Commission file No. 000-22182)
99.6
 
Form of Incentive Stock Option Agreement to the Company’s 2001 Stock Option Plan incorporated by reference to Exhibit 99.6 to Registration Statement on Form S-8 filed March 26, 2001 (Commission file No. 333-57602)
 
99.799.2
 
Form of Non-Qualified Stock Option Agreement to the Company’s 2001 Stock Option Plan incorporated by reference to Exhibit 99.7 to Registration Statement on Form S-8 filed March 26, 2001 (Commission file No. 333-57602)
 
99.899.3
 
Form of Incentive Stock Option Agreement to the Company’s 2003 Stock Option Plan incorporated by reference to Exhibit 99.8 to Registration Statement on Form S-8 filed September 4, 2003 (Commission file No. 333-108489)
 
99.999.4
 
Form of Non-Qualified Stock Option Agreement to the Company’s 2003 Stock Option Plan incorporated by reference to Exhibit 99.9 to Registration Statement on Form S-8 filed September 4, 2003 (Commission file No. 333-108489)
99.5
Form of Incentive Stock Option Agreement to the Company’s 2006 Stock Option Plan incorporated by reference to Exhibit 99.10 on Form 10-K for the fiscal year ended May 31, 2009, filed August 14, 2009 (Commission file No. 000-22182)
99.6
Form of Non-Qualified Stock Option Agreement to the Company’s 2006 Stock Option Plan incorporated by reference to Exhibit 99.11 on Form 10-K for the fiscal year ended May 31, 2009, filed August 14, 2009 (Commission file No. 000-22182)

3337


Patriot Scientific Corporation

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS


  Page 
   
Report of Independent Registered Public Accounting Firm F-2F-2
 
Financial Statements:
    
Consolidated Balance Sheets F-3F-3
 
Consolidated Statements of IncomeOperationsF-4
  F-4 
Consolidated Statements of Stockholders’ Equity and Comprehensive IncomeLossF-5
  F-5 
Consolidated Statements of Cash Flows F-6F-7
 
Notes to Consolidated Financial Statements F-9F-8 


F-1


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors
Patriot Scientific Corporation

We have audited the accompanying consolidated balance sheets of Patriot Scientific Corporation and subsidiaries (the “Company”"Company") as of May 31, 20082011 and 2007,2010, and the related consolidated statements of income,operations, stockholders’ equity and comprehensive loss and cash flows for each of the two years in the three-year period ended May 31, 2008.2011. These consolidated financial statements are the responsibility of the Company’sCompany's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit on its internal control over financial reporting for the year ended May 31, 2011. Our audit for the year ended May 31, 2011 included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion for the year ended May 31, 2011. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Patriot Scientific Corporation and subsidiaries as of May 31, 20082011 and 2007,2010, and the consolidated results of their operations and their cash flows for each of the two years in the three-year period ended May 31, 20082011, in conformity with accounting principles generally accepted in the United States of America.

As discussed in Note 2 to the consolidated financial statements, effective June 1, 2006, the Company changed its method of accounting for share-based compensation to adopt Statement of Financial Accounting Standards No. 123(R), Share-Based Payment.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of May 31, 2008, based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated August 14, 2008 expressed an adverse opinion on the Company’s internal control over financial reporting.

/s/ KMJ Corbin & Company LLP
Irvine,Costa Mesa, California
August 14, 200829, 2011







F-2


Patriot Scientific Corporation
Consolidated Balance Sheets

May 31,
 2008  2007  2011  2010 
      
ASSETS            
      
Current assets:            
Cash and cash equivalents $6,424,015  $21,605,428  $8,453,665  $10,340,110 
Restricted cash and cash equivalents  51,122   102,346   20,809   20,705 
Marketable securities and short term investments  298,243   4,349,314 
Current portion of marketable securities  2,207,009   12,105 
Accounts receivable  538,500   352,390   187,465   149,504 
Accounts receivable – affiliated company  7,501   -   129,345   7,010 
Notes receivable  450,115   - 
Inventory  388,141   46,361 
Notes receivable, net  -   1,116,382 
Work-in-process  30,581   136,637 
Prepaid income taxes  222,311   2,070,981   904,200   930,272 
Deferred tax assets  1,390,832   2,439,975 
Current portion of deferred tax assets  -   472,707 
Prepaid expenses and other current assets  79,840   431,840   262,629   231,718 
Total current assets  9,850,620   31,398,635   12,195,703   13,417,150 
                
Marketable securities  12,527,675   - 
        
Marketable securities, net of current portion  -   5,133,835 
Property and equipment, net   68,504   85,518   17,613   37,099 
        
Goodwill  -   642,981 
Other intangible assets, net  -   1,722,222 
Deferred tax assets, net of current portion  -   5,911,732 
Other assets  8,190   8,190   83,804   43,033 
        
Investments in affiliated companies   2,913,614   2,883,969 
        
Patents and trademarks, net of accumulated amortization of $622,003 and $607,657
  63,299   38,317 
Investment in affiliated company  300,283   507,629 
Total assets $25,431,902  $34,414,629  $12,597,403  $27,415,681 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY                
        
Current liabilities:                
Accounts payable $555,690  $934,298  $328,245  $493,519 
Accrued expenses and other  373,848   1,086,496   196,830   292,004 
Deferred revenue  50,502   156,084 
Total current liabilities  929,538   2,020,794   575,577   941,607 
                
Deferred tax liabilities   1,085,181   12,222,944 
Other non-current liabilities  3,240   - 
Long term debt, including accrued interest  -   3,122,144 
Total liabilities  2,014,719   14,243,738   578,817   4,063,751 
                
Commitments and contingencies                 
                
Minority interest  115,406   - 
        
Stockholders’ equity                
Preferred stock, $.00001 par value; 5,000,000 shares authorized: none outstanding  -   - 
Common stock, $.00001 par value: 500,000,000 shares authorized: 410,979,163 shares issued and 389,414,915 shares outstanding at May 31, 2008 and 406,668,661 shares issued and 393,201,134 shares outstanding at May 31, 2007  4,109   4,066 
Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding  -   - 
Common stock, $0.00001 par value: 600,000,000 shares authorized: 438,167,618 shares issued and 407,526,799 shares outstanding at May 31, 2011 and 438,167,618 shares issued and 408,821,071 shares outstanding at May 31, 2010  4,381   4,381 
Additional paid-in capital  70,004,814   72,150,581   77,314,301   77,241,227 
Accumulated deficit  (33,763,357)  (43,151,678)  (51,077,059)  (39,561,669)
Common stock held in treasury, at cost – 21,564,248 shares at May 31, 2008 and 13,467,527 shares at May 31, 2007  (12,723,172)  (8,832,078)
Common stock held in treasury, at cost – 30,640,819 shares at May 31, 2011 and 29,346,547 shares at May 31, 2010  (14,223,037)  (14,085,015)
Accumulated other comprehensive loss  (220,617)  -   -   (246,994
Total stockholders’ equity  23,301,777   20,170,891   12,018,586   23,351,930 
Total liabilities and stockholders’ equity $25,431,902  $34,414,629  $12,597,403  $27,415,681 

See accompanying notes to consolidated financial statements

F-3


Patriot Scientific Corporation
Consolidated Statements of IncomeOperations

Years Ended May 31, 2008  2007  2006 
          
Revenues:         
Licenses and royalties $-  $-  $10,000,000 
Product sales and other  3,708,218   638,784   309,709 
   3,708,218   638,784   10,309,709 
             
Cost of sales  1,510,450   319,374   103,351 
             
Gross profit  2,197,768   319,410   10,206,358 
             
Operating expenses:            
Research and development  -   -   225,565 
Selling, general and administrative  6,964,861   7,558,712   4,151,099 
Settlement and license expense  836,400   7,524,537   1,918,054 
Total operating expenses  7,801,261  ��15,083,249   6,294,718 
Operating income (loss)  (5,603,493)  (14,763,839)  3,911,640 
             
Other income (expense):            
Unrealized loss on marketable securities  -   -   (1,466)
Interest and other income  1,470,008   714,790   330,055 
Gain (loss) on sale of assets  (4,139)  (3,163)  2,724 
Interest expense  (389)  (355)  (516,465)
Loss on debt extinguishments  -   -   (445,427)
Change in fair value of warrant and derivative liabilities  -   -   (2,456,736)
Impairment of note receivable  -   (339,551)  - 
Impairment of investment in affiliated company  -   (126,746)  - 
Gain on sale of subsidiary interest  150,000   -   - 
Equity in earnings of affiliated companies  19,917,769   48,965,084   27,848,363 
Total other income, net  21,533,249   49,210,059   24,761,048 
             
Income before income taxes and minority interest  15,929,756   34,446,220   28,672,688 
             
Provision for income taxes  6,426,029   10,755,033   - 
             
Minority interest  115,406   -   - 
             
Net income $9,388,321  $23,691,187  $28,672,688 
             
Basic income per common share $0.02  $0.06  $0.09 
             
Diluted income per common share $0.02  $0.06  $0.07 
             
Weighted average number of common shares outstanding - basic  390,956,153   378,036,989   316,100,499 
             
Weighted average number of common shares outstanding - diluted  397,485,699   413,599,373   412,963,173 
See accompanying notes to consolidated financial statements.
F-4

Patriot Scientific Corporation
Consolidated Statements of Stockholders’ Equity and Comprehensive Income

  Common Stock           Accumulated    
  Shares  Amounts  
Additional
Paid-in Capital
  Accumulated Deficit  Treasury Stock  Other Comprehensive Loss Stockholders’ Equity (Deficit)Comprehensive Income 
Balance, June 1, 2005  280,492,013  $2,805  $55,459,253  $(62,702,442) $-  $-  $(7,240,384) $- 
                                 
Issuance of common stock for services at $1.53 per share  193,548   2   296,127   -   -   -   296,129   - 
Exercise of warrants and options at $.02 to $.69 per share  12,824,544   128   851,070   -   -   -   851,198   - 
Conversion of debentures payable plus accrued interest at $.02 and $.04 per share  30,819,187   308   998,729   -   -   -   999,037   - 
Cashless exercise of warrants  41,245,473   412   (412)  -   -   -   -   - 
Issuance of common stock to co-inventor of technology at $.13 per share  625,000   6   81,244   -   -   -   81,250   - 
Extension of term of options previously issued to consultant  -   -   125,000   -   -   -   125,000   - 
Repurchase of warrants  -   -   (252,420)  -   -   -   (252,420)  - 
Issuance of warrants to a consultant  -   -   108,102   -   -   -   108,102   - 
Intrinsic value of options issued to employees and directors  -   -   120,000   -   -   -   120,000   - 
Cash dividends at $.02 and $.04 per share  -   -   -   (24,698,337)  -   -   (24,698,337)  - 
Reclassification of derivative value associated with debt conversions and warrant exercises  -   -   5,021,353   -   -   -   5,021,353   - 
Reclassification of warrant and derivative liabilities at settlement date  -   -   6,743,935   -   -   -   6,743,935   - 
Net income              28,672,688   -   -   28,672,688   - 
                              
Balance, May 31, 2006  366,199,765  $3,661  $69,551,981  $(58,728,091) $-  $-  $10,827,551  $- 
                                 
Exercise of warrants and options at $.05 to $.40 per share  1,787,500   18   213,982   -   -   -   214,000   - 
Cashless exercise of warrants  38,681,396   387   (387)  -   -   -   -   - 
Non-cash compensation  -   -   2,359,036   -   -   -   2,359,036   - 
Extension of stock options previously issued to a consultant  -   -   324   -   -   -   324   - 
Tax effect of exercise of stock options granted under APB 25  -   -   25,645   -   -   -   25,645   - 
Purchase of common stock for treasury  (13,467,527)  -   -   -   (8,832,078)  -   (8,832,078)  - 
Cash dividends at $.02 per share  -   -   -   (8,114,774)  -   -   (8,114,774)  - 
Net income  -   -   -   23,691,187   -   -   23,691,187   - 
                       -         
Balance, May 31, 2007  393,201,134  $4,066  $72,150,581  $(43,151,678) $(8,832,078) $-  $20,170,891  $- 

F-5

Patriot Scientific Corporation
Consolidated Statements of Stockholders’ Equity and Comprehensive Income, continued

  Common Stock                   
  Shares  Amounts  Additional Paid-in Capital  Accumulated Deficit    Treasury Stock  
Accumulated
Other Comprehensive Loss
  Stockholders’ Equity (Deficit)  Comprehensive Income 
Exercise of warrants and options at $.05 to $.10 per share  425,000  $4  $30,846  $-  $-  $-  $30,850  $- 
Cashless exercise of options  982,846   10   (10)  -   -   -   -   - 
Cashless exercise of warrants  2,702,656   27   (27)  -   -   -   -   - 
Non-cash compensation  -   -   509,971   -   -   -   509,971   - 
Repurchase of warrants  -   -   (2,760,900)  -   -   -   (2,760,900)  - 
Tax effect of exercise of stock options granted under APB 25  -   -   (25,645)  -   -   -   (25,645)  - 
Issuance of stock in connection with settlement with former CFO  200,000   2   99,998   -   -   -   100,000   - 
Purchase of common stock for treasury  (8,096,721)  -   -   -   (3,891,094)  -   (3,891,094)  - 
Net income  -   -   -   9,388,321   -   -   9,388,321   9,388,321 
Unrealized loss on investments, net of tax  -   -   -   -   -   (220,617)  (220,617)  (220,617)
Total comprehensive income                             $9,167,704 
Balance, May 31, 2008  389,414,915  $4,109  $70,004,814  $(33,763,357) $(12,723,172) $(220,617) $23,301,777     
Years Ended May 31, 2011  2010 
Revenues:      
License and service revenue $468,678  $567,934 
         
Cost of sales:        
License and service revenue  76,242   119,568 
Amortization of purchased intangibles  252,593   551,154 
Impairment of purchased intangibles  1,469,629   3,530,263 
 Total cost of sales  1,798,464   4,200,985 
Gross loss  (1,329,786)  (3,633,051)
         
Operating expenses:        
Research and development  753,017   1,503,724 
Selling, general and administrative  3,713,240   6,530,972 
Impairment of goodwill  642,981   1,096,268 
Total operating expenses
  5,109,238   9,130,964 
Operating loss  (6,439,024)  (12,764,015)
         
Other income (expense):        
Interest and other income  109,246   154,482 
Interest expense  (20,810)  (80,567)
Gain on sale of Verras Medical, Inc. assets  -   182,397 
Gain on sale of Vigilys business line  60,000   - 
Recovery of (reserve for) loan loss  1,013,151   (1,013,151)
Impairment of investment in affiliated companies  -   (1,548,807)
Realized loss on sale of marketable securities  (600,879)  - 
Equity in earnings of affiliated companies, net  600,460   4,461,483 
Total other income, net  1,161,168   2,155,837 
         
Loss before income taxes  (5,277,856)  (10,608,178)
         
Provision (benefit) for income taxes  6,237,534   (3,928,357)
         
Net loss $(11,515,390) $(6,679,821)
         
Basic loss per common share $(0.03) $(0.02)
         
Diluted loss per common share $(0.03) $(0.02)
         
Weighted average number of common shares outstanding - basic  405,252,953   407,051,407 
         
Weighted average number of common shares outstanding - diluted  405,252,953   407,051,407 


See accompanying notes to consolidated financial statements.

F-6F-4


Patriot Scientific Corporation
Consolidated Statements of Stockholders’ Equity and Comprehensive Loss
  Common Stock           Accumulated       
  Shares  Amounts  Additional Paid-in Capital  Accumulated Deficit  Treasury Stock  Other Comprehensive Loss  Stockholders’ Equity  Comprehensive Loss 
Balance, June 1, 2009  410,354,054  $4,380  $77,008,332  $(32,881,848) $(13,850,659) $(629,314) $29,650,891    
Exercise of options at $0.07 per share  100,000   1   7,449               7,450    
Share-based compensation          221,642               221,642    
Tax effect of exercise of stock options          3,804               3,804    
Purchase of common stock for treasury  (1,632,983)  -   -   -   (234,356)  -   (234,356)   
Net loss              (6,679,821)          (6,679,821)  (6,679,821)
Unrealized gain on investments, net of tax  -   -   -   -   -   382,320   382,320   382,320 
Total comprehensive loss                             $(6,297,501)
Balance, May 31, 2010  408,821,071  $4,381  $77,241,227  $(39,561,669) $(14,085,015) $(246,994) $23,351,930     
Share-based compensation      -   76,879   -   -   -   76,879     
Tax effect of exercise of stock options      -   (3,805)  -   -   -   (3,805)    
Purchase of common stock for treasury  (1,294,272)  -   -   -   (138,022)  -   (138,022)    
Net loss      -   -   (11,515,390)  -   -   (11,515,390)  (11,515,390)
Reversal of unrealized loss due to recognition in current fiscal year                      246,994   246,994   246,994 
    Total comprehensive loss                             $(11,268,396
Balance May 31, 2011  407,526,799  $4,381  $77,314,301  $(51,077,059) $(14,223,037) $-  $12,018,586     








See accompanying notes to consolidated financial statements.


F-5


Patriot Scientific Corporation
Consolidated Statements of Cash Flows

Years Ended May 31, 2008  2007  2006 
Operating activities:         
Net income $9,388,321  $23,691,187  $28,672,688 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:            
Minority interest in variable interest entity  115,406   -   - 
Amortization and depreciation  50,705   64,861   59,415 
Non-cash interest expense related to convertible debentures, notes payable and warrants  -   -   470,736 
Expense related to extension of expiration date of stock options  -   324   125,000 
Net gain related to warrant re-pricing, reconveyance and issuance  -   -   (538,208)
Loss on extinguishment of debt  -   -   445,427 
Accrued interest income added to investments  (1,391)  (2,026)  (19,778)
Equity in earnings of affiliated companies  (19,917,769)  (48,965,084)  (27,848,363)
(Gain) loss on sale of assets  4,139   3,163   (2,724)
Unrealized loss on marketable securities  -   -   1,466 
Issuance of stock, options and warrants for services  100,000   -   554,245 
Change in fair value of derivative liabilities  -   -   2,456,736 
Intrinsic value of options issued  -   -   120,000 
Non-cash compensation relating to issuance and vesting of stock options and vesting of warrants  509,971   2,359,036   - 
Impairment of note receivable  -   339,551   - 
Impairment of investment in affiliated company  -   126,746   - 
Gain on variable interest entity sale of portion of subsidiary interest  (150,000)  -   - 
Deferred taxes  (9,936,912)  9,782,969   - 
Changes in operating assets and liabilities:            
Accounts receivable  (186,110)  (186,560)  (4,113)
Receivable from affiliated company  (7,501)  -   - 
Inventory  (341,780)  1,970   - 
Prepaid expenses and other current assets  355,990   (24,294)  (261,769)
Prepaid income taxes  1,848,670   (2,070,981)  - 
Licenses receivable  -   -   2,000,000 
Accounts payable and accrued expenses  (1,091,256)  1,122,499   194,811 
Accrued contested fee payable  -   (394,063)  48,063 
Net cash provided by (used in) operating activities  (19,259,517)  (14,150,702)  6,473,632 
Investing activities:            
Proceeds from sale of short-term investments  22,076,589   8,832,078   2,027,557 
Purchase of short-term investments  (30,925,518)  (9,662,513)  (4,832,482)
Proceeds from sale of fixed assets  225   -   6,540 
Purchase of restricted investments  -   -   (100,000)
Proceeds from sale of restricted investments  52,500   -   203,210 
Payment for security deposit  -   -   (8,190)
Purchase of property and equipment  (27,699)  (5,827)  (71,037)
Costs incurred for patents and trademarks  (39,328)  -   - 
Proceeds from variable interest entity sale of portion of subsidiary interest  100,000   -   - 
Investment in affiliated companies  (400,000)  (120,000)  (2,000,000)
Distributions from affiliated company  20,288,124   50,034,029   25,895,449 
Purchase of convertible note receivable  (400,000)  -   - 
Issuance of note receivable  -   (589,551)  - 
Cash received in consolidation of variable interest entity  -   40,970   - 
Net cash provided by investing activities  10,724,893   48,529,186   21,121,047 
Financing activities:            
Payment of cash dividends  -   (8,114,774)  (24,698,337)
Principal payments on notes payable  -   (50,089)  (100,000)
Payments for capital lease obligations  -   -   (2,306)
Proceeds from exercise of common stock warrants and options  30,850   214,000   851,198 
Repurchase of warrants  (2,760,900)  -   (252,420)
Repurchase of common stock for treasury  (3,891,094)  (8,832,078)  - 
Tax effect of exercise of options granted under APB 25  (25,645)  25,645   - 
Net cash used in financing activities  (6,646,789)  (16,757,296)  (24,201,865)
Years Ended May 31, 2011  2010 
Operating activities:      
Net loss $(11,515,390) $(6,679,821)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization and depreciation  277,163   602,226 
Share-based compensation relating to issuance of stock options  76,879   221,642 
Impairment of intangibles  1,469,629   3,530,263 
Impairment of goodwill  642,981   1,096,268 
Accrued interest income added to investments and notes receivable  (13,826)  (55,020)
Equity in earnings of affiliated companies  (600,460)  (4,461,483)
Realized loss on sale of marketable securities  600,879   - 
Impairment of investment in affiliated companies  -   1,548,807 
Gain on sale of Verras Medical, Inc. assets  -   (182,397)
Gain on sale of Vigilys business line  (60,000)  - 
Loss on sale of assets  1,719   3,122 
Reserve for (recovery of) loan loss  (1,013,151)  1,013,151 
Deferred income taxes  6,215,268   (3,508,416)
Changes in operating assets and liabilities:        
Accounts receivable  (37,961)  18,146 
Receivable from affiliated company  (122,335)  (1,543)
Work-in-process  106,056   (109,358)
Prepaid expenses and other current assets  (11,682)  83,213 
Prepaid income taxes  26,072   (423,746)
Deferred revenue  (105,582  129,773 
Accounts payable and accrued expenses  (257,208)  (142,083)
Net cash used in operating activities  (4,320,949)  (7,317,256)
Investing activities:        
Proceeds from sale of marketable securities  4,961,226   6,146,187 
Purchases of marketable securities  (2,205,000)  - 
Proceeds from sale of restricted investments  -   31,643 
Purchases of property and equipment  (6,803)  (72,669)
Issuance of note receivable  -   (2,005,000)
Repayment of note receivable  2,141,246   628,112 
Investments in affiliated companies  -   (612,500)
Distributions from affiliated company  807,806   7,557,827 
Net cash provided by investing activities  5,698,475   11,673,600 
Financing activities:        
Proceeds from exercise of common stock options  -   7,450 
Repurchase of common stock for treasury  (138,022)  (234,356)
Tax effect of expiration/cancellation/exercise of stock options  (3,805)  3,804 
Payment on note payable  (3,122,144)  - 
Net cash used in financing activities  (3,263,971)  (223,102)
Net increase (decrease) in cash and cash equivalents  (1,886,445)  4,133,242 
Cash and cash equivalents, beginning of year  10,340,110   6,206,868 
Cash and cash equivalents, end of year $8,453,665  $10,340,110 


F-7F-6





Patriot Scientific Corporation
Consolidated Statements of Cash Flows, continued

Years Ended May 31, 2008  2007  2006 
          
Net increase (decrease) in cash and cash equivalents  (15,181,413)  17,621,188   3,392,814 
Cash and cash equivalents, beginning of year
  21,605,428   3,984,240   591,426 
Cash and cash equivalents, end of year $6,424,015  $21,605,428  $3,984,240 
             
             
Supplemental Disclosure of Cash Flow Information:            
             
Cash payments for interest $389  $355  $2,983 
Cash payments for income taxes $14,528,000  $3,017,400  $- 
             
Supplemental Disclosure of Non-Cash Investing and Financing Activities:            
             
Convertible debentures, notes payable and accrued interest exchanged for common stock $-  $-  $999,037 
Reclassification of derivative liabilities associated with debt conversions and warrant exercises $-  $-  $5,021,353 
Reclassification of warrant and derivative liabilities at settlement date $-  $-  $6,743,935 
Cashless exercise of warrants $27  $387  $412 
Cashless exercise of stock options $10  $-  $- 
Note receivable issued in connection with variable interest entity sale of portion of subsidiary interest $50,000  $-  $- 
Reclassification of prepaid software costs to property and equipment $3,990  $-  $- 
Deferred taxes related to unrealized loss on investments in marketable securities charged to other comprehensive income $151,708  $-  $- 
Fair market value of assets received in collection of note receivable and subsequently contributed for preferred stock of affiliate $-  $250,000  $- 
Years Ended May 31, 2011  2010 
       
Supplemental Disclosure of Cash Flow Information:      
Cash payments for interest $137,785  $- 
Cash payments for income taxes $-  $- 
         
Supplemental Disclosure of Non-Cash Investing and Financing Activities:        
Unrealized recovery on investments in marketable securities charged to other comprehensive income adjusted for deferred tax benefit $-  $382,320 
Reversal of unrealized loss charged to other comprehensive income at May 31, 2010 adjusted for deferred tax benefit due to recognition of loss in current fiscal year $(246,994) $- 


See accompanying notes to consolidated financial statements.
 
 
See accompanying notes to consolidated financial statements.


F-8F-7


Patriot Scientific Corporation
Notes to Consolidated Financial Statements

1. Organization and Business

Patriot Scientific Corporation (“we”(the “Company”, “PTSC”, “we”, “us”, or “our”), was organized under Delaware law on March 24, 1992 and is the successor by merger to Patriot Financial Corporation, a Colorado corporation, incorporated on June 10, 1987. In 1997, we acquired Metacomp, Inc. which we dissolved in September 2008 and in June 2005 we entered into a joint venture agreement with Technology Properties Limited, Inc. (“TPL”) to form Phoenix Digital Solutions, LLC (“PDS”).  In March 2007, we became the primary beneficiary of Scripps Secured Data, Inc. (“SSDI”), a variable interest entity and were required to consolidate SSDI effective in March 2007.  During May 2008, we acquired a 15%an interest in Talis Data Systems, LLC (“Talis”), a Delaware LLC that produces multi-domain hardware.  At May 31,During the third quarter of fiscal 2010, Talis was dissolved.  In September 2008, SSDI haswe acquired Patriot Data Solutions Group, Inc. (formerly known as Crossflo Systems, Inc.) (“PDSG”), a 12% interestCalifornia company.  During the fiscal year 2009, we acquired preferred shares of Avot Media, Inc. (“Avot”) an innovator of video transcoding and near real-time streaming to web-enabled mobile devices.  In March 2010, Avot sold substantially all of its assets.  In January 2010, we sold the assets of Verras Medical, Inc. and in Talis.August 2010 we sold the Vigilys business line both formerly associated with PDSG.

Our primary operating activity has been as an intellectual property company that licenses our jointly held patent portfolio technology, through our interest in PDS, to others and litigates against those who infringe upon the patent portfolio technology.  Through the acquisition of PDSG, an additional primary operating activity is providing data sharing services and secure data solutions.

SSDI developsLiquidity and manufactures network-security hardwareManagement’s Plans

Cash shortfalls currently experienced by PDS and TPL, and continued negative cash flows incurred by PDSG, will have an adverse effect on our liquidity.  Accordingly, we have and may continue to government, military,examine alternatives that could allow for the partnering or divestiture of PDSG.  If successful, these measures may provide for a further reduction in expenses and other high-security facilities.cash use, or additionally in the event of divestiture, cash proceeds, although given the operational history of PDSG to date there can be no guarantee that a divestiture will result in the realization of material consideration.  With respect to PDS and TPL, we do not intend to fund any cash requirements of these entities.

While our current liquid cash resources as of May 31, 2011, are expected to provide the funds necessary to support our operations through at least the next twelve months, the cash flows from our interest in PDS represents our primary significant source of cash generation.  In the event of a continued decrease or interruption in MMP Portfolio licensing we will incur a significant reduction to our cash position as the revenues from our PDSG subsidiary are insufficient to cover the costs of their operations and the costs of Patriot Scientific Corporation as a whole.  While our cash position has been enhanced as a result of our September 2010 auction rate securities settlement with Deutsche Bank, it is highly unlikely that we would be able to obtain any additional sources of financing to supplement our cash and short-term investment position of $10,660,674 at May 31, 2011.

2. Summary of Significant Accounting Policies

Basis of Consolidation
The consolidated balance sheet at May 31, 2011 includes our accounts and those of our wholly owned subsidiary PDSG which includes Crossflo Systems, Inc., and our inactive subsidiary Plasma Scientific Corporation.  All significant intercompany accounts and transactions have been eliminated.  In August 2010, we sold the business line Vigilys.

The consolidated balance sheet at May 31, 2010 includes our accounts and those of our wholly owned subsidiary PDSG which includes our acquisitions of Crossflo Systems, Inc., the business line Vigilys and our inactive subsidiary Plasma Scientific Corporation.  All significant intercompany accounts and transactions have been eliminated.  In January 2010, we sold the assets of Verras Medical, Inc.

The consolidated statement of incomeoperations for the fiscal year ended May 31, 20062011 includes our accounts, and those of our majoritywholly owned subsidiary PDSG which includes Crossflo Systems, Inc., the business line Vigilys (until August 2010) and our inactive subsidiaries, Metacomp, Inc. andsubsidiary Plasma Scientific Corporation. The consolidated balance sheets at May 31, 2008 and 2007 and the statements of income for the fiscal years ended May 31, 2008 and 2007 include our accounts, those of our majority owned inactive subsidiaries that are not considered variable interest entities (“VIE”s) and all VIEs for which we are the primary beneficiary.  All significant intercompany accounts and transactions have been eliminated.

Consolidation of Affiliate
In January 2003, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation 46, Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51 (“FIN 46”). In December 2003, the FASB modified FIN 46 (“FIN 46(R)”). FIN 46 provides a new framework for identifying VIEs and determining when a company should include the assets, liabilities, noncontrolling interests and results of activities of a VIE in its consolidated financial statements.

A VIE is a corporation, partnership, limited liability corporation, trust or any other legal structure used to conduct activities or hold assets that either (1) has an insufficient amount of equity to carry out its principal activities without additional subordinated financial support, (2) has a group of equity owners that are unable to make significant decisions about its activities, or (3) has a group of equity owners that do not have the obligation to absorb losses or the right to receive returns generated by its operations.

FIN 46 requires a VIE to be consolidated if a party with an ownership, contractual or other financial interest in the VIE is obligated to absorb a majority of the risk of loss from the VIE’s activities, is entitled to receive a majority of the VIE’s residual returns (if no party absorbs a majority of the VIE’s losses), or both. A variable interest holder that consolidates the VIE is called the primary beneficiary. Upon consolidation, the primary beneficiary generally must initially record all of the VIE’s assets, liabilities, and noncontrolling interests at fair value and subsequently account for the VIE as if it were consolidated based on majority voting interest.

FIN 46 was effective immediately for VIEs created after January 31, 2003. The provisions of FIN 46(R), were adopted as of December 31, 2003, for our interests in all VIEs. Beginning with the quarter ended May 31, 2007, we consolidated SSDI as SSDI was deemed a VIE and we determined that we were the primary beneficiary of SSDI.

F-9F-8


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Basis of Consolidation (continued)
The consolidated statement of operations for the fiscal year ended May 31, 2010 includes our accounts, and those of our wholly owned subsidiary PDSG which includes Crossflo Systems, Inc., the operations of Verras Medical, Inc. (until January 2010), and the business line Vigilys and our inactive subsidiary Plasma Scientific Corporation.  All significant intercompany accounts and transactions have been eliminated.

Financial Instruments and Concentrations of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, cash equivalents, investments in marketable securities, and trade accounts receivable.

At times, our balance of cash maintained with our bank may exceed the Federal Deposit Insurance Corporation’s (“FDIC”) insured limit of $100,000.$250,000. At May 31, 2008,2011 and 2010, neither PTSC’s nor PDSG’s cash and cash equivalents balance exceedingbalances subject to FDIC insurance exceeded the FDIC limit was $25,000.limit.  At May 31, 2008, SSDI’s cash2011 and cash equivalents balance exceeding the FDIC limit was $203,888.  Certain other cash equivalents are not insured by the FDIC. At May 31, 2008,2010, PTSC’s cash and cash equivalents balance consisting of money market accounts not subject to FDIC insurance was $6,121,546.$8,080,005 and $10,095,240, respectively.  We limit our exposure of loss by maintaining our cash with financially stable financial institutions. When we have excess cash, our cash equivalents are placed in certificates of deposit and high quality money market accounts with major financial institutions. We believe this investment policy limits our exposure to concentrations of credit risk.

InvestmentsAt May 31, 2011, investments in marketable securities consist of certificates of deposit with maturities greater than three months.  Each certificate of deposit is invested with a financial institution for $245,000 or less so as not to exceed the FDIC insurance limit.

At May 31, 2010, investments in marketable securities consisted of AAA rated student loan auction rate instruments issued by various state agencies pursuant to the Federal Family Educational Loan Program (“FFELP”).  These investments arewere collateralized in excess of the underlying obligations, arewere insured by the various state educational agencies, and arewere guaranteed by the Department of Education as an insurer of last resort.

Concentrations of credit risk with respect to accounts receivable are limited due to the wide variety of customers and markets which comprise our customer base, as well as their dispersion across many different geographic areas.can be significant. We routinely assess the financial strength of our customers and, as a consequence, believe that our accounts receivable credit risk exposure is limited. Generally, we do not require collateral or other security to support customer receivables.  AsThe table below illustrates PDSG’s gross accounts receivable concentrations by customer as of May 31, 2008, Anixter accounted for 15.8% of gross accounts receivable2011 and Graybar Electric Company, Inc. accounted for 38% of gross accounts receivable.  As of May 31, 2007, Anixter accounted for 80.7% of gross accounts receivable and Graybar Electric Company, Inc. accounted for 11.1% of gross accounts receivable.2010:

  2011  2010 
Customer A  13.2%   71.5 
Customer B  -   22.1 
Customer C  71.3%   - 
Customer D  15.5%   - 

Fair Value of Financial Instruments

Our financial instruments consist principally of cash and cash equivalents, investments in marketable securities, and short-term investments, accounts receivable, accounts payable, accrued expenses and accrued expenses.long term debt.  The carrying value of these financial instruments, other than the investments in marketable securities consisting of auction rate securities, approximates fair value because of the immediate or short-term maturity of the instruments.

Our  The interest rate on our long term debt was based on market indices,  The fair value of our cash equivalents and investments in marketable securities consistis determined based on quoted prices in active markets for identical assets or Level 1 inputs. The fair value of auction rate securities.  Historically, the carrying value ofour auction rate securities approximated fair value duewas based on Level 3 inputs. Level 3 inputs are unobservable inputs used to the frequent resetting of the interest rate.  While we continue to receive interest payments on our auction rate investments despite failed auctions, we believe the carrying value of these auction rate securities no longer approximates fair value.  We estimatedestimate the fair value of these securities at May 31, 2008 based on an independent valuation performed by Houlihan Smith & Company Inc., an independent valuation firm.  In determiningassets or liabilities and are utilized to the estimateextent observable inputs are not available. We recognize transfers between Levels 1 through 3 of the fair value consideration was given to credit quality, estimated cash flows, and estimated probabilities of default, auction failure and a successful auctionhierarchy at par or repurchase at par.  Based on this valuation, we recorded a net temporary impairment of $220,617 in other comprehensive income at May 31, 2008, which represents the gross valuation adjustment of $372,325, netbeginning of the related tax benefitreporting period. We believe that the carrying values of $151,708 (see Note 6).all other financial instruments approximate their current fair values due to their nature and respective durations.



F-9


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Cash Equivalents, Restricted Cash, and Short-Term InvestmentsMarketable Securities
For purposes of balance sheet classification and the statements of cash flows, we consider all highly liquid investments acquired with a maturity of three months or less to be cash equivalents.

Restricted cash and cash equivalents at May 31, 20082011 and 20072010 consist of twoa savings accounts required to beaccount held as collateral for our corporate credit card accounts.

F-10

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Cash Equivalents, Restricted Cash, and Short-Term Investments (continued)account.

At May 31, 2007,2011 our short-term investments consist primarily of money market mutual funds and accounts, and are reported at cost, which approximate fair market value.  At May 31, 2008, PTSC’s short-term investmentsmarketable securities in the amount of $288,099$2,207,009 consist of accrued interest receivable on our auction rate securities which is receivable semi-annually according to the terms specified in each auction rate security instrument.  At May 31, 2008, SSDI’s short-term investments consist of a certificatecertificates of deposit in the amountwith various financial institutions, with maturity dates of $10,144 with a maturity date of December 11, 2008.  These values are reported at cost, which approximate fair market value.twelve months or less.

Accounts Receivable
OurAt May 31, 2011 and 2010, our accounts receivable consists primarily of the accounts of SSDI.  SSDI’sPDSG.  PDSG’s accounts receivable consist of trade receivables recorded at the original invoice amount, less an estimated allowance for uncollectible accounts of which there was none at May 31, 2008.2011 and 2010.  Trade receivables are periodically evaluated for collectibility based on past credit histories with customers and their current financial condition.  Changes in the estimated collectibility of trade receivables are recorded in the results of operations for the period in which the estimate is revised.  Trade receivables that are deemed uncollectible are offsetwritten off against the allowance for uncollectible accounts.  SSDI also calculates a sales returns reserve based on terms of its distribution contracts with Anixter and Graybar Electric Company, Inc.

InventoryWork-In-Process
InventoryAt May 31, 2011 and 2010, work-in-process represents the excess of SSDI consists of raw materials and finished goods manufactured by third party vendors. The cost of inventory is determined using a method that approximates first-in, first-out and has been stated at the lower of cost or net realizable value.recognized revenue over invoices to customers on PDSG’s current contracts in-progress.

Investments in Marketable Securities
We account for our investments in marketable securities in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 115, Accounting for Certain Investments in Debt and Equity Securities, and FASB Staff Position SFAS No. 115-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments.  We determine the appropriate classification of our investments at the time of purchase and reevaluate such designation at each balance sheet date.  Our investments in marketable securities have been classified and accounted for as available-for-sale based on management’s investment intentions relating to these securities.  Available-for-sale marketable securities are stated at market value based on market quotes.fair value.  Unrealized gains and losses, net of deferred taxes, are recorded as a component of other comprehensive income (loss).  We follow the authoritative guidance provided by Emerging Issues Task Force (“EITF”) Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments, to assess whether our investments with unrealized loss positions are other than temporarily impaired.  Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income, (expense), net in the consolidated statements of income.operations.  During the year ended May 31, 2011, we disposed of our remaining investments in auction rate securities which had an aggregate fair value of $5.2 million (see Note 4).

Property, Equipment and Depreciation
Property and equipment are stated at cost and are depreciated using the straight-line method over the estimated useful lives of the assets, ranging from twothree to five years.  Major betterments and renewals are capitalized, while routine repairs and maintenance are charged to expense when incurred.

PatentsBusiness Combinations and TrademarksIntangible Assets Including Goodwill
PTSC’s patentsBusiness combinations are accounted for using the purchase method of accounting and trademarksaccordingly, the assets and liabilities of the acquired entities are carriedrecorded at cost less accumulated amortizationtheir estimated fair values at the acquisition date.  Goodwill represents the excess of the purchase price over the fair value of net assets, including the amount assigned to identifiable intangible assets.  Obtaining information needed to finalize the fair value of the acquired assets and liabilities takes time and frequently occurs over several quarters.  Accordingly, it is common for initial fair value estimates to be subsequently revised.  The results of operations of acquired businesses are included in our consolidated financial statements from the acquisition date.

Identifiable intangible assets with finite lives are amortized on a straight-line basis over their estimated useful liveslives.  They are reviewed for impairment if indicators of four years. In fiscal year 2008 PTSC’s patents were fully amortized.potential impairment exist.  Goodwill is tested for impairment on an annual basis.

SSDI holds patents expiringImpairment of Goodwill, Intangible Assets and Other Long-Lived Assets
Management assesses the recoverability of our long-lived assets by determining whether the carrying value can be recovered through projected undiscounted future cash flows for identifiable intangible assets with infinite lives and based on a valuation utilizing the income approach for goodwill.  The amount of long-lived asset impairment, if any, is measured based on fair value and is charged to operations in 14 years and 20 years. Estimated future annual amortization expense arising from these patentsthe period in which long-lived asset impairment is approximately $4,112 per year.determined by management. 

Total amortization expense related to patents and trademarks was $14,346, $23,192 and $34,824 during the years ended May 31, 2008, 2007 and 2006, respectively.

F-11F-10


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Impairment of Goodwill, Intangible Assets and Other Long-Lived Assets (continued)
Based on a combination of factors occurring during fiscal 2011 and fiscal 2010, including the current economic environment, market conditions, and decline in value of our common stock, management has determined that indicators for impairment of goodwill and intangible assets existed.

The inability of PDSG to meet its business plan and the general economic environment were indicators of potential impairment on our goodwill and intangible assets, accordingly, management determined that goodwill was impaired by approximately $643,000 and $1,096,000, respectively, for the fiscal years ended May 31, 2011 and 2010 and PDSG’s intangibles were impaired by approximately $1,470,000 and $3,530,000, respectively, for the fiscal years ended May 31, 2011 and 2010.  We have recorded these as impairments of goodwill and purchased intangibles on our consolidated statements of operations for the fiscal years ended May 31, 2011 and 2010 in general and administrative expenses and cost of sales, respectively.

Investments in Affiliated Companies
We have a 50% interest in PDS (see Note 9). Effective June 1, 2010, we adopted new authoritative guidance for consolidation of variable interest entities (“VIE”).  The adoption of this guidance did not have a material effect on our consolidated financial statements.  As of the date of this filing, PDS is a VIE of which we are not the primary beneficiary and therefore do not consolidate PDS’ accounts with our own as we cannot direct the licensing activity of TPL on behalf of PDS.  This investment is accounted for using the equity method of accounting since the investment provides us the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if we have an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize our share of net earnings or losses of the investee andwhich is recognizedpresented in the consolidated statements of incomeoperations in the caption “Equity in earnings of affiliated companies”.companies, net” and also is adjusted by contributions to and distributions from PDS.

We havehad a 15.09%39.4% interest in Talis (see Note 9).  We accountPrior to the write-off of our investment in Talis during the quarter ended August 31, 2009, we were accounting for our investment using the equity method of accounting pursuant to paragraph 8 of AICPA Statement of Position 78-9, Accounting for Investments in Real Estate Ventures (which has applicability to non-real estate entities as well) as our membership share of this limited liability company is more than minor.accounting.  Under the equity method of accounting, the investment, originally recorded at cost, iswas adjusted to recognize our share of net earnings or losses of the investee and is recognizedwas presented in the consolidated statementstatements of incomeoperations in the caption “Equity in earnings of affiliated companies”.companies, net.”  In December 2009,  Talis was dissolved.

We owned 37.1% of the preferred stock of Avot (see Note 9).  Prior to the write-off of our investment in Avot during the quarter ended November 30, 2009, we were accounting for our investment at cost since we did not have the ability to exercise significant influence over the operating and financial policies of Avot.  During March 2010, Avot sold substantially all of its assets and we collected our note receivable and accrued interest.
We own 100% of the preferred stock of Holocom (see Note 9). Prior to impairment, this investment was accounted for at cost since we did not have the ability to exercise significant influence over the operating and financial policies of Holocom.
We review our investments in these affiliated companies to determine whether events or changes in circumstances indicate that the carrying amounts may not be recoverable. The primary factors we consider in our determination are the financial condition, operating performance and near term prospects of the investees. If the decline in value is deemed to be other than temporary, we would recognize an impairment loss.

Long-Lived Assets
Management assessesDuring the recoverabilityfiscal year ended May 31, 2010, management determined that: our investment in Talis was impaired by approximately $680,000, our investment in Avot was impaired by approximately $433,000 and that the inability of Holocom to meet its business plan, raise capital, and the general economic environment were indicators of impairment on our long-lived assets by determining whetherinvestment, and accordingly we wrote-off our investment in the depreciation and amortizationpreferred stock of long-lived assets over their remaining lives can be recovered through projected undiscounted future cash flows.  The amountHolocom amounting to approximately $435,000.  We have recorded these as “Impairment of long-lived asset impairment, if any, is measured basedinvestment in affiliated companies, net” on fair value and is charged toour consolidated statement of operations in other income (expense) for the period in which long-lived asset impairment is determined by management.  Atfiscal year ended May 31, 2008, management believes there is no impairment of our long-lived assets.  There can be no assurance, however, that market conditions will not change or demand for our products will continue, which could result in impairment of long-lived assets in the future.2010.

Treasury Stock
We account for treasury stock under the cost method and include treasury stock as a component of stockholders’ equity.

Derivative Financial Instruments
In connection with the issuance of certain convertible debentures (see Note 12), the terms of the debentures included an embedded reset conversion feature which provided for a conversion of the debentures into shares of our common stock at a rate which was determined to be variable. We determined that the reset conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended, and EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock. The accounting treatment of derivative financial instruments required that we record the derivatives and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date.  In addition, under the provisions of EITF Issue No. 00-19, as a result of entering into the convertible debenture agreements, we were required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date.  Any change in fair value was recorded as non-operating, non-cash income or expense at each balance sheet date.  If the fair value of the derivatives was higher at the subsequent balance sheet date, we recorded a non-operating, non-cash charge.  If the fair value of the derivatives was lower at the subsequent balance sheet date, we recorded non-operating, non-cash income.

During the year ended May 31, 2006, we recognized other expense of approximately $2,457,000 related to recording the warrant and derivative liabilities at fair value. During fiscal 2006, the related variable debt instruments were settled in full.  At the settlement date, the remaining warrant liabilities with a value of approximately $6,744,000 were reclassified to additional paid-in capital.

Our derivative instruments were valued using a Monte Carlo simulation model incorporating the instruments’ multiple reset dates.
F-12F-11


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Derivative Financial Instruments (continued)

The following assumptions were used for valuing the embedded derivatives during the year ended May 31, 2006:
May 31, 2006
Estimated dividendsNone
Expected volatility101 - 229%
Risk-free interest rate3.5 - 5.1%
Expected term (years)2 - 7

Comprehensive Income (Loss)
Comprehensive Income
Comprehensive income (loss) as presented in the consolidated statements of stockholders’ equity includes unrealized gains and losses which are excluded from the consolidated statements of income in accordance with SFAS No. 130, Reporting Comprehensive Income.operations.  For the fiscal year ended May 31, 2008,2010, this amount included unrealized gains and losses on investments classified as available-for-sale.  The amount is presented net of fiscal year 2010 tax-related effectsexpense of $151,708.$253,126.  For the fiscal year ended May 31, 2011 due to the settlement of our ARS, we reversed the unrealized loss of $416,165 adjusted for deferred tax benefit of $169,171 as of August 31, 2010.

Revenue Recognition
We recognize revenueRevenue from technology license agreements is recognized at the sale of our product upon shipment totime a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), and the customer at which time title transfers and we have no further obligations.is provided with the licensed technology, if applicable.  Fees for maintenance or support are recorded on a straight-line basis over the underlying period of performance. Revenue from technology license agreements is recognized at the time we enter into a contract, determine the license method (paid-in-advance or on-going royalty), and provide the customer with the licensed technology, if applicable.

SSDIPDSG sells software and services to end users primarily through relationships with systems integrators and prime contractors.  PDSG recognizes revenue upon shipmentin accordance with authoritative guidance for the software industry.  PDSG’s revenue is derived primarily from the following sources: (i) software licensing, (ii) related professional services, and (iii) post contract customer support (“PCS”) agreements.  PCS agreements typically include software updates, on a when and if available basis, telephone and Internet access to technical support personnel. Software updates provide customers with rights to unspecified software product upgrades and to maintenance releases and patches released during the term of its productthe support period.

PDSG’s contracts with customers, including systems integrators and prime contractors, are multiple element arrangements which contain professional services that are considered essential to the functionality of the other elements of the arrangement.  PDSG accounts for revenue on these arrangements according to authoritative guidance for contract accounting. Under this guidance, PDSG recognizes revenue based on progress towards contract completion measured by actual hours incurred in relation to the estimate of total expected hours. PDSG measures these revenues by applying the contract-specific estimated percentage of completion to the total contract amount for software and professional services.  PDSG routinely updates the estimates of future hours for agreements in process and reports any cumulative effects of such adjustments in current operations. PDSG immediately recognizes any loss expected on these contracts when it is projected that loss is probable.

On June 1, 2010, we adopted new authoritative guidance on a prospective basis for revenue arrangements containing multiple deliverables.  This guidance requires us to allocate PDSG’s revenues to all deliverables based on their relative selling price using a specific hierarchy.  The hierarchy is as follows:  vendor-specific objective evidence (“VSOE”), third-party evidence of selling price (“TPE”) or best estimate of selling price (“BESP”).

When a sale involves multiple elements, PDSG allocates the entire fee from the arrangement to each respective element based on VSOE of fair value and recognizes revenue when each element’s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately.  PDSG has established VSOE for its short-term installation contracts as timeCDX software licenses and materials costs are incurred.PCS based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts.  PCS is recognized on a straight-line basis over the support period.

SSDI maintains agreementsPDSG has not yet demonstrated VSOE for the professional services that are rendered in conjunction with stocking distributors. These agreements provideits software license sales.  In accordance with the hierarchy we attempt to establish the selling price of professional services using TPE.  PDSG’s product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained.  PDSG is typically not able to obtain TPE for professional services.

When we are unable to establish selling prices using VSOE or TPE, we use BESP.  The objective of BESP is to determine the price at which PDSG would transact a limited product warrantysale if professional services were sold on a stand-alone basis.  BESP is generally used for offerings that are not typically sold on a period of one year fromstand-alone basis or for highly customized offerings which is the date of salecase with PDSG’s professional services deliverable.

Due to the end user. The warranty does not cover damage to the product after it has been delivered to the distributor. SSDI’s stocking distributor agreements also allow limited rights to periodic stock rotation.  These rotation rights allow for the exchange of a percentage of distributor inventory for replacement products of the distributor’s choosing.  At May 31, 2008, SSDI  has evaluated the potential for rotated product and has provided for the estimated impact in the accounting records.   

Sales through large distributors account forfact that the majority of SSDI’s product revenues, with a majorityPDSG’s contracts require significant customization of sales to Anixter duringsoftware, we are recognizing revenue for the fiscal year 2007,CDX software licenses and Anixter, Graybar Electric Company, Inc. and Victory Global Solutions, Inc. during fiscal year 2008.

Shipping and Handling
EITF Issue No. 00-10, Accounting for Shipping and Handling Fees and Costs, requires shipping and handling fees billed to customers to be classified as revenue and shipping and handling costs to be classified as either costprofessional services over the customization period using contract accounting which reflects continuous release of sales or disclosed incontrol of the notessoftware to the customer. The adoption of this guidance did not have a material effect on our consolidated financial statements. SSDI includes shipping and handling fees billed to customers in net sales. Shipping and handling costs associated with inbound freight are included in cost of sales.

Advertising
We expense advertising costs as incurred. For the fiscal year ended May 31, 2008, we incurred $2,097 of advertising costs.  There were no advertising costs for the years ended May 31, 2007 and 2006.



F-13F-12


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Selling, General and Administrative
Selling expenses include items such as sales salaries and commissions, marketing and advertising costs and consultant services.  Advertising costs are expensed as incurred and were not significant for the fiscal years ended May 31, 2011 and 2010.  General and administrative expenses include costs for items such as salaries, legal and accounting, and insurance.

Research and Development
Research and development costs are expensed as incurred and primarily include payroll and related benefit costs and contractor fees.

Income Taxes
We account forrecognize deferred income taxes under SFAS No. 109, Accounting for Income Taxes. Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. ValuationWe establish valuation allowances are established when necessary to reduce deferred tax assets to the amount expectedwe expect to be realized.  realize.  

Additionally,We must assess the likelihood that we adopted Financial Accounting Standards Board, (“FASB”) Interpretation No. 48, Accountingwill be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for Uncertainty in Income Taxes – An Interpretation of FASB Statement No. 109, (“FIN 48”),taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that the deferred tax assets recorded on June 1, 2007, the first day of fiscal 2008.  FIN 48 seeksour balance sheet will not be recovered. Accordingly, we have a full valuation allowance on our net deferred tax assets.

We follow authoritative guidance to reduce the diversity in practice associated with certain aspects of measurement and recognition in accounting for income taxes.  FIN 48This authoritative guidance prescribes a recognition threshold and measurement requirement for the financial statement recognition of a tax position that has been taken or is expected to be taken on a tax return and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.  Under FIN 48this guidance we may only recognize tax positions that meet a “more likely than not” threshold.

Net IncomeLoss Per Share
We apply SFAS No. 128, Earnings Per Share, for the calculation of "Basic" and "Diluted" earnings per share. Basic earningsnet loss per share includes no dilution and is computed by dividing incomeloss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflectsreflect the potential dilution of securities that could share in the earnings of an entity. At May 31, 2008, 2007 and 2006,2011 potential common shares of 2,645,000, 330,000 and 2,295,000, respectively,3,010,000 related to our outstanding options were not included in the calculation of diluted income per share as we had no income.  At May 31, 2010 potential common shares of 5,962,917 related to our outstanding warrants and options were not included in the calculation of diluted income per share as theywe had no income.  Had we reported net income for the years ended May 31, 2011 and 2010, an anti-dilutive effect.additional 755,000 and 410,000, respectively, shares of common stock would have been included in the calculation of diluted income per share.

In connection with our acquisition of Crossflo, which is now a part of PDSG, we issued 2,844,630 escrow shares that are contingent upon certain representations and warranties made by Crossflo at the time of the merger agreement (see Note 14).  We exclude these escrow shares from the basic loss per share calculations and include the escrowed shares in the diluted earnings per share calculations.

The following presents the basic loss per share for the years ended May 31, 2011 and 2010:
 
  Year Ended May 31, 2008 
  Numerator (Income) Denominator (Shares) Per Share Amount 
Basic EPS:       
Net income $9,388,321 390,956,153 $0.02 
          
Diluted EPS:         
Effect of dilutive securities:         
Options and warrants  - 6,529,546    
          
Income available to common shareholders $9,388,321 397,485,699 $0.02 


  Year Ended May 31, 2011 
  
Numerator
(Loss)
 
Denominator
(Shares)
  
Per Share
Amount
 
Basic EPS:         
Net loss $(11,515,390)  405,252,953  $(0.03)
Diluted EPS:  -   -     
Loss available to common shareholders $(11,515,390)  405,252,953  $(0.03)
F-14

F-13


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Net IncomeLoss Per Share (continued)

  Year Ended May 31, 2007 
  Numerator (Income) Denominator (Shares) Per Share Amount 
Basic EPS:       
Net income $23,691,187 378,036,989 $0.06 
          
Diluted EPS:         
Effect of dilutive securities:         
Options and warrants  - 35,562,384    
          
Income available to common shareholders $23,691,187 413,599,373 $0.06 
  
Year Ended May 31, 2010
 
  
Numerator
(Loss)
  
Denominator
(Shares)
  
Per Share
Amount
 
Basic EPS:         
Net loss $(6,679,821)  407,051,407  $(0.02)
Diluted EPS:  -   -     
 
Loss available to common shareholders
 $(6,679,821)  407,051,407  $(0.02)

  Year Ended May 31, 2006 
  Numerator (Income) Denominator (Shares) Per Share Amount 
Basic EPS:       
Net income $28,672,688 316,100,499 $0.09 
          
Diluted EPS:         
Interest on convertible debentures  458,467      
Effect of dilutive securities:         
Options and warrants  - 80,273,769    
Convertible debentures  - 16,588,905    
          
Income available to common shareholders $29,131,155 412,963,173 $0.07 
Use of Estimates
The preparation of financial statements in conformityaccordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying footnotes.  Actual results could differ from those estimates.  On an ongoing basis we evaluate our estimates, including, but not limited to: the realizability of accounts and notes receivable, valuation of inventory,work-in-process, fair values of investments in marketable securities, the use, recoverability, and /or realizability of certain assets, including investments in affiliated companies, intangible assets, goodwill, deferred tax assets, and stock-based compensation.

Minority Interest
Minority interest in our consolidated financial statements results from the accounting for the acquisition of a noncontrolling interest in SSDI. Noncontrolling interest represents a partially owned subsidiary’s income, losses, and components of other comprehensive income which should be attributed to the controlling and noncontrolling interests or other parties with a right or obligation that affects the attribution of comprehensive income or loss, on the basis of their contractual rights or obligations, if any, otherwise, on the basis of ownership interests.

F-15

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Net Income Per Share (continued)

The noncontrolling interest in SSDI, which we are required to consolidate as we are the primary beneficiary, had been reduced to zero due to the initial allocation of losses prior to the period in which we were required to consolidate. If a noncontrolling interest has been reduced to zero, the primary beneficiary must absorb any losses that are in excess of the value of the noncontrolling interest’s equity. For the period in which we are required to consolidate, March 27, 2007 through May 31, 2007 we absorbed $169,913 of SSDI’s losses as we are the primary beneficiary.  For the fiscal year ended May 31, 2008, SSDI had net income of $285,319 after taxes.  Under the provisions of FIN 46 (R), we are able to recover our absorbed losses before allocating income to the noncontrolling interest.  At May 31, 2008, the minority interest presented in our consolidated financial statements is $115,406, the amount of SSDI’s fiscal 2008 net income after tax less our absorbed losses during fiscal 2007.

Stock-BasedShare-Based Compensation
On June 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based Payment, which establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, primarily focusing on accounting for transactions where an entity obtains employee services in share-based payment transactions. SFAS No. 123(R) requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

We adopted SFAS No. 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of June 1, 2006, the first day of our fiscal year 2007. Our consolidated financial statements as of May 31, 2007 reflect the impact of adopting SFAS No. 123(R). In accordance with the modified prospective transition method, our consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of SFAS No. 123(R). SFAS No. 123(R) requires us to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statement of income. Prior to the adoption of SFAS No. 123(R), we accounted for stock-based awards to employees and directors using the intrinsic value method in accordance with APB No. 25 as allowed under SFAS No. 123. Under the intrinsic value method, no employee stock-based compensation expense had been recognized in our consolidated statements of income, other than as related to option grants to employees and directors below the fair market value of the underlying stock at the date of grant.

Stock-basedShare-based compensation expense recognized during the periodyear is based on the grant date fair value of the portion of share-based payment awards that is ultimately expected to vest during the period. Stock-based compensation expense recognized in our consolidated statements of income for the fiscal years ended May 31, 2007 and 2008 included compensation expense foryear.  As share-based payment awards granted prior to, but not yet vested as of May 31, 2006 based on the grant date fair value estimated in accordance with the pro forma provisions of SFAS No. 123, Accounting for Stock-Based Compensation, and compensation expense for the share-based payment awards granted subsequent to May 31, 2006 based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123(R). As stock-based compensation expense recognized in the consolidated statements of incomeoperations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures.  SFAS No. 123(R) requires forfeitures to beForfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.  The estimated average forfeiture rate for the fiscal years ended May 31, 2008 and May 31, 2007, of approximately 5% wasForfeiture rates are based on historical forfeiture experience and estimated future employee forfeitures. The estimated pricing term of option grants for the fiscal years ended May 31, 2008 and May 31, 2007 was five years.  In our proforma information required under SFAS123(R) for fiscal 2006, we accounted for forfeitures as they occurred.

In November 2005, FASB issued FASB Staff Position No. FAS 123R-3, Transition Election Related to Accounting for Tax Effects of Share-Based Payment Awards (“FAS 123R-3”).  We have elected to adopt the alternative transition method provided in FAS 123R-3.  The alternative transition method includes a simplified method to establish the beginning balance of the additional paid-in capital pool (“APIC pool”) related to the tax effects of employee share-based compensation, which is available to absorb tax deficiencies recognized subsequent to the adoption of SFAS No. 123(R). Excess tax benefits exist when the tax deduction resulting from the exercise of options exceeds the compensation cost recorded. SFAS No. 123(R)

F-16


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stock-Based Compensation (continued)

requires the cash flows resulting from such excess tax benefits to be classified as financing cash flows. During the year ended May 31, 2007, we classified excess tax benefits of $25,645 as financing cash inflows.

The stock options exercised and canceled during the year ended May 31, 2008 resulted in a net reduction in a deferred income tax asset of $636,245 because the share-based compensation cost previously recognized by us was greater than the deduction allowed for income tax purposes based on the price of our common stock on the date of exercise. This reduction in the deferred income tax asset resulted in a reduction to our APIC pool of $25,645. The remaining reduction in the deferred income tax asset in excess of our APIC pool of $414,782 resulted in an increase in our effective income tax rate for the year ended May 31, 2008 and an increase in our income taxes payable of $195,818.

Summary of Assumptions and Activity
The following table illustrates the effect on net income per share for the year ended May 31, 2006 as if we had applied the fair value recognition provisions of SFAS No. 123 to options granted under our stock option plans. For purposes of this pro forma disclosure, the fair value of the options is estimated using the Black-Scholes option-pricing model and amortized on a straight-line basis to expense over the options' vesting period:

  
Year Ended
May 31, 2006
 
Net income - as reported $28,672,688 
     
Add: Share-based employee compensation included in net income, net of tax effects  120,000 
     
Deduct: Share-based employee compensation expense determined under fair value method, net of tax effects  (1,639,913)
     
Net income - pro forma $27,152,775 
     
Net income per common share - as reported    
Basic $0.09 
Diluted $0.07 
     
Net income per common share - pro forma    
Basic $0.09 
Diluted $0.07 

The fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the pricing term of the grant effective as of the date of the grant. The expected volatility for the fiscal years ended May 31, 2008, 2007 and 2006 is based on the historical volatilities of our common stock.  These factors could change in the future, affecting the determination of stock-based compensation expense in future periods.

F-17

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stock-Based Compensation (continued)

Year Ended
May 31, 2008
Year Ended
May 31, 2007
Year Ended
May 31, 2006
Expected term5 yrs5 yrs5 yrs
Expected volatility122 - 128%146 – 156%115 – 158%
Risk-free interest rate2.23 - 4.96%4.78 - 5.00%3.78 - 4.93%
Expected dividends2.82%--

A summary of option activity as of May 31, 2008 and changes during the fiscal year then ended, is presented below:








In September 2006,June 2009, the FASB issued SFAS No. 157, Fair Value Measurements.  SFAS No. 157 defines fair value, establishes a frameworkFinancial Accounting Standards Board (“FASB”) revised the authoritative guidance for measuring fair value in generally accepted accounting principals and expands disclosures about fair value measurements.the consolidation of variable interest entities.  The statement does not require new fair value measurements, butobjective of this authoritative guidance is applied to the extent that other accounting pronouncements require or permit fair value measurements.improve financial reporting by enterprises involved with variable interest entities.  The statement emphasizes that fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability.  Companies that have assets and liabilities measured at fair value will be required to disclose information that enables the users of its financial statements to access the inputs used to develop those measurements.  The reporting entity is encouraged, but not required, to combine the fair value information disclosed under this statement with the fair value information disclosed under other accounting pronouncements.  SFAS No. 157revised authoritative guidance is effective for fiscal yearsas of the beginning of each reporting entity’s first annual reporting period that begins after November 15, 2007.2009.  We expect to adopt SFAS No. 157adopted this guidance on June 1, 2008.  In February 2008, the FASB released FASB Staff Position 157-2, Effective Date of FASB Statement No. 157, which delayed the effective date of SFAS No. 157 for all nonfinancial assets2010 and nonfinancial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually) until the fiscal year beginning May 31, 2009.  We are in the process of evaluating the provisions of the statement, but do not anticipate that the adoption of SFAS No. 157 will have a materialhad no impact on our consolidated financial statements.

In February 2007,July 2009, the FASB issued SFAS No. 159,revised the authoritative guidance relating to software revenue recognition to exclude all tangible products containing both software and non-software components that function together to deliver the product’s essential functionality. The Fair Value Optionrevised authoritative guidance is effective for Financial Assets and Financial Liabilities. SFAS No. 159 permits entities to choose to measure at fair value many financial instruments and certain other items that are not currently required to be measured at fair value. The objective is to improve financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS No. 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 does not affect any existing accounting literature that requires certain assets and liabilities to be carried at fair value. SFAS No. 159 does not establish requirements for recognizing and measuring dividend income, interest income,revenue arrangements entered into or interest expense. This Statement does not eliminate disclosure requirements included in other accounting standards. SFAS No. 159 is effectivematerially modified in fiscal years beginning on or after NovemberJune 15, 2007. We are in the process of evaluating the provisions2010, and shall be applied on a prospective basis. Earlier application is permitted as of the statement, but dobeginning of an entity’s fiscal year provided it has not anticipatepreviously issued financial statements for any period within that year. We adopted this guidance on June 1, 2010, and the adoption of SFAS No. 159 will have a materialhad no impact on our consolidated financial statements.


F-19F-14


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Recent Accounting Pronouncements (continued)

In December 2007,January 2010, the FASB issued SFAS No. 141(R), Business Combinations. SFAS No. 141(R)guidance to amend the disclosure requirements related to fair value measurements. The guidance requires acquiring entities in a business combination to recognizethe disclosure of roll forward activities on purchases, sales, issuance, and settlements of the assets acquired and liabilities assumed in the transaction; establishes the acquisition-datemeasured using significant unobservable inputs (Level 3 fair value asmeasurements). The guidance will become effective for us with the measurement objective for all assets acquired and liabilities assumed; and requires the acquirer to disclose to investors the information it needs to evaluate and understand the nature and financial effect of the business combination. SFAS No. 141(R) is effective in fiscal yearsreporting period beginning after December 15, 2008. We expect to adopt SFAS No. 141(R) on June 1, 2009.  We are currently assessing the impact2011. Other than requiring additional disclosures, the adoption of SFAS No. 141(R)this new guidance will not have a material impact on our consolidated financial statements.

In December 2007,May 2011, the FASB issued SFAS No. 160, Noncontrolling Interestsguidance to amend the accounting and disclosure requirements on fair value measurements. The new guidance limits the highest-and-best-use measure to nonfinancial assets, permits certain financial assets and liabilities with offsetting positions in Consolidated Financial Statements. SFAS No. 160 requires entitiesmarket or counterparty credit risks to report noncontrolling (minority) interestsbe measured at a net basis, and provides guidance on the applicability of premiums and discounts. Additionally, the new guidance expands the disclosures on Level 3 inputs by requiring quantitative disclosure of the unobservable inputs and assumptions, as well as description of the valuation processes and the sensitivity of the fair value to changes in subsidiaries as equity in the consolidated financial statements. SFAS No. 160 isunobservable inputs. The new guidance will be effective in fiscal yearsfor us beginning after December 15, 2008.March 1, 2012. We expectdo not anticipate adoption to adopt SFAS No. 160 on June 1, 2009.  We are currently assessing thehave a material impact the adoption of SFAS No. 160 will have on our consolidated financial statements.

In June 2011, the FASB issued guidance on presentation of comprehensive income. The new guidance eliminates the current option to report other comprehensive income and its components in the statement of changes in equity. Instead, an entity will be required to present either a continuous statement of net income and other comprehensive income or in two separate but consecutive statements. The new guidance will be effective for us beginning June 1, 2012 and will result in presentation changes only for our consolidated financial statements.

3. Goodwill and Other Intangible Assets

Goodwill originating from acquisitions is not amortized and is tested for impairment on an annual basis and between annual tests based on certain circumstances.

Purchased intangible assets were being amortized over a period of 9 months to 10 years.  After impairment, the technology of PDSG was being amortized over 81 months.

Management’s plan of restructuring on October 5, 2009 and the continuing inability of PDSG to meet its business plan were indicators of potential impairment on our intangible assets. Accordingly, during the fiscal years ended May 31, 2011 and 2010, it was determined that intangibles were impaired by approximately $1,470,000 and $3,530,000, respectively.  We have recorded this as an impairment of purchased intangibles on our consolidated statements of operations for the fiscal years ended May 31, 2011 and 2010.

The following tables present detail of our other intangible assets and related accumulated amortization balances, which were recorded as a result of business combinations and asset purchases:

 
Estimated
Life in
Years
  
Allocated
Value
  
Accumulated
Amortization
  Impairment  
Net Carrying Value
May 31,
2011
 
               
Technologies and processes  6.75  $1,722,222  $(252,593) $(1,469,629) $- 




F-15


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Goodwill and Other Intangible Assets (continued)

 Estimated       
Net Carrying
Value
 
 Life in Allocated Accumulated   May 31, 
 Years Value Amortization Impairment 2010 
           
Customer contracts –open orders  0.75  $63,600  $(63,600) $-  $- 
Customer relationships  5.00   65,000   (11,064)  (53,936)  - 
Maintenance agreements  4.00   75,400   (23,565)  (51,835)  - 
Trademarks/names  10.00   124,500   (11,972)  (112,528)  - 
Technologies and processes  5.00–8.00   6,136,900   (1,102,714)  (3,311,964)  1,722,222 
      $6,465,400  $(1,212,915) $(3,530,263) $1,722,222 

We have included the amortization expense and related impairment charges on intangible assets that relate to products sold in cost of sales.  

The amortization expense related to intangible assets was as follows:

  Fiscal Year Ended  Fiscal Year Ended 
  May 31, 2011  May 31, 2010 
Amortization of intangible assets included in:      
Cost of sales $252,593  $551,154 

Management’s plan of restructuring on October 5, 2009 and the continuing inability of PDSG to meet its business plan were indicators of potential impairment on our goodwill. Accordingly, during the fiscal years ended May 31, 2011 and 2010, management determined that goodwill was impaired by an aggregate of approximately $643,000 and $1,096,000, respectively.  We have recorded this as an impairment of goodwill on our consolidated statement of operations for the fiscal years ended May 31, 2011 and 2010.
The changes in the carrying amount of goodwill for the fiscal years ended May 31, 2011 and 2010 are as follows:

Balance, June 1, 2009 $1,739,249 
Impairment of Verras goodwill  (196,512)  
Impairment of Vigilys goodwill  (110,004)  
Impairment of Crossflo goodwill  (789,752)  
Balance, May 31, 2010 $642,981 
Impairment of Crossflo goodwill  (642,981)
Balance, May 31, 2011 $- 

F-16


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

4. Fair Value Measurements

At May 31, 2011, our current portion of marketable securities in the amount of $2,207,009 consists of the par value plus accrued interest of time deposits.  At May 31, 2010, our current portion of marketable securities in the amount of $12,105 consists of accrued interest receivable on our auction rate securities which was receivable semi-annually according to the terms specified in each auction rate security instrument.  These values are reported at cost, which approximate fair market value.

We follow authoritative guidance to account for our financial assets and liabilities at fair value.  Under this authoritative guidance we are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. We determine fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment or valuations by third party professionals. The three levels of inputs that we may use to measure fair value are:

3.Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).
The following tables detail the fair value measurements within the fair value hierarchy of our cash, cash equivalents and investments in marketable securities:

     Fair Value Measurements at May 31, 2011 Using 
     Quoted Prices  Significant    
     in Active  Other  Significant 
  Fair Value at  Markets for  Observable  Unobservable 
  May 31,  Identical Assets  Inputs  Inputs 
  2011  (Level 1)  (Level 2)  (Level 3) 
Cash and cash equivalents:            
Cash:            
Cash $128,655  $128,655  $-  $- 
Restricted cash  20,809   20,809   -   - 
Cash equivalents:                
Money market funds  8,080,005   8,080,005   -   - 
Certificates of deposit  245,005   245,005   -   - 
Marketable securities:                
Certificates of deposit  2,207,009   2,207,009   -   - 
Total $10,681,483  $10,681,483  $-  $- 


F-17


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Fair Value Measurements (continued)

     Fair Value Measurements at May 31, 2010 Using 
     Quoted Prices  Significant    
     in Active  Other  Significant 
  Fair Value at  Markets for  Observable  Unobservable 
  May 31,  Identical Assets  Inputs  Inputs 
  2010  (Level 1)  (Level 2)  (Level 3) 
Cash and cash equivalents:            
Cash:            
Cash $244,870  $244,870  $-  $- 
Restricted cash  20,705   20,705   -   - 
Cash equivalents:                
Money market funds  10,095,240   10,095,240   -   - 
Marketable securities:                
Auction rate securities  5,133,835   -   -   5,133,835 
Total $15,494,650  $10,360,815  $-  $5,133,835 

The following table summarizes the activity for the period by investment type for the fiscal years ended May 31, 2011 and 2010:
  
Fair Value 
Measurements Using Quoted Prices in Active Markets for Identical Assets  
(Level 1)
  
Fair Value 
Measurements Using
Significant Unobservable Inputs
(Level 3)
 
  Time Deposits  
Auction Rate
 Securities
 
Beginning balance June 1, 2010 $-  $5,133,835 
Purchases and interest  2,452,014   - 
Total realized/unrealized recovery (losses):        
Realized loss included in earnings  -   (600,879)
Reversal of unrealized losses included in other comprehensive income (loss)  -   416,165 
Settlements  -   (350,000)
Settlements  -   (4,599,121)
Ending balance May 31, 2011 $2,452,014  $- 

F-18


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Fair Value Measurements (continued)

  
Fair Value 
Measurements Using 
Significant
Unobservable Inputs
(Level 3)
 
Description
 
Auction Rate
 Securities
 
Beginning balance, June 1, 2009 $10,598,389 
Transfers in to Level 3  —   
Total realized/unrealized recovery (losses):  —   
Included in earnings  —   
Recoveries of unrealized losses included in other comprehensive loss  635,446 
Unrealized losses included in other comprehensive income (loss)  - 
Settlements  (6,100,000)
Ending balance, May 31, 2010 $5,133,835 
     
     
Total amount of unrealized losses for the fiscal year ended May 31, 2010 included in accumulated other comprehensive loss (before taxes) attributable to the change in fair market value relating to assets still held at the reporting date. $(416,165) 

During the fiscal year ended May 31, 2011 we purchased certificates of deposit with varying maturity dates.  The following table summarizes the maturities, gross unrealized gains or losses and fair value of the certificates of deposit as of May 31, 2011:
 May 31, 2011 
 Cost Gross Unrealized Gains/(Losses) 
Fair
Value
 
Maturity         
Due in one year or less $2,452,014  $-  $2,452,014 
The following table summarizes unrealized losses on our investments in marketable securities based on an independent third-party valuation at May 31, 2010:

 
As of May 31, 2010
 
  
Amortized
Cost
  
Gross
Unrealized
 Losses
  
Estimated
 Fair
 Value
 
Short-term         
Accrued interest - auction rate securities $12,105  $  $12,105 
Long-term            
Auction rate securities  5,550,000   (416,165)  5,133,835 
             
Total $5,562,105  $(416,165) $5,145,940 


F-19


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)
Fair Value Measurements (continued)
At May 31, 2010, we held four investments that were in an unrealized loss position.  The following table presents the amortized cost and fair value of our investments in marketable securities classified as available-for-sale at May 31, 2010 by contractual maturity:
 May 31, 2010 
 
Amortized
Cost
 
Fair
Value
 
Maturity      
Greater than two years $5,550,000  $5,133,835 
At May 31, 2010, we held auction rate securities with a par value totaling approximately $5.6 million which failed to sell at auction.  In the event we needed to access funds invested in these auction rate securities we would not have been able to liquidate these securities until (i) a future auction of these securities was successful, (ii) they were refinanced and redeemed by the issuers, or (iii) a buyer was found outside of the auction process.  The investments consisted of student loan auction rate instruments issued by various state agencies pursuant to the Federal Family Educational Loan Program (“FFELP”).  These instruments were insured by the various state educational agencies and were guaranteed by the Department of Education as an insurer of last resort.  We had the intent and the ability to hold these investments until the anticipated recovery period.

As a result of temporary declines in the fair value of our auction rate securities, which we attributed to liquidity issues rather than credit issues, we recorded an unrealized loss of $246,994 in other comprehensive loss at May 31, 2010 which represented the gross valuation adjustment of $416,165, net of the related tax benefit of $169,171.

Due to the uncertainty surrounding the timing of a market recovery, we classified our auction rate securities as long- term investments in our consolidated balance sheet as of May 31, 2010.
During September 2010, we reached a confidential settlement agreement with Deutsche Bank.  Under terms of the agreement, we transferred approximately $5.2 million in illiquid auction rate securities instruments to Deutsche Bank for a substantial portion of the face value of the securities, and if the instruments are redeemed by a certain date then we will receive the full face amount of the instruments.  On October 4, 2010, we received settlement proceeds from Deutsche Bank of $4,551,260 plus $6,330 of interest income.  During the fiscal year ended May 31, 2011 we received proceeds of $47,860 pursuant to this agreement and during June 2011 we received proceeds of $39,005 based on partial redemptions of these securities at par value.

During June 2008, we obtained a credit facility for as long as needed, which provided for financing up to 50% of the par value balance of our outstanding auction rate securities on that date. The facility was collateralized by the full value of the outstanding auction rate securities, required no origination fee, and bore interest at the federal funds rate plus 3% (see Note 11).  On September 20, 2010, we paid $2,642,954, which consisted of the balance on the credit facility at August 31, 2010 plus interest through September 20, 2010.  The credit facility was terminated in connection with the settlement agreement with Deutsche Bank.

5.  Accounts Receivable

Trade accounts receivable at May 31, 20082011 and 2010 is $538,500, of$187,465 and $149,504, respectively, which $511,541 is held by SSDI.  At May 31, 2007, trade accounts receivable was $352,390, of which $348,890 was held by SSDI.relates entirely to PDSG.  No allowance for doubtful accounts has been recorded for the fiscal years ended May 31, 20082011 or 2007.2010.

At May 31, 2008,2011 and 2010, accounts receivable from our investee PDS was $7,501 with no such amount recorded at May 31, 2007.  The fiscal 2008 balance represents$129,345 and $7,010, respectively.  These balances represent reimbursements we submit to PDS for our legal and related costs incurred in various legal matters of which we are listed as co-defendant with TPL.

4.  Notes Receivable

During fiscal year 2008, SSDI sold a membership interest in its subsidiary DataSecurus, LLC (now known as Talis) to an unrelated third party for $100,000 in cash and a $50,000 non-interest bearing note receivable due in June 2008.  On June 1, 2008, SSDI assigned the $50,000 note receivable to us and we agreed to reduce the amount of our line of credit with SSDI by the amount of the note receivable.  On June 26, 2008, we were paid in full by the third party debtor.

On May 30, 2008, we purchased a secured convertible promissory note from Crossflo Systems, Inc., a California corporation (“Crossflo”) with a face amount of $400,000.  Interest accrues on the note at a rate of 5.25% per annum and will be due with principal at the earlier of (i) September 30, 2008, (ii) consummation of a equity financing by Crossflo which closes on or before September 30, 2008, in which Crossflo  sells and issues shares of its convertible preferred stock resulting in aggregate gross proceeds to Crossflo of at least $2.5 million (a “Qualified Financing”), or (iii) upon or after the occurrence of an event of default, as defined.  The note is secured by substantially all assets of Crossflo.

The Crossflo note receivable is convertible at our option, at any time prior to September 30, 2008, into shares of Crossflo’s Series F convertible preferred stock equal to 4% of Crossflo’s then issued and outstanding equity securities. In addition, the entire principal is automatically convertible into shares of Crossflo’s Series F convertible preferred stock at the closing of a Qualified Financing. The number of shares of Series F convertible preferred stock to be issued upon automatic conversion of the principal amount is the greater of (i) 4% of Crossflo’s then issued and outstanding equity securities, and (ii) the principal amount divided by the per share purchase price paid by the investors participating in the Qualified Financing. Upon an event of default, as defined, the principal amount of the note may be converted into shares of Crossflo’s Series F convertible preferred stock equal to 4% of Crossflo’s then issued and outstanding equity securities. Upon maturity on September 30, 2008, the principal amount of the note will automatically be converted into shares of Crossflo’s Series F convertible preferred stock equal to 4% of Crossflo’s then issued and outstanding equity securities.

Upon conversion of the principal amount of the note pursuant to the above, we are entitled to receive shares of Crossflo’s common stock equal to all accrued and unpaid interest divided by $0.20.

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Notes Receivable (continued)

In connection with our purchase of the secured convertible promissory note from Crossflo, we also received a warrant to purchase 200,000 shares of Crossflo’s common stock at $0.20 per share.  Notwithstanding the foregoing, in the event a Qualified Financing is not consummated prior to September 30, 2008, the warrant will instead be exercisable into 1,000,000 shares of Crossflo’s common stock at $0.20 per share.  The warrant is exercisable until the earlier of (i) October 11, 2012, (ii) the closing of an underwritten public offering by Crossflo pursuant to a registration statement under the Securities Act, (iii) the closing of a merger or other reorganization by Crossflo with another entity, or (iv) the closing of a sale of all or substantially all of the assets of Crossflo.  The value attributed to the warrant was insignificant, and accordingly, the principal amount of the loan has been recorded as a note receivable at May 31, 2008.

As of May 31, 2008, the balance of the note receivable is $400,115, including accrued interest receivable of $115 recognized during the year ended May 31, 2008.

On November 22, 2006, we entered into a Revolving Line of Credit Facility Agreement (the “Line of Credit Agreement”) with Holocom Networks (“Holocom”) which provided for borrowings of up to $700,000 under a revolving line of credit extended by us to Holocom. On November 22, 2006, we advanced Holocom $350,000 and further advanced an additional $230,000 during the three months ended February 28, 2007. Borrowings under the Line of Credit Agreement were used by Holocom for its operating cash flow needs. The borrowings bore interest at the prime rate, as announced by Bank of America, plus 2% per annum, and interest-only payments were due monthly. Pursuant to the terms of the Line of Credit Agreement, all unpaid principal and accrued and unpaid interest was due February 22, 2007. Borrowings under the Line of Credit Agreement were collateralized by substantially all of the assets of Holocom.
During the quarter ended February 28, 2007, we determined that the outstanding borrowings under the Line of Credit Agreement of $589,551, which included accrued interest and late fees of $9,551, were uncollectible as Holocom was unable to make the required interest payments. As a result, we foreclosed on the assets of Holocom. At the foreclosure sale, we acquired the patents, trademarks, equipment, inventory, and certain other collateral of Holocom pursuant to the terms of a Security Agreement entered into between us and Holocom in connection with the Line of Credit Agreement.
We originally accounted for our loan receivable, and related accrued interest, due from Holocom at cost. In accordance with SFAS No. 114, Accounting by Creditors for Impairments of a Loan, based on current information and events, we determined that we were unable to collect all amounts due from Holocom according to the contractual terms of the Line of Credit Agreement. As a result, we determined that the loan receivable was impaired. Accordingly, we recorded an impairment loss of $339,551 during the three months ended February 28, 2007. The impairment loss was determined based on an independent valuation of the assets of Holocom acquired in the foreclosure sale and management’s analysis of the fair value of such assets at time of acquisition.
The fair value of the assets acquired in foreclosure of $250,000 was contributed to SSDI.

5. Inventory

Inventory at May 31, 2008, consisted of raw materials of $142,410 and finished goods of $245,731.  Inventory at May 31, 2007, consisted of raw materials of $46,361.

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

6.  Investments in Marketable SecuritiesNotes Receivable

On December 24, 2009, we entered into a secured note receivable with TPL for $950,000, intended to cover its operating costs including the furtherance of Moore Microprocessor Patent (“MMP”) portfolio licensing, which was due and payable on or before July 12, 2010.  Terms of the note required interest payable at the rate of 10%.  The following table summarizes unrealized lossesnote was secured by TPL’s specific portion of its future license receivable distribution.  At May 31, 2010 the balance of the note receivable was $991,382, including accrued interest receivable of $41,382.  The note named both TPL and PDS individually; both jointly and severally liable to pay us.  Accordingly, on our investments in marketable securities basedJuly 15, 2010, PDS paid us $1,003,095 which included the principal balance of the note plus interest of $53,095 through July 15, 2010.

On January 12, 2010, we entered into an unsecured note receivable with TPL for $1,000,000, intended to cover its operating costs including the furtherance of MMP portfolio licensing, which was due and payable on or before February 28, 2010.  Terms of the note required interest payable at the rate of 10%.  TPL defaulted on the valuation by Houlihan Smith & Company Inc. at May 31, 2008:note on February 28, 2010.  During the third quarter of fiscal 2010, the $1,013,151 balance of the note receivable including accrued interest through February 28, 2010, was fully reserved for.  On January 19, 2011, we and TPL reached a settlement regarding the San Diego Superior Court action (see Note 9) and we received $1,098,903 in January 2011 consisting of the principal balance of the note plus accrued interest through January 2011.

 
As of May 31, 2008
 
  
 
Cost
  
Gross
Unrealized
 Losses
  
Estimated
 Fair
 Value
 
Short-term         
Accrued interest - auction rate securities $288,099  $  $288,099 
             
Long-term            
Auction rate securities  12,900,000   (372,325)  12,527,675 
             
Total $13,188,099  $(372,325) $12,815,774 
Index for Clinical Excellence, Ltd.

AsOn January 25, 2010, the assets of May 31, 2008,Verras were sold for $250,000.  At closing we held auction rate securities withreceived $62,500 and a par value totaling $12.9 million that failed to sell at auction.  In the event we need to access funds invested in these auction rate securities we would not be able to liquidate these securities until (i) a future auction of these securities is successful, (ii) they are refinanced and redeemed by the issuers, or (iii) a buyer is found outsidenon-interest bearing promissory note for $187,500 from Index for Clinical Excellence, Ltd.  Terms of the auction process.  The investments consist of student loan auction rate instruments issued by various state agencies pursuant to the Federal Family Educational Loan Program (“FFELP”).  These investments are of high credit quality and the AAA credit ratingsnote required payment on each of the investments have been reaffirmed since May 2008.  These instruments are collateralized in excessthree, six and nine month anniversaries of the underlying obligations, are insured by the various state educational agencies, and are guaranteed by the Department of Education as an insurer of last resort.  We have the intent and the ability to hold these investments until the anticipated recovery period.

closing date.  Due to the uncertainty surroundingnominal amount of the timingnote and its short term duration interest income was not separately accounted for.  During April 2010, July 2010 and October 2010 we received the three, six and nine month anniversary payments consisting of a market recovery, we have classified our auction rate securities as long- term investments$62,500 each on the note.  At May 31, 2010 the balance of the note was $125,000 and the balance was paid in our consolidated balance sheetfull as of May 31, 2008.  As a result of temporary declines in the fair value of our auction rate securities, which we attribute to liquidity issues rather than credit issues, we have recorded an unrealized loss of $220,617 in other comprehensive income at May 31, 2008, which represents the gross valuation adjustment of $372,325, net of the related tax benefit of $151,708.

We will continue to evaluate the fair value of our investments in auction rate securities each reporting period for a potential other-than-temporary impairment.

During June 2008 we obtained a credit facility for as long as needed, which provides for financing up to 50% of the par value balance of our outstanding auction rate securities. The facility is collateralized by the full value of the outstanding auction rate securities, required no origination fee, and if drawn upon will bear interest at the federal funds rate plus 3%.


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)2011.

7. Work-In-Process

At May 31, 2011, work-in-process consisting of recognized revenue on PDSG’s current contracts was $455,381 and invoices to customers were $424,800.  At May 31, 2010, work-in-process consisting of recognized revenue on PDSG’s current contracts was $264,637 and invoices to customers were $128,000.  These amounts are shown on our May 31, 2011 and 2010 balance sheets at net of $30,581 and $136,637, respectively, due to their immateriality.

8. Property and Equipment

Property and equipment consisted of the following at May 31, 20082011 and 2007:2010:

 2008  2007  2011  2010 
Computer equipment and software $50,802  $42,270  $82,865  $92,416 
Furniture and fixtures  72,981   72,454   31,580   51,725 
Leasehold improvements  5,046   - 
  128,829   114,724   114,445   144,141 
Le LLess: accumulated depreciation and amortization  (60,325)  (29,206)
Less: accumulated depreciation and amortization  (96,832)  (107,042)
Net property and equipment $68,504  $85,518  $17,613  $37,099 

Depreciation and amortization expense related to property and equipment was $36,359, $24,352$24,570 and $24,591$35,695 for the years ended May 31, 2008, 20072011 and 2006,2010, respectively.

8. License Agreements

F-21
In February 2005, we entered into two separate licensing agreements with one customer for our patent portfolio and Ignite microprocessor technology. The aggregate amount of the two licenses was $3,050,000, of which $2,950,000 was for licensing fees and $100,000 was for maintenance services. Maintenance under the agreement is expected

Patriot Scientific Corporation
Notes to be provided over a period not to exceed four years. Maintenance revenue recognized during the fiscal years ended May 31, 2008, 2007 and 2006 was $25,000 per year. The payment terms of the agreements required aggregate payments of $300,000 at the time of execution, three quarterly payments of $750,000 each on April 1, August 15, and November 15, 2005 and one final payment of $500,000 on February 15, 2006. The $500,000 payment due on February 15, 2006 was paid in March 2006. Total payments received in fiscal 2005 amounted to $1,050,000, and total payments received in fiscal 2006 amounted to $2,000,000. The agreements also provide for the future payment of royalties to us based on sales of product using the Ignite licensed technology. In connection with this license agreement, we became obligated to the co-inventor of the patent portfolio technology for $207,600 pursuant to a July 2004 agreement under which we were obligated to pay a percentage of all patent portfolio licensing proceeds to the co-inventor. The amount due under that license was payable in four installments of $51,900. The co-inventor of the patent portfolio technology filed a lawsuit against us seeking damages and/or enforcement of the July 2004 agreement. We challenged the enforceability of the agreement by counterclaim in that action. On February 14, 2007, a settlement of the litigation was finalized. Terms of the settlement required us to pay $3,400,000 in cash on February 14, 2007 and $3,000,000 on May 1, 2007, which amounted to approximately the debt claimed by the co-inventor to be owed to him under the July 2004 agreement. In addition, the settlement required us to make a donation of $15,000 on February 14, 2007 on behalf of Russell H. Fish III (“Fish”) to Maasai Power and Education Project, Inc., and to pay Fish the equivalent of 4% of 50% of the next $100 million of gross license fees as they are collected by PDS and as distributions are made to us, after excluding the first $20 million collected by PDS after December 1, 2006. Our commitment to make payments to Fish related to such future license revenues was limited to $2 million. During the fiscal years ended May 31, 2008 and 2007, we recorded $836,400 and $7,524,537, respectively in settlement and license expenses relating to royalty payments due to the Fish parties.  In January 2008, we made the final payment under the Fish settlement agreement.Consolidated Financial Statements (Continued)

9. Investments in Affiliated Companies

Phoenix Digital Solutions, LLC

On June 7, 2005, we entered into a Master Agreement (the “Master Agreement”) with TPL, and Charles H. Moore (“Moore”), the co-inventor of certainthe technology which is the subject of our technology,the MMP Portfolio of microprocessor patents, pursuant to which we, TPL and Moorethe parties resolved all legal disputes between us.them. Pursuant to the Master Agreement, we and TPL entered into the Limited Liability Company Operating Agreement of PDS (the “LLC Agreement”) into which we and Moore contributed our rights to certain of our technologies.

F-23

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Investments in Affiliated Companies (continued)

We and TPL each own 50% of the membership interests of PDS, and each of us has the right to appoint one member of the three member management committee. The two appointees are required to select a mutually acceptable third member of the management committee. Pursuant to the LLC Agreement, we and TPL agreed to establish a working capital fund for PDS of $4,000,000, of which our contribution was $2,000,000. The working capital fund increases to a maximum of $8,000,000 as license revenues are achieved. We and TPL are obligated to fund future working capital requirements at the discretion of the management committee of PDS in order to maintain working capital of not more than $8,000,000.  Neither we nor TPL are required to contribute more than $2,000,000 in any fiscal year.  During the fiscal year ended May 31, 2010 we and TPL each contributed $580,000 to PDS for working capital requirements.  No such contributions were made during the fiscal year ended May 31, 2011.  Distributable cash and allocation of profits and losses will beare allocated to the members in the priority defined in the LLC Agreement.

Pursuant to the Master Agreement, PDS has committed to pay a quarterly amount ranging between $500,000 and $1,000,000 (based upon a percentage of the working capital fund balance of PDS) for supporting efforts to secure licensing agreements by TPL on behalf of PDS. During the fiscal years ended May 31, 2008, 20072011 and 2006,2010, PDS paid $2,952,362, $3,871,602$2,500,000 and $2,500,000,$1,500,000, respectively, to TPL pursuant to this commitment.  This expense is recorded in the accompanying statements of operations presented below.

PDS reimburses TPL for payment of all legal and third-party expert fees and other related third-party costs and expenses, and certain internally generated costs as approved on August 17, 2009 and more fully described below.  During the fiscal years ended May 31, 2011 and 2010, PDS expensed $6,833,708 and $3,684,154, respectively, to TPL pursuant to the agreement.  This expense is recorded in the accompanying statements of operations presented below.

On August 17, 2009, the management committee of PDS resolved to pay TPL $500,000 per quarter beginning on June 1, 2009 and continuing through May 31, 2010 relating to TPL’s special work and effort regarding the MMP litigation and U.S. Patent Office re-examinations.  In the event that PDS had insufficient funds to make such payments, we were required to advance half of the quarterly amount to PDS.  Our advances to PDS were to be without interest and were to be repaid to us no later than May 31, 2010.  During the fiscal year ended May 31, 2010, TPL received $1,500,000 from PDS pursuant to this agreement which is included in the fiscal 2010 legal and third-party expenses of PDS above.  We aredid not advance any funds to PDS under this resolution.  On May 31, 2010, the resolution terminated. On January 19, 2011, in accordance with our settlement agreement with TPL, PDS agreed to pay TPL an additional $750,000 pursuant to this agreement representing reimbursement of special litigation support costs incurred by TPL.

During April 2010, we filed two separate actions against TPL in the Superior Courts of San Diego and Santa Clara counties.  We and TPL had been in negotiations to restructure our relationship.  On January 19, 2011, we settled the San Diego Superior Court action.

F-22


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Investments in Affiliated Companies (continued)

On July 15, 2010, we received payment from PDS of $1,003,095 consisting of principal and interest through July 15, 2010 on our $950,000 secured note with TPL for which PDS was jointly and severally liable.  This amount was recorded as a note receivable from TPL on PDS’ balance sheet on July 15, 2010.  Due to TPL’s inability to pay the note, it was fully reserved for at July 15, 2010 and the allowance was recorded as “Reserve for loan loss and uncollectable receivable” on PDS’ statement of operations for the six months ended November 30, 2010.  On January 19, 2011, pursuant to our settlement agreement with TPL, $1,048,903 consisting of principal and interest through January 2011 was applied against the March 1, 2010 and June 1, 2010 $500,000 quarterly expense amounts payable to TPL in accordance with the LLC Agreement for supporting efforts to secure licensing agreements and a portion of the fiscal 2010 special litigation support payments owed to TPL by PDS.  PDS has paid TPL in cash for the September 1, 2010 and subsequent quarters’ expense amounts pursuant to the LLC Agreement for supporting efforts to secure licensing agreements.

During June 2010, PDS advanced Alliacense, LLC TPL’s intellectual property licensing enterprise, $410,000 to fund payroll and rent obligations.  Due to non-payment by Alliacense, this amount was fully reserved for at August 31, 2010 and the allowance was recorded as “Reserve for loan loss and uncollectable receivable” on PDS’ statement of operations for the six months ended November 30, 2010. On January 19, 2011, pursuant to our settlement agreement with TPL, the $410,000 was applied against the fiscal 2010 special litigation support payments owed to TPL by PDS.

On January 19, 2011, pursuant to our settlement agreement with TPL, PDS agreed to pay TPL $67,000 per month from September 1, 2010 to April 30, 2011 relating to TPL’s special work and effort regarding internal costs related to litigation support and patent re-examinations.

Based on our analysis of current authoritative accounting guidance with respect to our investment in PDS, we continue to account for our investment in PDS under the equity method of accounting, and accordingly have recorded our share of PDS’ net income of $19,926,145, $48,965,084$600,460 and $27,848,363$4,483,190 during the years ended May 31, 2008, 20072011 and 2006,2010, respectively, as an increase in our investment.  Cash distributions of $20,288,124, $50,034,029$807,806 and $25,895,449$7,557,827 received from PDS during the years ended May 31, 2008, 20072011 and 2006,2010, respectively, have been recorded as a reduction in our investment.  Cash contributions of $580,000 made during the fiscal year ended May 31, 2010 have been recorded as in increase in our investment.  Our investment in PDS of $2,521,990$300,283 and $2,883,969$507,629 at May 31, 20082011 and 2007,2010, respectively,  and has been recorded as “Investments“Investment in Affiliated Companies”affiliated company”.  We have recorded our share of PDS’ net income as “Equity in Earningsearnings of Affiliated Companies”affiliated companies, net” in the accompanying consolidated statements of incomeoperations for the years ended May 31, 2008, 20072011 and 2006.

Concurrently with forming PDS, we entered into a license agreement with a third party pursuant to which we received $10,000,000.  This amount was recorded as license revenue during the year ended May 31, 2006. In connection with entering into the license agreement and forming PDS, we incurred various cash and non-cash expenses. Direct, incremental cash costs incurred with the transactions included $170,000 paid to a committee of our board of directors for their efforts in consummating the transactions, approximately $1,328,000 paid to certain of our warrant holders to obtain their approval of the agreement and release of their lien and blocking rights. Additionally, $960,000 was paid to the co-inventor of the technology.

We also granted new warrants and agreed to re-price other outstanding warrants in order to obtain the necessary approvals from certain security interest holders as well as to obtain the release of their security interests in our intellectual property, and to finalize the LLC Agreement. We granted a warrant to TPL to acquire up to 3,500,000 shares of our common stock at a per share price of $0.125. The warrant has a term of seven years. At the date of grant, the right to acquire 1,400,000 common shares vested. The right to acquire the remaining 2,100,000 shares will vest in 700,000 increments only upon our common stock attaining a per share stock price of $0.50, $0.75 and $1.00. On February 21, 2006, February 22, 2006 and March 1, 2006 the rights to acquire the remaining 700,000 share increments vested as our stock price reached $0.50, $0.75 and $1.00, respectively. As additional consideration to the warrant holders for providing approval for the transaction, we agreed to reset the per share exercise price of approximately 35,000,000 warrants to $0.015 for which the warrant holders also conveyed other warrants to acquire 12,000,000 shares back to us. Further, we issued additional warrants to acquire approximately 290,000 shares of our common stock at a per share price of $0.03. The warrants issued and re-priced were valued using a Monte Carlo simulation model and the following assumptions: volatility of 101% to 229%, no dividends, risk-free interest rates of approximately 3.5% to 5.1%, and contractual terms ranging from two to seven years. The fair value of the warrants issued and re-priced in excess of previously recorded expense was approximately $83,000 and the fair value of the reconveyed warrants was approximately $622,000. These amounts, together with the direct, incremental cash costs previously described, are recorded as an expense and included in settlement and license expense in the year ended May 31, 2006.2010.

During the years ended May 31, 2008, 20072011 and 2006,2010, TPL entered into licensing agreements with third parties, pursuant to which PDS received aggregate proceedsrecorded license revenues of approximately $59,283,000, $110,879,000$11,090,000 and $60,000,000,$14,279,000, respectively.

At May 31, 2011, PDS had accounts payable balances of approximately $1,754,000 and $129,400 to TPL and PTSC, respectively.  At May 31, 2010, PDS had accounts payable and accrued expense balances of approximately $1,724,000 and $7,000 to TPL and PTSC, respectively.

Variable Interest Entity Disclosures

At August 26, 2011, PDS’ cash and cash equivalents balance was $689,169.  Management has concluded that PDS’ equity investment at risk is insufficient to finance its activities as the volume of license revenue has not supported litigation costs independent of additional working capital funding.

We have not provided financial support to PDS other than required capital contributions and we are not contractually obligated to provide financial support to PDS other than to fund the working capital account at the discretion of PDS’ management committee.  In the event we, and not TPL, provide working capital funding to PDS we would consolidate PDS’ financials with our own as our ownership in PDS would be greater than 50%.

Our variable interest in PDS consists of 50% of PDS’ Members Equity or $300,283 at May 31, 2011.  We are unable to quantify our maximum exposure to loss associated with this VIE as we may incur future capital funding requirements.


F-24F-23


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Investments in Affiliated Companies (continued)

The condensed balance sheets of PDS at May 31, 20082011 and 20072010 and statements of income of PDS for the years ended May 31, 2008, 20072011 and 20062010 are as follows:

Condensed Balance Sheets

ASSETS:Assets:
  2011  2010 
Cash and cash equivalents $1,895,653  $779,932 
Prepaid expenses  600,000   25,000 
Licenses receivable  -   2,000,000 
Total assets $2,495,653  $2,804,932 

  2008  2007 
Cash and cash equivalents $8,260,288  $6,989,847 
Prepaid expenses  -   175,000 
Total assets $8,260,288  $7,164,847 
Liabilities and Members’ Equity:
Related party payables and accrued expenses $1,883,296  $1,777,884 
LLC tax payable  11,790   11,790 
Members’ equity  600,567   1,015,258 
Total liabilities and members’ equity $2,495,653  $2,804,932 

LIABILITIES AND MEMBERS’ EQUITY:

Accounts payable and accrued expenses $3,204,519  $1,385,118 
Income taxes payable  11,790   11,790 
Members’ equity  5,043,979   5,767,939 
Total liabilities and members’ equity $8,260,288  $7,164,847 

Condensed Statements of Income

 2008  2007  2006  2011  2010 
License revenues $59,282,971  $110,878,985  $60,000,000  $11,090,000  $14,278,855 
Operating expenses  18,627,032   12,189,575   4,486,955   9,922,580   5,301,273 
Operating income  40,655,939   98,689,410   55,513,045   1,167,420   8,977,582 
Interest income  216,902   421,407   183,682 
Income before income taxes  40,872,841   99,110,817   55,696,727 
Provision for income taxes  11,790   11,790   - 
Interest and other income  46,091   588 
Income before LLC taxes  1,213,511   8,978,170 
Provision for LLC taxes  12,590   11,790 
Net income $40,861,051  $99,099,027  $55,696,727  $1,200,921  $8,966,380 

Talis Data Systems, LLC

On May 16, 2008, we paid $400,000We had a 39.4% interest in Talis.  The inability of Talis to acquire a 15.09% share in Talis, a companymeet its business plan, to raise capital, and the general economic environment were indicators of impairment on our investment, accordingly at August 31, 2009, management determined that produces multi-domain computer and network security products to government, military, and enterprise customers. Talis develops and markets PCs incorporating the company's Datagent security device, a patented, hardware based data security solution that avoids the vulnerability of software–based approaches.

On August 1, 2008, we increased our investment in Talis to 37.4%was impaired by approximately $680,000.  We have recorded this as a resultan impairment of purchasing additional shares offered by Talis, as well as acquiring shares from minority shareholders which includedinvestment in affiliated company on our consolidated statement of operations for the acquisition of all Talis shares previously held by SSDI. The acquisition of SSDI’s Talis shares was made for $100,000 in cash and a reduction on their outstanding line of credit of $219,000.fiscal year ended May 31, 2010.

We were accounting for our investment in Talis under the equity method of accounting.  We had recorded our share of Talis’ net loss of $21,706 during the two months ended July 31, 2009 as “Equity in earnings of affiliated companies, net” in the accompanying consolidated statement of operations for the fiscal year ended May 31, 2010.  The carrying value of our investment in Talis after impairment was zero at August 31, 2009.  During the third quarter of fiscal 2010, Talis was dissolved.

Due to the immaterial nature of Talis’ operations, no condensed financial statement information is presented herein.

F-25F-24


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Investments in Affiliated Companies (continued)

Avot Media, Inc.

During the quarter ended August 31, 2008, we invested an aggregate of $1,300,000, including conversion of a note receivable in the amount of $250,000, to obtain 14,444,444 shares of Series B preferred stock issued by Avot, representing 53.3% of the Series B preferred stock and 37.1% of all Avot’s preferred shares issued and outstanding.

We arereviewed the Series B Preferred Stock Purchase Agreement and related agreements in addition to evaluating our voting rights for our investment in the preferred stock of Avot, and as such we concluded that we did not have the ability to exercise significant control over Avot.  As a result, we were accounting for our investment in Talis underAvot at cost.

The inability of Avot to meet its business plan, to raise capital, and the equity methodgeneral economic environment were indicators of accounting, asimpairment of our limited liability company share is deemed more than minor.  We have recorded our share of Talis’ net loss of $8,376 during the period ended May 31, 2008 as a decrease in our investment.  Our investment, in Talis is $391,624accordingly at May 31, 2008 and has been2009, management determined that our investment in Avot was impaired by approximately $867,000.  We had recorded this as “Investmentsan impairment of investment in Affiliated Companies”.  We have recordedaffiliated company on our share of Talis’ net loss as “Equity in Earnings of Affiliated Companies” in the accompanying consolidated statement of incomeoperations for the fiscal year ended May 31, 2008.2009.

10. Consolidated Variable Interest EntityDuring the quarter ended November 30, 2009, we wrote-off $433,333 which represented the remaining carrying value of our preferred stock investment in Avot.  We have presented the $433,333 as an impairment of investment in affiliated companies on our consolidated statement of operations for the fiscal year ended May 31, 2010.

During March 2010, Avot sold substantially all of its assets and we collected our note receivable.  There was not adequate consideration to redeem any portion of our preferred stock investment which had been fully written off during the fiscal quarters ending in May 2009 and November 2009.

Scripps Secured Data, Inc. (d/b/a Holocom, Inc.)
On February 2, 2007, we invested an aggregate of $370,000 in SSDI for 2,100,000 shares of convertible preferred stock. This representsstock, representing all of SSDI’sthe issued preferred stock and a 46% ownership interest, of and in SSDI,Holocom, a California corporation that manufactures products that protect information transmitted over secure networks. The investment consisted of certain assets we contributed by us to SSDIHolocom valued at $250,000 and cash of $120,000. The investment is represented by 2,100,00 shares of convertible preferred stock, and the shares are convertible at our option into shares of SSDI’sHolocom’s common stock on a one-to-one basis. The convertible preferred stock entitles us to receive non-cumulative dividends at the per annum rate of $0.04 per share, when and if declared by the Board of Directors of SSDI.Holocom. The investment in SSDI’sHolocom’s convertible preferred stock also entitles us to a liquidation preference of $0.40 per share, plus an amount equal to all declared but unpaid dividends.

On March 27, 2007,We reviewed the Preferred Stock Purchase Agreement and related agreements to determine whether our convertible preferred stock investment in Holocom was in substance an investment in common stock pursuant to authoritative guidance.  We also evaluated our voting rights pursuant to other agreements with Holocom and, when considered together with authoritative guidance, we entered into an 18-month revolving line of credit with SSDI for a maximum amount of $500,000. The line of credit matures on September 27, 2008. Ifbelieve that we do not provide noticehave the ability to SSDI at least 90 days prior to the maturity date, the maturity date automatically extends 12 months. The line of credit is collateralized by all assets presently owned or hereafter acquired by SSDI. The carrying value of the collateral is approximately $765,861 at May 31, 2008. The creditors of SSDI do not have recourse to our other assets. During the fiscal years ended May 31, 2008 and 2007 we advanced $250,000 and $250,000, respectively, under terms of the agreement.  The total amount drawn on the line of credit at May 31, 2008 is $500,000 of which $100,000 has been repaid. On June 18, 2008, we gave SSDI notice under terms of the line of credit that we would not be extending the maturity date by the additional twelve month period provided for in the line of credit.exercise significant influence over Holocom. As a result, we were accounting for our investment in Holocom at cost.
Management determined that the lineinability of credit will terminate,Holocom to meet its business plan, raise capital, and full paymentthe general economic environment were indicators of any outstanding balance will be dueimpairment on September 27, 2008.

The line of credit carries a floating interest rate which is defined as the prime rate as announced by Bank of America.our investment.  At May 31, 2008, the interest rate on the note was 5.00%. SSDI is required to make minimum monthly payments on the line consisting of unpaid and accrued interest on the first day of the month following the initial advance.

During the quarter ended February 29, 20082010, we subordinatedwrote-off our interestinvestment in the repaymentpreferred stock of principal due underHolocom amounting to $435,182.  We have presented the revolving line$435,182 as an impairment of credit, up to a maximuminvestment in affiliated companies on our consolidated statement of $100,000,operations for the benefit of a customer of SSDI.

As a result of the line of credit, we have a variable interest in SSDI, a variable interest entity, and we have determined that we are the primary beneficiary as we absorb more than half of the variable interest entity’s expected losses. FIN 46(R) requires us to consolidate SSDI as long as we are deemed to be the primary beneficiary. The equity interests of SSDI not owned by us are reported as a minority interest in our May 31, 2008 and 2007 consolidated balance sheets.  As of May 31, 2007, the noncontrolling interest in SSDI, which we are required to consolidate as we are the primary beneficiary, has been reduced to zero due to the initial allocation of losses prior to the period in which we were required to consolidate. If a noncontrolling interest has been reduced to zero, the primary beneficiary must absorb any losses that are in excess of the value of the noncontrolling interest’s equity. For the period in which we were initially required to consolidate, March 27, 2007 through May 31, 2007 we absorbed $169,913 of SSDI’s losses as we are the primary beneficiary.  For the fiscal year ended May 31, 2008, SSDI had net income of $285,319 after taxes.  Under2010.

We review our investments in affiliated companies to determine whether events or changes in circumstances indicate that the provisions of FIN 46 (R),carrying amounts may not be recoverable. The primary factors we are able to recover our absorbed losses before allocating income to the noncontrolling interest.  At May 31, 2008 the minority interest presentedconsider in our consolidateddetermination are the financial statementscondition, operating performance and near term prospects of the investees. If a decline in value is $115,406, the amount of SSDI’s fiscal 2008 net income after taxes less our absorbed losses during fiscal 2007.

Priordeemed to initial consolidation,be other than temporary, we recognized a $126,746would recognize an impairment loss on our investment for the losses of SSDI for the period February 2007 through March 26, 2007.loss.
 

F-26F-25


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Consolidated Variable Interest Entity (continued)

Upon initial consolidation of the variable interest entity, on March 27, 2007, $251,146 of current assets, $43,199 of net property and equipment, $47,240 of other assets, $98,331 of current liabilities and no minority interest were included on the consolidated balance sheet.

During the three months ended August 31, 2007, SSDI sold a membership interest in DataSecurus, LLC (now known as Talis Data Systems, LLC) to an unrelated third party for $100,000 in cash and a $50,000 note receivable due June 1, 2008.  On June 1, 2008, SSDI assigned this note receivable to us and we agreed to reduce the amount of our line of credit with SSDI by the amount of the note.  On June 26, 2008 we were paid in full by the third party debtor.

 SSDI has a 2007 Stock Option Plan that covers its employees, directors, and consultants and provides for the granting of options to acquire up to 500,000 shares of SSDI’s common stock.  The options under this plan are not tied to our common stock and do not have a dilutive effect on our shareholders.  Any option granted under the plan must be exercised within ten years of the date they are granted.  During the fiscal year ended May 31, 2008, SSDI granted options to purchase 393,500 shares of its common stock at $0.10 per share under this plan.  At May 31, 2008, options to purchase 354,500 shares of SSDI’s common stock are outstanding, 45,900 of the outstanding options are exercisable due to vesting provisions within the options and 39,000 shares have been forfeited/cancelled.
The weighted average grant date fair value of SSDI’s options granted during the fiscal year ended May 31, 2008 was $0.06 per option.

As of May 31, 2008, there was approximately $13,095 of total unrecognized compensation cost related to employee stock option compensation arrangements.  That cost is expected to be recognized by SSDI on a straight-line basis over the next 24 months.

During the fiscal year ended May 31, 2008, SSDI recognized $7,201 of employee, consultant and director stock-based compensation expense related to stock options under SFAS No. 123(R).

11.10. Accrued Expenses and Other

At May 31, 20082011 and 2007,2010, accrued expenses and other consisted of the following:

  2008  2007 
Accrued lease obligation $4,006  $7,279 
Deferred maintenance fee  18,750   43,750 
Compensation and benefits  210,153   75,068 
Deferred material credit  95,377   163,399 
Accrued expenses  45,562   - 
Royalties payable  -   797,000 
  $373,848  $1,086,496 
  2011  2010 
Accrued lease obligation $17,362  $19,837 
Compensation and benefits  175,864   269,611 
Commissions payable  3,604   2,556 
  $196,830  $292,004 

12. Convertible Debentures11. Notes Payable

From fiscal 2002 through fiscal 2005, we raised approximately $5,400,000 through the issuance of convertible debentures, having stated interest rates ranging from 8% to 12%, to a limited group of investors. The convertible debentures entitled the debenture holders to convert the principal, and any accrued interest thereon, into shares of our common stock for up to two years from the date of issuance.Long Term

F-27

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Convertible Debentures (continued)

On October 14, 2008, we borrowed $3,000,000 on our credit facility with Wedbush.  The debentures were initially convertible into shares of common stock at conversion prices ranging from approximately $0.02 to $0.10 per share. The debentures contained provisions which allowed forfacility was collateralized by the conversion rate to be reset on a periodic basis based on a comparison of the market price of our common stock to the conversion price of the debentures. On the measurement dates when the market price was less than the conversion rate, a new conversion rate was set based on a weighted average of the market price for the ten days prior to the reset measurement date.

Concurrent with the issuance of the convertible debentures, we issued the debenture holders warrants to purchase shares of our common stock. These warrants are exercisable for five years from the date of issuance at either initial negotiated exercise prices or prices equal to 115% of the volume weighted average price for our common stock for the ten days previous to the debenture date. The warrant exercise price is generally subject to being reset on each six-month anniversary of its issuance; however, if the warrant holder elects to have the warrant shares registered, then the exercise price is fixed at the price in effect on the date of the election.

Except for one debenture issued on March 23, 2004, we are responsible for registering the resale of the shares of our common stock which will be issued on the conversion of the debentures. As of May 31, 2008, there have been seven registration statements. The convertible debentures were secured by substantially all our assets.

The terms of the convertible debentures included certain features that were considered embedded derivative financial instruments, such as the conversion feature and a reset conversion feature which provided for a conversion of the debentures into shares of our common stock at a rate which was determined to be variable. Because the debentures were not conventional convertible debt, we were also required to record the related warrants at their fair values. In addition, under the provisions of EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, as a result of entering into the convertible debenture agreements, we were required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date.

During the year ended May 31, 2006, thefull value of the warrantoutstanding auction rate securities, required no origination fee and derivative liabilities increasedbore interest at the federal funds rate plus 3%.  The amount we could borrow on the facility was limited by $2,456,736 which is reflected as a component of other income (expense) in the accompanying consolidated statement of income.

During the year endedFinancial Industry Regulatory Authority (“FINRA”).  At May 31, 2006,2010, the balance on the facility of $3,122,144 included accrued interest of $122,144 at an approximate average annual rate of 2.6%.  During June 2010, we entered into two reset agreements withpaid $500,000 on the debenture holders to fixcredit facility.  On September 20, 2010, we paid $2,642,954, the conversion price ofbalance on the then outstanding debenturescredit facility at their current price. We determined that one of the debt modifications did not result in a debt extinguishment under EITF Issue No. 96-19, Debtor’s Accounting for a Modification or Exchange of Debt Instruments, or EITF Issue No. 05-7, Accounting for Modifications to Conversion Options Embedded in Debt Instruments and Related Issues. In connection with the reset agreement of one of the outstanding debentures, we issued 7,000,000 warrants to the debenture holder as consideration for entering into the reset agreement. We determined that the issuance of the warrants,August 31, 2010 plus interest through September 20, 2010.  The credit facility was terminated in connection with the reset agreement, resulted in a debt extinguishment under EITF Issue No. 96-19. Accordingly, we recorded the fair value of the warrants issued of $445,427 as a loss on debt extinguishment in the accompanying consolidated statement of income for the year ended May 31, 2006.settlement with Deutsche Bank.

During the year ended May 31, 2006, holders of debentures with a principal balance of $880,668 converted their debentures, together with accrued interest thereon of $118,369, into 30,819,187 shares of our common stock.  As of May 31, 2006, all outstanding debentures were repaid or converted into shares of our common stock.

As a result of the settlement of the remaining debentures during 2006, we reclassified $6,743,935 related to the fair values of all outstanding warrants at the date of settlement to additional paid-in capital.

We recorded the fair value of the derivative instruments and warrants as a debt discount which was amortized to interest expense over the term of the convertible debentures. During the year ended May 31, 2006, we recorded interest expense of $412,879 related to the amortization of the debt discount. If the total fair value of the derivative instruments and warrants was in excess of the proceeds received on the convertible debentures, we recorded the excess as additional interest expense. Since no convertible debentures or warrants in connection with convertible debentures were issued during the year ended May 31, 2006, no excess fair value was recorded during fiscal 2006.
F-28

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

13.12. Stockholders’ Equity

Share Repurchases

During July 2006, we commenced our Board of Director approved stock buyback program in which we repurchase our outstanding common stock from time to time on the open market.  The repurchase plan has no maximum number of shares and is solely at the discretion of the Board of Directors. The repurchase plan has no set expiration date.

The following table summarizes share repurchases during the years ended May 31, 20082011 and 2007:2010:

  2008  2007 
Number of shares repurchased  8,096,721   13,467,527 
Aggregate cost $3,891,094  $8,832,078 

Dividends

During February 2007, we announced dividends of $0.02 per share to shareholders and qualified warrant holders of record as of March 6, 2007. The dividend of $8,114,774 was paid on April 9, 2007. During this time, we announced a semi-annual dividend policy contingent upon our financial condition, other possible applications of available resources, and relevant business considerations.

During February 2006, we announced a dividend of $0.02 per share of common stock for stockholders of record and qualified warrant holders as of February 24, 2006. The dividend of $8,114,378 was paid in March 2006. In March 2006, we announced a dividend of $0.04 per share of common stock for stockholders of record and qualified warrant holders as of March 31, 2006. The dividend of $16,583,959 was paid in April 2006

Private Stock Offerings

On July 22, 2005, 625,000 shares of common stock valued at $0.13 per share (based on the fair value on the date of issuance) were issued to the co-inventor of certain technology. We recorded an expense of $81,250 in connection with the issuance of these shares.

On March 21, 2006, 193,548 shares of common stock valued at $1.53 per share (based on the fair value on the date of issuance) were issued to a former debenture holder in connection with a dispute regarding the number of shares of common stock issued upon conversion. We recorded an expense of $296,129 in connection with the issuance of these shares.

On November 5, 2007, 200,000 shares of common stock valued at $0.50 per share (based on the fair value on the date of issuance) were issued to a former officer in connection with a legal settlement.  We recorded an expense of $100,000 in connection with the issuance of these shares.
  2011  2010 
Number of shares repurchased  1,294,272   1,632,983 
Aggregate cost $138,022  $234,356 

Warrants

At May 31, 2006,2010, we had warrants outstanding to purchase 53,349,220325,000 common shares at exercise prices ranging from $0.02$0.15 to $1.00 per share, expiring at various dates through 2012. Some2011.  On January 25, 2010, we issued 25,000 warrants expiring on December 21, 2010 with an exercise price of those outstanding$0.15 to a former consultant in connection with a legal settlement.  We recorded $857 of share-based compensation in connection with the issuance.  On November 9, 2009, we gave notice to our current investor relations firm of our intent to cancel our contract within 30 days.  Accordingly, the 250,000 warrants granted under contract that were not exercisable asvested were cancelled.  In connection with the cancellation of May 31, 2006 as they were subject to meeting vesting criteria. During the year ended May 31, 2006,unvested warrants we issued warrants to purchase 12,457,049 sharesreversed approximately $10,400 of common stock, investors exercised warrants to purchase 8,728,544 shares of common stock for proceeds of $470,657 and investors exercised warrants of 44,110,139 to purchase 41,245,473 shares of common stock on a cashless basis. During the year ended May 31, 2006, we cancelled warrants to purchase 13,391,727 shares of our common stock. Included in the aforementioned warrants issuedshare-based compensation previously recorded, including $6,932 recorded during the year ended May 31, 2006 were warrants to purchase 300,000 shares of common stock issued to a consultant. The value of these warrants of $176,866 was recorded as an expense during the year ended May 31, 2006. We also granted new warrants and agreed to re-price certain outstanding warrants in2009.


F-29F-26


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)

order to obtain the necessary approvals from certain security interest holders as well as to obtain the release of their security interests in our intellectual property,The following table presents outstanding warrants at May 31, 2011 and to finalize the LLC Agreement to form PDS.   As additional consideration to the warrant holders for providing approval for the transaction, we agreed to reset the per share exercise price of approximately 35,000,000 warrants to $0.015 for which the warrant holders also conveyed other warrants to acquire 12,000,000 shares back to us (see Note 9).2010:

Effective January 11, 2006, we entered into a warrant redemption agreement with a warrant holder, whereby at our option, we agreed to redeem certain warrants representing the right to acquire an aggregate of up to 10,000,000 shares of our common stock, through April 2006. The warrants may be redeemed in quantities not to exceed 2,000,000 warrants in any one calendar month, at a price equal to the product of (a) the volume weighted average of the daily volume weighted average prices of our common stock for all trading days in the applicable calendar month, minus the exercise price of the warrant, multiplied by (b) the number of shares being redeemed from that warrant. On February 3, 2006, we agreed to redeem 2,000,000 warrants for $252,420 and payment for the redemption occurred in March 2006.
  2011  2010 
Issued in conjunction with:      
Services $-   300,000 
Legal settlements  -   25,000 
Total warrants outstanding  -   325,000 

Effective February 9, 2006, we entered into “Reset Agreements” with certain warrant holdersShare-based Compensation Summary of Assumptions and received waiversActivity

The fair value of share-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the warrant holders with regardcalculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to certain terms of certain warrants held by the warrant holders. Under the terms of the Reset Agreements, we and the warrant holders agreed to amend the terms of (i) each of the warrants held by the warrant holders such that the exercise price of the warrantsvalue any particular grant is no longer subject to downward resets based on the trading price of our common stock, and (ii) eachU.S. Treasury rate that corresponds to the pricing term of the debentures held by the warrant holders such that the conversion pricegrant effective as of the debentures is fixed at its current level. No additional expense was required for the modification of the exercise price of the warrants since the new fixed price of the warrants was equal to the original exercise price at date of issuance or was equal to the then reset price in effect for which we had previously recognized an expense for the modification. Under the terms of the Reset Agreements, we and the warrant holders also agreed to amend all of the agreements entered into between us and the warrant holders that limit the ability of the warrant holders to be the beneficial owner of more than 4.99% of our common stock to be amended to provide that the warrant holders may not, through the exercise of warrants, the conversion of debentures, or otherwise, be the beneficial owner of more than 9.99% of our common stock.

Under the terms of the waiver agreements, the warrant holders agreed to amend their rights under the terms of certain warrants held by each of them to receive a payment in the event of a payment of a dividend by us. Prior to entering into the waiver agreements, if at any time after the issuance date of the subject warrants, we made any distributions to holders of our common stock, the warrant holders would be entitled to receive a payment equal to the amount of such distribution which would have been payable to them had they owned the shares of common stock issuable upon exercise of the subject warrants as of the record dategrant.  The expected volatility for the distribution. Under the terms of the waiver agreement, if the market price of our common stock on the record date for a distribution is greater than or equal to $0.15 per share, the payment to the warrant holders would be reduced to the amount which would be payable to the warrant holders had they engaged in a cashless exercise of the subject warrants as of the record date for the distribution. In consideration for entering into the agreements, we issued warrants for the right to acquire 7,000,000 shares of our common stock to one warrant holder and recognized a loss on debt extinguishment of $445,427 (see Note 12).

In connection with a previous debt agreement, we entered into an Antidilution Agreement (the “Antidilution Agreement”) with Swartz Private Equity, LLC (“Swartz”) wherein we were obligated to issue to Swartz warrants equal to 11% of the common stock issued between January 28, 2002 and March 11, 2002, 20% of the common stock issued between March 12, 2002 and April 1, 2003, and after April 1, 2003, 30% of the common stock issued to any parties other than Swartz. There were no warrants issued during thefiscal years ended May 31, 2007 or 2006 in connection with2011 and 2010 is based on the Antidilution agreement. On October 10, 2006, we entered into an Approval Rights Agreement and Termination of Antidilution Agreement and Addendum to Warrants (the “Termination Agreement”) with Swartz to terminate the Antidilution Agreement. In consideration for entering into the Termination Agreement, we agreed that through May 31, 2008 we would obtain Swartz’s written approval at least 30 days prior to entering into (i) any acquisition of any business entity or asset of any kind where the aggregate number of shares of common stock and derivative securities (on a fully diluted basis) issued as consideration for the acquisition equals or exceeds 10% of the number of shareshistorical volatilities of our common stock outstanding atstock.  These factors could change in the timefuture, affecting the determination of the acquisition (on a fully diluted basis) or (ii) any acquisition (regardless of size) by us of any business entity or asset of any kind that is not unanimously approved by our board of directors.stock-based compensation expense in future periods.

Year Ended
May 31, 2011
Year Ended
May 31, 2010
Expected term5 yrs5 yrs
Expected volatility106%116 – 117%
Risk-free interest rate2.17%2.14 - 2.55%
F-30

A summary of option activity as of May 31, 2011 and changes during the fiscal year then ended, is presented below:

  Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term (Years)  Aggregate Intrinsic Value 
Options outstanding at June 1, 2010  5,637,917  $0.42       
Options granted  650,000  $0.10       
Options exercised  -  $-       
Options forfeited  (3,277,917) $0.44       
 
Options outstanding at May 31, 2011
  3,010,000  $0.33   2.19  $- 
 
Options vested and expected to vest at May 31, 2011
  2,901,306  $0.33   2.18  $- 
 
Options exercisable at May 31, 2011
  2,792,612  $0.34   2.17  $- 
The weighted average grant date fair value of options granted during the fiscal years ended May 31, 2011 and 2010 was $0.08 and $0.15 per option, respectively. The total intrinsic value of options exercised during the fiscal year ended May 31, 2010 was $9,550 based on the difference in market price on the date of exercise and the option exercise price.


F-27


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)

AtThe aggregate intrinsic value in the table above represents the differences in market price at the close of the fiscal year ($0.08 per share on May 31, 2007, we had warrants2011) and the exercise price of outstanding, to purchase 12,060,915 common shares atin-the-money options (those options with exercise prices ranging from $0.02 to $1.00 per share, expiring at various dates through 2012. Some of those outstanding warrants were not exercisable asbelow $0.08) on May 31, 2011.

As of May 31, 2007 as they were subject2011, there was $16,759 of total unrecognized compensation cost related to meeting vesting criteria. Duringemployee stock option compensation arrangements.  That cost is expected to be recognized on a straight-line basis over the yearnext 24 months.
The following table summarizes employee and director stock-based compensation expense for PTSC and employee stock-based compensation expense for PDSG for the fiscal years ended May 31, 2007, investors exercised warrants to purchase 1,272,500 shares of common stock for proceeds of $172,2502011 and investors exercised warrants of 40,000,805 to purchase 38,681,396 shares of common stock on a cashless basis. During the year ended May 31, 2007, 15,000 warrants expired and 1,319,409 warrants were cancelled due to cashless exercises.2010, which was recorded as follows:
  Year Ended  Year Ended 
  May 31, 2011  May 31, 2010 
Research and development - PDSG $2,038  $19,523 
Selling, general and administrative expense - PDSG  18,462   49,498 
Selling, general and administrative expense - PTSC  56,379   158,696 
Total $76,879  $227,717 

At May 31, 2008, we had warrants outstanding to purchase 300,000 common shares at exercise prices ranging from $0.20 to $1.00 per share, expiring at various dates through 2011.  During the year ended May 31, 2008, we issued no warrants to purchase shares of common stock, an investor exercised warrants to purchase 125,000 shares of common stock for proceeds of $6,250, 1,933,259 warrants expired or were cancelled due to cashless exercises, 3,700,000 warrants were exercised utilizing the cashless method of exercise for 2,702,656 shares, and we repurchased 7,000,000 warrants for $2,760,900 under terms of our warrant repurchase agreement with Lincoln Ventures, LLC.

On August 1, 2008, we issued a warrant to purchase 250,000 shares of our common stock for $0.23 per share to our institutional investor relations firm.  The warrant is subject to vesting provisions.

The following table presents outstanding warrants at May 31, 2008 and 2007:

  2008 2007
     
Issued in conjunction with:    
Convertible debentures  - 560,915
Anti-dilution agreements  - -
Equity lines of credit  - -
Waiver agreements  - 7,000,000
Other  300,000 4,500,000
      
Total warrants outstanding  300,000 12,060,915

1996 Stock Option Plan

Effective March 1996, as amended, we adopted the 1996 Stock Option Plan. Under the 1996 Stock Option Plan, which expired March 24, 2006, options to purchase up to 4,000,000 shares of our common stock may be granted to either full or part time employees, directors and our consultants at a price not less than the fair market value on the date of grant for incentive stock options or not less than 85% of the fair market value on the date of grant for non-qualified stock options. In the case of a significant stockholder, the option price of the share is not less than 110 percent of the fair market value of the shares on the date of grant. Any option granted under the 1996 Stock Option Plan must be exercised within ten years of the date they are granted (five years in the case of a significant stockholder). During the fiscal year ended May 31, 2006,2010, we granted optionsexpensed $857 relating to purchase 50,000 shareswarrants issued during the fiscal year and we recognized an adjustment of common stock at market value, under($6,932) relating to the 1996 Stock Option Plan. Asforfeiture of warrants during the fiscal year.  We incurred no such expense during the fiscal year ended May 31, 2008, options to purchase 100,000 shares of common stock are outstanding under the 1996 Stock Option Plan. The options outstanding continue to be governed by the terms of the 1996 Stock Option Plan.

F-31

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)2011.

2001 Stock Option Plan

The 2001 Stock Option Plan, which expiresexpired in February 2011, providesprovided for the granting of options to purchase up to 3,000,000 shares of our common stock to either full or part time employees, directors and our consultants at a price not less than the fair market value on the date of grant for incentive stock options or not less than 85% of the fair market value on the date of grant for non-qualified stock options. In the case of a significant stockholder, the option price of the share is not less than 110 percent of the fair market value of the shares on the date of grant. Any option granted under the 2001 Stock Option Plan must be exercised within ten years of the date they are granted (five years in the case of a significant stockholder).  During the fiscal years ended May 31, 2008, 2007 and 2006, we granted options to purchase 699,000, 230,000 and 145,000 shares of our common stock, respectively, at market value,We made no grants under this plan.plan during fiscal 2011 and 2010. As of May 31, 2008,2011, options to purchase 874,000240,000 shares of common stock are outstanding under the 2001 Stock Option Plan.

2003 Stock Option Plan

The 2003 Stock Option Plan, which expires in July 2013, provides for the granting of options to acquire up to 6,000,000 shares of our common stock to either full or part time employees, directors and our consultants at a price not less than the fair market value on the date of grant for incentive stock options or not less than 85% of the fair market value on the date of grant for non-qualified stock options. In the case of a significant stockholder, the option price of the share is not less than 110 percent of the fair market value of the shares on the date of grant. Any option granted under the 2003 Stock Option Plan must be exercised within ten years of the date they are granted (five years in the case of a significant stockholder). During the fiscal years ended May 31, 2008 and 2006, we granted options to purchase 3,723,000 and 1,550,000 shares of our common stock, respectively, at market value, under this plan. There were no grants made under the 2003 Stock Option Plan during the fiscal yearyears ended May 31, 2007.2011 and 2010. As of May 31, 2008,2011, there are no options to purchase 2,973,000 shares of common stock are outstanding under the 2003 Stock Option Plan.
F-28


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)

2006 Stock Option Plan

The 2006 Stock Option Plan, as amended, which expires in March 2016, provides for the granting of options to acquire up to 5,000,00010,000,000 shares, with a limit of 3,000,0008,000,000 Incentive Stock Option (“ISO”) shares of our common stock to either full or part time employees, directors and our consultants at a price not less than the fair market value on the date of grant. In the case of a significant stockholder, the option price of the share is not less than 110 percent of the fair market value of the shares on the date of grant. Any option granted under the 2006 Stock Option Plan must be exercised within ten years of the date they are granted (five years in the case of a significant stockholder).  On March 11, 2008 we amended our 2006 Stock Option Plan to increase the total number of shares of our common stock issuable under the plan from 5,000,000 to 7,000,000.  Shareholders will be asked to ratify the amendment to the plan at our next annual meeting.  During the fiscal years ended May 31, 2008, 20072011 and 2006,2010, we granted options to purchase 2,203,000, 1,070,000650,000 and 2,050,000670,000 shares of our common stock, respectively, under this plan 200,000, 70,000 and 192,857 shares, respectively,none of which were ISOs.  In connection with May 31, 2006 option grants, we recognized compensation expense of $120,000 related to options granted below the fair market value of our common stock at the date of grant. As of May 31, 2008,2011, options to purchase 4,248,0002,770,000 shares of common stock are outstanding under the 2006 Stock Option Plan.

On June 5, 2006, we issued options to acquire 1,500,000 shares of our common stock at a per share price of $0.165 to an officer outside of the above referenced plans.


F-32

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)

A summary of the status of our stock option plans and warrants as of May 31, 2008, 20072011 and 20062010 and changes during the years ended on those dates is presented below:
 
  Options  Warrants 
  Shares  Weighted Average Exercise Price  Shares  Weighted Average Exercise Price 
             
Outstanding, June 1, 2005  7,148,000  $0.13   109,122,581  $0.04 
Granted  3,795,000   0.46   12,457,049   0.09 
Cancelled/Expired  (1,387,000)  0.30   (13,391,727)  0.05 
Repurchased  -   -   (2,000,000)  0.02 
Exercised  (4,096,000)  0.09   (52,838,683)  0.03 
                 
Outstanding, May 31, 2006  5,460,000   0.34   53,349,220   0.05 
Granted  2,800,000   0.39   -   - 
Cancelled/Expired  (500,000)  0.09   (1,334,409)  0.03 
Exercised  (515,000)  0.08   (39,953,896)  0.03 
                 
Outstanding, May 31, 2007  7,245,000   0.40   12,060,915   0.10 
Granted  6,625,000   0.43   -   - 
Cancelled/Expired  (4,392,154)  0.45   (1,933,259)  0.09 
Repurchased  -   -   (7,000,000)  0.08 
Exercised  (1,282,846)  0.15   (2,827,656)  0.12 
                 
Outstanding, May 31, 2008  8,195,000  $0.44   300,000  $0.57 
                 
Exercisable, May 31, 2006  5,115,000  $0.35   52,849,220  $0.05 
                 
Exercisable, May 31, 2007  7,245,000  $0.40   11,685,915  $0.10 
                 
Exercisable, May 31, 2008  4,265,372  $0.47   300,000  $0.57 
                 
Weighted average fair value of options and warrants granted during the year ended May 31, 2006     $0.49      $0.19 
                 
Weighted average fair value of options granted during the year ended May 31, 2007     $0.82      $- 
                 
Weighted average fair value of options granted during the year ended May 31, 2008     $0.32      $- 
  Options  Warrants 
  Shares  Weighted Average Exercise Price  Shares  Weighted Average Exercise Price 
             
Outstanding, June 1, 2009  10,210,000  $0.39   550,000  $0.41 
Granted  670,000   0.18   25,000   0.15 
Cancelled/Expired  (5,142,083)  0.33   (250,000)  0.23 
Exercised  (100,000)  0.07   -   - 
Outstanding, May 31, 2010  5,637,917   0.42   325,000   0.53 
Granted  650,000   0.10   -   - 
Cancelled/Expired  (3,277,917)  0.44   (325,000)  0.53 
Exercised  -   -   -   - 
                 
Outstanding, May 31, 2011  3,010,000  $0.33   -  $- 
                 
Exercisable, May 31, 2010  5,000,108  $0.45   325,000  $0.53 
                 
Exercisable, May 31, 2011  2,792,612  $0.34   -  $- 
                 
Weighted average fair value of options and warrants granted during the year ended May 31, 2010     $0.15      $0.03 
                 
Weighted average fair value of options granted during the year ended May 31, 2011     $0.08         

Included in the above table are certain options and warrants for which vesting is contingent based on various future performance measures.
 
F-33F-29


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Stockholders’ Equity (continued)

The following table summarizes information about stock options and warrants outstanding at May 31, 2008:

 
Range of
Exercise Prices
OutstandingExercisable
Number Outstanding
Weighted
Average Remaining
Contractual Life (Years)
Weighted
Average
Exercise Price
Number
Exercisable
Weighted
Average
Exercise Price
       
Options$ 0.05-0.201,350,0001.82$0.131,350,000$0.13
    0.30-0.504,625,0004.660.41695,372 0.43
    0.60-0.902,220,0003.160.682,220,000 0.68
 $ 0.05-0.908,195,0003.79$0.444,265,372$0.47
       
Warrants$ 0.20-1.00300,0002.72$0.57300,000$0.57

14.13. Income Taxes

The provision (benefit) for income taxes is as follows for the years ended May 31:

 2008  2007  2006  2011  2010 
Current:               
Federal $12,540,914  $-  $-  $(110,102) $(627,000)
State  3,973,734   972,064   -   (36,803)  (46,066)
Total current  16,514,648   972,064   -   (146,905)  (673,066
                    
Deferred:                    
Federal  (7,615,720)  7,767,761   -   5,161,525   (2,447,633)
State  (2,472,899)  2,015,208   -   1,222,914   (807,658)
Total deferred  (10,088,619)  9,782,969   -   6,384,439   (3,255,291)
Total provision $6,426,029  $10,755,033  $- 
Total provision (benefit) $6,237,534  $(3,928,357)

No provision for income taxes was recorded forDuring the fiscal year ended May 31, 20062011, we determined that all of our deferred tax assets would not be realized in the future due to the significant net operating loss carryforwards.

F-34

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Income Taxes (continued)our continuing pre-tax and taxable losses.  As a result of this determination we have placed a full valuation allowance against our deferred tax assets and increased our tax provision by approximately $8,971,000.

The reconciliation of the effective income tax rate to the Federal statutory rate is as follows for the years ended May 31:

 2008  2007  2006  2011  2010 
               
Statutory federal income tax rate  35.0%  34.0%  34.0%  35.0 %   35.0 % 
State income tax rate, net of Federal effect  6.1%  5.7%  -%  (13.8%)  5.3 % 
Change in tax rate  1.3%  -%  -%  (1.0%)  (1.0%)
Change in deferred tax related to non cash compensation  2.2%  -%  -%
Foreign tax credit  (3.7) %  -%  -%
Stock option expense  (0.7%)  - % 
Tax credits  - %   0.2 % 
Tax exempt interest  - %   0.2 % 
Deconsolidation of variable interest entity  - %   (0.2%)
Goodwill  (4.1%%)  (2.5%)
Other  -%  0.3%  -%  (4.5%)  - % 
(Decrease) increase in valuation allowance  (0.6) %  (8.7) %  (34.0) %
            
Change in valuation allowance  (129.1%)  - % 
Effective income tax rate  40.3%  31.0%  -%  (118.2%)  37.0 % 

F-30


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Income Taxes (continued)

Deferred tax assets and liabilities reflect the net tax effect of temporary differences between the carrying amount of assetassets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of our deferred tax assets are as follows as of May 31:

 2008  2007  2011  2010 
Current deferred tax assets (liabilities):            
Net operating loss carryforwards $-  $1,894,097 
Accruals and state taxes  1,412,500   376,257 
Basis difference in fixed assets  -   - 
Basis difference in intangibles  -   - 
Investment in affiliated companies  -   - 
Credits  -   242,411 
State taxes $49,287  $(34,509)
Accrued expenses  72,031   73,182 
Reserve for loan loss  -   434,034 
Less: valuation allowance  (21,668)  (72,790)  (121,318)  - 
Total net deferred tax asset  1,390,832   2,439,975 
Total net current deferred tax asset  -   472,707 
                
Long-term deferred tax assets (liabilities):                
Investment in affiliated company  (2,682,823)  (14,128,084)  (507,180)  212,202 
Basis difference in fixed assets  (1,918)  (2,870)
Basis difference in property and equipment  5,905   (5,486)
Basis difference in intangibles  927,088   1,072,117   176,415   (240,892)
Stock based compensation expense  235,779   835,893   462,607   480,869 
Impairment of note receivable  148,859   -   331,896   331,896 
Deferred state taxes  94,796   - 
State taxes  -   (796,678)
Deferred rent  5,721   8,498 
Other comprehensive loss  163,227   -   -   178,285 
Capital loss carryover  29,811   -   887,155   29,131 
Total net long-term deferred tax liability  (1,085,181)  (12,222,944)
Net deferred tax asset (liability) $305,651  $(9,782,969)
Net operating loss carryforwards  7,919,035   6,178,342 
Credit carryover  111,090   78,090 
Valuation allowance  (9,392,644)  (542,525)
Total net long-term deferred tax asset  -   5,911,732 
Net deferred tax asset $-  $6,384,439 


F-35


Patriot Scientific Corporation
NotesWe have carried back a federal net operating loss of approximately $1,394,000 to Consolidated Financial Statements (Continued)

Income Taxes (continued)

Atthe tax year ending May 31, 2008, the $21,668 valuation allowance above relates entirely to SSDI as management has not determined that it is more likely than not that the deferred tax asset relating to various accruals will be realized.  For2009.  We have federal and state tax purposes, SSDI is not consolidated with our corporate income tax filings. SSDI is consolidated however, in the components of our net deferred tax assets and liabilities as indicated above.

During fiscal year 2007, the valuation allowance of $2,872,255 relating to our deferred tax assets was released as we determined that we would utilize our net operating loss carryforwards available to offset future taxable income of approximately $17,827,000 and other deferred tax assets. For federal and state tax purposes, SSDI is not consolidated with our corporate income tax filings. SSDI is consolidated however,$21,018,000, respectively, at May 31, 2011.  These carryforwards begin to expire in the componentsyears ending May 31, 2023 and 2013, respectively.  The state of our net deferred tax assets and liabilities as indicated above. The $72,790 valuation allowance above relates entirely to SSDI as managementCalifornia has not determined that it is more likely than not that the deferred tax asset relating to net operating loss carryforwards will be realized.suspended NOL deductions for taxable years beginning in 2008 or 2009 for taxpayers with business income of $500,000 or more.

During fiscal year 2008, we have utilized our remaining federal net operating loss carryforward of approximately $4,870,000 and our general business credit carryforward of $242,411.

On June 1, 2007, we adopted FIN 48. This interpretation clarifies the application of SFAS No. 109, Accounting for Income Taxes, by definingauthoritative guidance which defines criteria that an individual tax position must meet for any part of the benefit of that position to be recognized in a company’s financial statements and also provides guidance on measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.  The adoption of FIN 48 on June 1, 2007this guidance did not result in any cumulative effect adjustment to retained earnings.  Interest and penalties, if any, related to unrecognized tax benefits are recorded in income tax expense.  As of June 1, 2007,May 31, 2011, we are subject to U.S. Federal income tax examinations for the tax years May 31, 19911994 through May 31, 2007,2010, and we are subject to state and local income tax examinations for the tax years May 31, 19992002 through May 31, 20072010 due to the carryover of net operating losses related to PDSG from previous years.


F-31


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

15.Income Taxes (continued)

The table below summarizes our liability relating to unrecognized tax benefits under the authoritative guidance for the fiscal years ended May 31, 2011 and 2010:

Balance at June 1, 2009  $- 
Increase in unrecognized tax benefit liability  - 
Decrease in unrecognized tax benefit liability  - 
Accrual of interest related to unrecognized tax benefits  7,000 
Balance at May 31, 2010 $7,000 
Increase in unrecognized tax benefit liability   
Decrease in unrecognized tax benefit liability  - 
Accrual of interest related to unrecognized tax benefits  - 
Balance at May 31, 2011 $7,000 

Our liability relating to unrecognized tax benefits has been presented net of our prepaid income taxes on our consolidated balance sheet at May 31, 2011 and 2010.

Our continuing practice is to recognize accrued interest and penalties related to unrecognized tax benefits as a component of tax expense.  This policy did not change as a result of our adoption of the authoritative guidance on June 1, 2007.  We do not expect our unrecognized tax benefits to change significantly over the next twelve months.

14. Commitments and Contingencies

Litigation

Patent Litigation

On February 8, 2008, the Company,we, TPL and Alliacense Ltd. were named as defendants in three separate lawsuits filed in the United States District Court for the Northern District of California by Asustek Computer, Inc., HTC Corporation, and Acer, Inc., and affiliated entities of each of them. On February 13, 2008, the Asustek claims were amended to include claims against MCM Portfolio, LLC (Alliacense and MCM Portfolio are TPL-related entities), which do not involve the Company.

The AsustekAcer case seeks declaratory relief that its products do not infringe enforceable claims of ourthe '336, '584‘749, '148 patents and '749 patents.  The Asustek case also seeks a similar declaration with respect to two patents owned by TPL that are not a part of the MMP Portfolio, and as such the Company is not engaged in this aspect of the litigation and defense.  The Acer case seeks declaratory relief that its products do not infringe enforceable claims of our '336, '584 and '749 patents.US 5,530,890 (the “890 patent”). The HTCcase similarly seeks declaratory relief that its products do not infringe enforceable claims of those threepatents.  We allege counterclaims for patent infringement of the '336, '749, '148 and '890 patents against Acer and our '148 patent.HTC.  On June 16, 2009, District Court Judge Jeremy Fogel stayed the HTC and Acer actions until September 18, 2009.  The stay has been lifted and the cases are in the discovery and claims construction phase.  A claims construction hearing is expected to be scheduled in late 2011.

On April 25,December 1, 2008, the Companywe, TPL and TPLAlliacense, Ltd. were named as defendants in a lawsuit filed five patent infringement lawsuits in the EasternUnited States District of Texas against HTC, Acer and Asustek.  These suits allege infringement by HTC and Acer with respect to our '336 '749 '584 and '148 patents; and by Asustek with respect to our '336, '749 and '584 patents.  On June 4, 2008, the Company and TPL filed patent infringement lawsuits against those parties in the Eastern District of Texas with respect to our '890 patent of the MMP Portfolio.  Motions to dismiss or transferCourt for the Northern District of California actionsby Barco, N.V.  The Barco case seeks declaratory relief that its products do not infringe enforceable claims of the '749 and '890 patents.  We allege counterclaims for patent infringement of our '749, '890 and '336 patents.  On June 22, 2009, Judge Fogel also stayed the Barco case until September 18, 2009.  That stay has been lifted and the case is deemed related to the Eastern District of Texas are currently pending with hearings set for August 29, 2008Acer and HTC cases.  The case is now in the Acer casediscovery and September 19, 2008claims construction phase.  Barco moved for Summary Judgment with respect to allegations that it has infringed on the HTC and Asustek'336 patent on grounds independent of claims construction.  That Motion was denied on February 25, 2011.  A claims construction hearing is expected to be scheduled in late 2011.


F-36F-32


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Commitments and Contingencies (continued)
Crossflo Systems, Inc. Litigation

cases.  At that point we expectUnder the terms of our Agreement and Plan of Merger (the "Merger Agreement") with Crossflo, and certain of its principal officers, an escrow account was established to learn wherehold back approximately 10% of the T-3 (“Acer, Asustek and HTC”) litigation will proceed.  Responsive pleadings in those cases are due at varying times in mid-August and early September 2008.  Similarmerger consideration payable to the actionsshareholders of Crossflo (the "Escrow Merger Consideration").  See Escrow Shares below.  We contend that certain representations and warranties made by Crossflo and certain of its principal officers in the Northern District of California, the Asustek action in the Eastern District of Texas is inclusive of matters with respect to two patents owned by TPL that are not a partMerger Agreement were false when made, and were false as of the MMP Portfolio, and as such we are not engaged in this aspectclosing of the litigationmerger.  We submitted a demand to the escrow agent on August 31, 2009 not to release the Escrow Merger Consideration to the Crossflo shareholders and defense.

Lowell Giffhorn Arbitrationto instead return it to us.  A sufficient number of Crossflo shareholders have opposed our demand that the escrow consideration has not been released to either side.

On September 23, 2005, Lowell Giffhorn, a former executive officer and a former director of the Company, submitted a demand forAugust 31, 2009, we initiated an arbitration withproceeding before the American Arbitration Association relatedagainst the three Crossflo principal officers who were signatories to the terminationMerger Agreement alleging they provided false representations and warranties in the Merger Agreement and alleging nondisclosure of Mr. Giffhorn's employmentinformation about Crossflo during the due diligence process leading up to the merger.  Those three principal officers deny our claims and have filed counterclaims.  The arbitration is scheduled to begin November 8, 2011.

TPL Litigation

On April 22, 2010, we filed an action against TPL and Alliacense LLC in Santa Clara Superior Court alleging claims for breach of contract, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and interference with contract, constructive fraud, for preliminary and permanent injunctions and for an accounting.  The Action stemmed from TPL's notification of a license written in April 2010 which included a license of the MMP patents and other patent to use portfolios and technologies co-owned and potentially owned by TPL in the future.  We objected to the amount of license consideration allocated to the MMP patent license as too low relative to the other license components.

On April 26, 2010, the Court granted our application for a Temporary Restraining Order ("TRO") precluding TPL from executing any license of the MMP patents without providing us five business days' notice of the proposed MMP license and any other proposed license with the Company. Mr. Giffhorn assertedlicensor, in order to allow us time to seek redress if we are dissatisfied by the proposed licenses.  At that time, TPL filed motions to seal the file and to bar press releases commenting on the contents of the court file, and a motion to compel private arbitration of the dispute.

TPL stipulated on August 3, 2010 that the terminationTRO already in place would become a Preliminary Injunction.  On August 12, 2010, the Court considered defendants’ request to seal the file indefinitely and to compel private arbitration of his employment with the Company was unlawful, retaliatory, wrongful, violated public policy, violateddispute and denied both Motions.  On September 30, 2010, the covenantCourt agreed to redaction of good faiththe court file at TPL’s request for commercially sensitive data such as dollar amounts of licenses, percentage allocation to MMP licenses and fair dealingother such confidential data.  TPL has appealed the denial of its Motion to Compel Arbitration which appeal stays the Superior Court proceeding.  The appeal is in the briefing stage and violated securities laws. Mr. Giffhorn sought damagesexpected to be decided in late 2011 or early 2012.  If the Appeal is unsuccessful then the Superior Court action will be activated.  If it is successful, some or all of approximately $4,500,000 (excluding claims for punitive damages and attorney’s fees). On November 1, 2007, the Company and Mr. Giffhorn reached a settlement where Mr. Giffhorn was given $500,000 and 200,000 shares of restricted Company stock in exchange for a comprehensive release of all claims against the Company.  We have recorded these costs in selling, general and administrative expenses for fiscal year ended May 31, 2008.case would proceed to arbitration.

401(k) Plan

WePatriot and PDSG have a retirement planplans that compliescomply with Section 401(k) of the Internal Revenue Code. All employees are eligible to participate in the plan. We matchplans. Prior to January 1, 2011 Patriot matched 50% of each participant’s voluntary contributions, subject to a maximum contribution of 6% of the participant’s compensation.  ParticipantsOn January 1, 2011 Patriot implemented a Safe Harbor 401(k) retirement plan which requires Patriot to match 100% of elective deferrals subject to a maximum of 4% of the participant’s eligible earnings. Patriot’s participants vest 33% per year over a three year period in ourtheir matching contributions. OurPatriot’s matching contributions during the fiscal years ended May 31, 2008, 20072011 and 20062010 were $9,596, $11,397$17,790 and $1,833,$18,242, respectively.  PDSG does not match participant voluntary contributions.

F-33


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)
Commitments and Contingencies (continued)
Employment Contracts

During the quarter ended August 31, 2005, we terminated two of our officers, each of whom had an employment contract with us. One of the officers agreed to accept as severance approximately $150,000 and to have the maturity date of options held by him extended for one year. Further, we agreed to accelerate the vesting of all outstanding options held by the officer and to extend their term to June 2006. We recorded an expense of approximately $125,000 related to this option modification in the year ended May 31, 2006.

On June 5, 2007, Mr. Pohl, our outgoing chief executive officer retired. As a result, we recorded a severance charge of $100,000 based on terms of his employment agreement which provided for salary continuation.

In connection with Mr. Turley’s appointment as President and Chief Executive Officer, and commencing on June 5, 2007, we entered into an employment agreement with Mr. Turley for a one-year term.  Pursuant to the agreement, if Mr. Turley was terminated without cause, he was entitled to his then current salary level for the remaining term of his agreement conditional upon the execution of a general release.  On February 28, 2008, Mr. Turley resigned.  As a result, we recorded a one-time severance charge of $95,192 during the fiscal year 2008 in full discharge of all remaining obligations to Mr. Turley.
In connection with Mr. Flowers’ appointment as the Chief Financial Officer, and commencing on September 17, 2007, we entered into an employment agreement with Mr. Flowers for an initial 120-day term if not terminated pursuant to the agreement, with an extension period of one year and on a continuing basis thereafter.  Pursuant to the agreement, if Mr. Flowers is terminated without cause or resigns with good reason within the first two years of employment, he is entitled to receive an amount equal to his annual base salary for the greater of (i) 6 months or (ii) the period remaining in the extended one-year term.  If Mr. Flowers is terminated without cause or resigns with good reason any time after two years of continuous employment, he is entitled to receive an amount equal to 12twelve months of his annual base salary.  Mr. Flowers is also entitled to certain payments upon a change of control of the Company if the surviving corporation does not retain him. All such payments are conditional upon the execution of a general release.
 
F-37

Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Commitments and Contingencies (continued)

In connection with Mr. Goerner’s appointment as Interim President and Chief Executive Officer, and commencing on February 29, 2008, (the “Effective Date”), we entered into an Employment Agreement (the “Agreement”)employment agreement with Mr. Goerner terms of which were finalized May 19, 2008. The agreement is for an initial 120-day term if not terminated pursuant to the agreement, with an extension period of one year and on a continuing basis thereafter.  Pursuant to the Agreement, Mr. Goerner is to receive a base salary of $250,000 per year and is eligible to receive a bonus of 100% of his base salary at the time his position is converted by the Board of Directors to standing President/CEO or nine months from the effective date of the agreement.  If Mr. Goerner is terminated without cause during the nine month period after the effective date he shall receive a pro-rata portion of the bonus based on the term of his actual employment with us.  Also pursuant to the Agreement and on the date of the Agreement, Mr. Goerner received a grant of incentive stock options to purchase 250,000 shares of our common stock and non-qualified stock options to purchase 50,000 shares of our common stock.  Mr. Goerner also received a grant of non-qualified stock options to purchase 700,000 shares of our common stock to vest upon conversion of his position to standing President/CEO or nine months from the effective date of the agreement, whichever is first to occur and Mr. Goerner also received a grant of non-qualified stock options to purchase 2,000,000 shares of our common stock to vest upon meeting performance conditions outlined in the grant.  The Agreement also provides for Mr. Goerner to receive customary employee benefits, including health, life and disability insurance, and an automobile allowance.

Pursuant to the agreement, if Mr. Goerner iswas terminated without cause within the first year of employment, after the initial 120-day term, he iswas entitled to receive an amount equal to his base salary for the period remaining in the agreement.  Payments arewere conditional upon the execution of a general release.  In connection with management’s restructuring plan on October 7, 2009, we entered into a Separation Agreement with Mr. Goerner which required us to pay his base salary for the next seven months in exchange for a general release of claims against us.  During the fiscal year 2010 we recorded a one-time severance charge of $145,833 pursuant to the Separation Agreement.  At May 31, 2010 we have satisfied all payments under the Separation Agreement.

Guarantees and Indemnities

We have made certain guarantees and indemnities, under which we may be required to make payments to a guaranteed or indemnified party. We indemnify our directors, officers, employees and agents to the maximum extent permitted under the laws of the State of Delaware and California for SSDI.PDSG. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying consolidated balance sheets.

Operating LeasesPursuant to the acquisition of Crossflo, we have agreed to indemnify the former owners of Crossflo for certain claims or losses resulting from any untrue, allegedly untrue or misleading statement made in a registration statement, prospectus or similar document.

We haveBonuses

In connection with the acquisition of Crossflo, retention bonuses were to be paid to individuals who were Crossflo employees pre-merger who remain with PDSG until March 1, 2010.  In connection with the acquisition of Vigilys, a non-cancelable operating lease agreementretention bonus was to be paid to a key employee who remains with PDSG until March 27, 2010.  The projected liability for such bonuses was $75,000.  These liabilities were being accrued ratably over the retention periods.  During March 2010 retention bonuses in the amount of $75,000 were paid to qualified key employees.

By the terms of his employment contract, our Carlsbad, California office facility. Future minimum lease payments required underCFO, who also currently serves as our interim CEO, is eligible to earn an annual bonus equivalent to 50% of his base salary.  In connection with management’s restructuring plan on October 5, 2009, our Compensation Committee determined that this bonus would be payable at the operating lease are $73,710end of the interim period.  The projected liability for such bonus was $145,875 and was recorded on our consolidated balance sheet in fiscal year 2009. Rent expense for the fiscal years ended“Accrued expenses and other” at May 31, 2008, 2007 and 20062010.  The bonus was $113,734, $92,928 and $30,976, respectively.

SSDI subleases their Carlsbad, California office facility which expired in June 2008 with a month-to-month option until not later than December 2008.  Future minimum lease payments required under the operating lease are $7,351 inpaid during fiscal year 2009.  Rent expense2011.  No such bonus has been accrued for the fiscal year ended May 31, 2008 and the fourth quarter of fiscal 2007 was $89,082 and $15,138, respectively.

SSDI leases their Anaheim, California warehouse facility under a lease which expires November 30, 2009.  Future minimum lease payments required under the operating lease are $75,432 in fiscal year 2009 and $31,430 in fiscal year 2010.  Rent expense for the fiscal year ended May 31, 2008 and the fourth quarter of fiscal 2007 was $58,800 and $14,700, respectively.

SSDI subleases a  San Diego, California office facility under a lease which began September 1, 2007 and expires August 31, 2008.  Future minimum lease payments required under the operating lease are $4,500 in fiscal year 2009.  Rent expense for the fiscal year ended May 31, 2008 was $13,500.

2011.

F-38F-34


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Commitments and Contingencies (continued)

Earn-Out Agreement

SSDI entered into an earn-out agreement with a former debt holder of Holocom Networks upon our contribution of the foreclosure sale collateral of Holocom Networks to SSDI. The agreement required the former debt holder to release all of his rights to any Holocom collateral in exchange for receiving 3% of the net sales (defined as cash revenues actually received less credits or discounts and other claims of customers) of SSDI’s protected distribution system products for a period of 48 months from the foreclosure sale date of February 2, 2007. The earn-out is to be paid each calendar quarter. A liability for payment under this agreement of $29,747 is included in accounts payable in the accompanying consolidated balance sheet at May 31, 2008.  Amounts paid under the earn-out agreement forDuring the fiscal year ended May 31, 2008 and2011, a retention bonus program was implemented to be paid to individuals who remain with PDSG until February 29, 2012.  The projected liability for such bonuses is $90,000.  This liability is being accrued ratably over the fourth quarter of fiscal 2007 were $62,570 and $6,783, respectively.retention period.

16.Escrow Shares

On August 31, 2009 we gave notice to the former shareholders of Crossflo and Union Bank of California (the “Escrow Agent”) under Section 2.5 of the Agreement and Plan of Merger between us and Crossflo (the “Agreement”), outlining damages incurred by us in conjunction with the acquisition of Crossflo, and seeking the return of 2,844,630 shares of our common stock held by the Escrow Agent.  Subsequently, former shareholders of Crossflo representing a majority of the escrowed shares responded in protest to our claim, delaying the release of the escrowed shares until a formal resolution is reached.  In the event we fail to prevail in our claim against the escrowed shares, we may be obligated to deposit into escrow approximately $256,000 of cash consideration due to the decline in our average stock price over the one year escrow period, calculated in accordance with the Section 2.5 of the Agreement.  We have evaluated the potential for loss regarding our claim and believe that it is probable that we will prevail although there is no assurance that we will.  Accordingly, we have not recorded a liability for this matter.

Operating Leases

We lease our facilities through operating leases that expire at various dates through 2013.  Rental expense, net of sublease income, is presented in the following table:

  Year Ended  Year Ended 
  May 31, 2011  May 31, 2010 
Rental expense $213,154  $275,392 

A summary of future minimum payments under our operating lease commitments, net of sublease income as of May 31, 2011 is as follows:

Fiscal Year   
2012 $112,166 
2013  21,253 
Total minimum lease payments  133,419 

15. Segment Information

SSDI began operationsWe acquired PDSG in February 2007a series of transactions in the second, third and we consolidated SSDIfourth quarters of fiscal 2009 and consolidate our wholly-owned subsidiary PDSG in our consolidated financial statements in March 2007. SSDI is an operating segment under SFAS No. 131, Disclosures About Segments of an Enterprise, as revenue is 10% or more ofstatements.  PDSG provides data sharing services and products to the total revenue of all operating segments.

SSDI is engaged in the business of developing and manufacturing network-security hardware to government, military, and other high-security facilities.public sector.  There is no inter-segment revenue and the accounting policies for segment reporting are the same as for us as a whole.

The “all other” category includes the results for Patriot Scientific Corporation.This reportable segment is a strategic business unit that is managed separately because it requires different technology and marketing strategies.

Operating segment net revenue, operating income (loss)loss and income (loss)loss before taxes for each of the years ended May 31 were as follows:

  2008  2007  2006 
Net revenue:         
SSDI $3,649,898  $558,484  $- 
All other  58,320   80,300   10,309,709 
Total net revenue $3,708,218  $638,784  $10,309,709 
             
Operating income (loss):            
SSDI $146,131  $(176,432) $- 
All other  (5,749,624)  (14,587,407)  3,911,640 
Total operating income (loss) $(5,603,493) $(14,763,839) $3,911,640 

  2008  2007  2006 
Income (loss) before taxes:         
SSDI $297,235  $(169,913) $- 
All other  15,632,521   34,616,133   28,672,688 
Total income (loss) before taxes $15,929,756  $34,446,220  $28,672,688 


F-39F-35


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Segment Information (continued)

  2011  2010 
Net revenue:      
PDSG $468,678  $567,934 
PTSC  -   - 
Total net revenue $468,678  $567,934 
Operating loss:        
PDSG $(3,888,358) $(8,948,008)
PTSC  (2,550,666)  (3,816,007)
Total operating loss $(6,439,024) $(12,764,015)
Loss before income taxes:        
PDSG $(3,827,595) $(8,756,032)
PTSC  (1,450,261)  (1,852,146
Total loss before income taxes $(5,277,856) $(10,608,178)
Provision (benefit) for income taxes:        
PDSG $4,267,167  $(2,996,841)
PTSC  1,970,367   (931,516
Total provision (benefit) for income taxes $6,237,534  $(3,928,357)

All PDSG sales were to unaffiliated customers within the United States.States, with the exception of a hosting arrangement with a customer in Japan.

Sales and accounts receivable concentration information for SSDIPDSG as of and for the yearsyear ended May 31, were2011 and 2010 was as follows:

 20082007
 Sales% of sales% of A/RSales% of sales% of A/R
Anixter$1,354,49437%16%$461,49485%85%
Graybar Electric Company, Inc.$889,72424%38%--------------
Victory Global Solutions$370,30110%6%--------------
  2011  2010 
  Sales  % of sales  % of A/R  Sales  % of sales  % of A/R 
Customer A $136,229   29%   -  $281,141   50%   22% 
Customer B $23,928   5%   13%  $106,064   19%   72% 
Customer C $81,642   17%   15%   -   -   - 
Customer D $151,323   32%   71%   -   -   - 

Operating segment depreciation and amortization for each of the years ended May 31and31 and total assets at May 31 were as follows:

 2008  2007  2006  2011  2010 
Depreciation and amortization:               
SSDI $21,877  $22,740  $- 
All other  28,828   42,121   59,415 
PDSG $267,797  $588,806 
PTSC  9,366   13,420 
Total depreciation and amortization $50,705  $64,861  $59,415  $277,163  $602,226 


  2008  2007 
Total assets:      
SSDI $1,383,941  $642,871 
All other  24,047,961   33,771,758 
Total assets $25,431,902  $34,414,629 

17. Subsequent Events

During the period June 1, 2008 through August 8, 2008, we purchased 1,966,160 shares of our common stock at an aggregate cost of $400,906 pursuant to our stock buyback program.

On June 1, 2008, SSDI assigned its note receivable of $50,000 to us and we agreed to reduce the amount of our line of credit with SSDI by the amount of the note.  On June 26, 2008, we were paid in full by the third party debtor.

On June 18, 2008, we gave SSDI notice under terms of the line of credit that we would not be extending the maturity date by the additional twelve month period provided for in the line of credit. As a result, the line of credit will terminate, and full payment of any outstanding balance will be due on September 27, 2008.

During June 2008, we obtained a credit facility, for as long as needed, which provides for financing up to 50% of the par value balance of our outstanding auction rate securities. The facility is collateralized by the full value of the outstanding auction rate securities, required no origination fee, and if drawn upon will bear interest at the federal funds rate plus 3%.

On July 11, 2008, we invested approximately $149,000 to purchase preferred shares of an unrelated private company which is a networking provider of software to facilitate the transfer of video content to mobile devices.  We are accounting for our investment using the cost method as we do not own any of the voting common stock of the company.

F-40F-36


Patriot Scientific Corporation
Notes to Consolidated Financial Statements (Continued)

Subsequent EventsSegment Information (continued)

During July 2008, SSDI obtained a credit facility for up to $300,000 from a third party, at an interest rate based on the Wall Street Journal Prime plus 1% (floating) with a floor of 6%.  The credit facility term extends to May 1, 2009, and is guaranteed by Patriot.
  2011  2010 
Total assets:      
PDSG $399,560  $7,227,033 
PTSC  12,197,843   20,188,648 
Total assets $12,597,403  $27,415,681 

On August 1, 2008, we increased our investment in Talis to 37.4% as a result of purchasing additional shares offered by Talis, as well as acquiring shares from minority shareholders which included16. Subsequent Events

During the acquisition of all Talis shares previously held by SSDI. The acquisition of Talis shares previously owned by SSDI was made for $100,000 in cash and a reduction on their outstanding line of credit of $219,000. After the purchase of SSDI’s Talis shares and theperiod June 1, assignment of the $50,000 note receivable from SSDI, SSDI’s outstanding balance on its Patriot line of credit was reduced to $131,000.

On2011 through August 1, 2008, SSDI paid $56,000 on its Patriot line of credit reducing the principal balance to $75,000.

On August 1, 2008,12, 2011, we issued a warrant to purchase 250,000purchased 554,089 shares of our common stock for $0.23 per shareat an aggregate cost of $43,023 pursuant to our institutional investor relations firm.  The warrantstock buyback program.

In July 2011 we received $38,985 from Deutsche Bank relating to partial redemptions of auction rate securities occurring on June 1, 2011.  Such amount is subjecta recovery on the $600,879 realized loss on sale of marketable securities recognized during the fiscal year ended May 31, 2011.  Deutsche Bank had repurchased our illiquid auction rate securities pursuant to vesting provisions.our settlement agreement with them in September 2010.

On August 4, 2008,2011 we announced our intentreceived a refund of federal taxes in the amount of $400,042 relating to acquire Crossflothe NOL carryback for $10 million comprised of cash and stock with an effective completion date of September 1, 2008, subject to approval by Crossflo’s shareholders.the fiscal year ended May 31, 2009.

On August 8, 2008, we purchased a secured convertible promissory note with an attached warrant for common stock from Crossflo with a face amount of $417,750.  Terms of the note are the same as those outlined in Note 4.




F-41F-37


Phoenix Digital Solutions, LLC


INDEX TO FINANCIAL STATEMENTS


  Page 
 Page
  
Report of Independent Registered Public Accounting Firm F-43F-39
 
Financial Statements:   
Balance Sheets F-44F-40
 
Statements of Income F-45F-41
 
Statements of Members’ Equity F-46F-42
 
Statements of Cash Flows F-47F-43
 
Notes to Financial Statements F-48F-44 


F-42F-38


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Members
Phoenix Digital Solutions, LLC

We have audited the accompanying balance sheets of Phoenix Digital Solutions, LLC (the "Company") as of May 31, 20082011 and 2007,2010, and the related statements of income, members' equity and cash flows for each of the two years in the three-year period ended May 31, 2008.2011. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company'sCompany’s internal control over financial reporting.  Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above, present fairly, in all material respects, the financial position of Phoenix Digital Solutions, LLC as of May 31, 20082011 and 2007,2010, and the results of its operations and its cash flows for each of the two years in the three-year period ended May 31, 20082011 in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming the Company will continue as a going concern.  As more fully described in Note 1 to the financial statements, the Company has experienced a decline in license revenues and because of the uncertain nature of the negotiations that lead to license revenues, there is no assurance that the Company will receive any future revenues from license agreements, or if it does, that such license revenues in the future will be consistent with amounts received in the past. These factors raise substantial doubt about the Company’s ability to continue as a going concern.  Management’s plans in regard to these matters are also described in Note 1.  The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

/s/ KMJ Corbin & Company LLP

Irvine,Costa Mesa, California
August 14, 200829, 2011


F-43F-39


Phoenix Digital Solutions, LLC
Balance Sheets


May 31, 2011  2010 
ASSETS      
       
Current assets:      
Cash and cash equivalents $1,895,653  $779,932 
Prepaid expenses  600,000   25,000 
Licenses receivable  -   2,000,000 
Total assets $2,495,653  $2,804,932 
         
LIABILITIES AND MEMBERS’ EQUITY        
         
Current liabilities:        
Related party payables and accrued expenses $1,883,296  $1,777,884 
LLC tax payable  11,790   11,790 
         
Total liabilities  1,895,086   1,789,674 
         
Commitments and Contingencies        
         
Members’ equity  600,567   1,015,258 
         
Total liabilities and members’ equity $2,495,653  $2,804,932 
May 31, 2008  2007 
       
ASSETS      
       
Current assets:      
Cash and cash equivalents $8,260,288  $6,989,847 
Prepaid expenses  -   175,000 
Total current assets $8,260,288  $7,164,847 
         
LIABILITIES AND MEMBERS’ EQUITY        
         
Current liabilities:        
Accounts payable $3,204,519  $1,225,118 
Accrued expenses  -   160,000 
Income tax payable  11,790   11,790 
         
Total current liabilities  3,216,309   1,396,908 
         
Commitments and Contingencies        
         
Members’ equity  5,043,979   5,767,939 
         
Total liabilities and members’ equity $8,260,288  $7,164,847 



See accompanying notes to financial statements.

F-44F-40


Phoenix Digital Solutions, LLC
Phoenix Digital Solutions, LLC
Statements of Income


Years Ended May 31, 2008  2007  2006  2011  2010 
               
License revenues $59,282,971  $110,878,985  $60,000,000  $11,090,000  $14,278,855 
                    
Operating expenses:                    
General and administrative  18,627,032   12,189,575   4,486,955   9,922,580   5,301,273 
        
Operating income  40,655,939   98,689,410   55,513,045   1,167,420   8,977,582 
                    
Other income:                    
Interest income  216,902   421,407   183,682 
Interest and other income  46,091   588 
                    
Income before income taxes  40,872,841   99,110,817   55,696,727 
Income before LLC taxes  1,213,511   8,978,170 
                    
Provision for income taxes  11,790   11,790   - 
Provision for LLC taxes  12,590   11,790 
                    
Net income $40,861,051  $99,099,027  $55,696,727  $1,200,921  $8,966,380 

See accompanying notes to financial statements.
F-45

Phoenix Digital Solutions, LLC
Statements of Members’ Equity


Balance June 1, 2005 $- 
Contributions  4,000,000 
Net income  55,696,727 
Distributions  (52,064,781)
Balance May 31, 2006  7,631,946 
Contributions  - 
Net income  99,099,027 
Distributions  (100,963,034)
Balance May 31, 2007  5,767,939 
Contributions  - 
Net income  40,861,051 
Distributions  (41,585,011)
Balance May 31, 2008 $5,043,979 


See accompanying notes to financial statements.

F-46F-41


Phoenix Digital Solutions, LLC
Statements of Members’ Equity

Balance June 1, 2009 $6,004,533 
Contributions  1,160,000 
Net income  8,966,380 
Distributions  (15,115,655)
Balance May 31, 2010  1,015,258 
Net income  1,200,921 
Distributions  (1,615,612)
Balance May 31, 2011 $600,567 



See accompanying notes to financial statements.

F-42


Phoenix Digital Solutions, LLC
Statements of Cash Flows


Years Ended May 31, 2008  2007  2006  2011  2010 
               
Operating activities:               
Net income $40,861,051  $99,099,027  $55,696,727  $1,200,921  $8,966,380 
Adjustments to reconcile net income to net cash provided by operating activities:                    
Changes in operating assets and liabilities:                    
Prepaid expenses  175,000   (160,000)  (15,000)  (575,000)  (25,000)
Accounts payable and accrued expenses  1,819,401   1,236,356   148,762 
Income tax payable  -   11,790   - 
Licenses receivable  2,000,000   4,148,750 
Related party payables and accrued expenses  105,412   290,085 
LLC tax payable  -   11,790 
Net cash provided by operating activities  42,855,452   100,187,173   55,830,489   2,731,333   13,392,005 
                    
Financing activities:                    
Contributions from members  -   -   4,000,000   -   1,160,000 
Distributions to members  (41,585,011)  (100,963,034)  (52,064,781)  (1,615,612)  (15,115,655)
Net cash used in financing activities  (41,585,011)  (100,963,034)  (48,064,781)  (1,615,612)  (13,955,655)
                    
Net increase (decrease) in cash and cash equivalents  1,270,441   (775,861)  7,765,708   1,115,721   (563,650)
Cash and cash equivalents, beginning of year
  6,989,847   7,765,708   -   779,932   1,343,582 
Cash and cash equivalents, end of year $8,260,288  $6,989,847  $7,765,708  $1,895,653  $779,932 
                    
Supplemental Disclosure of Cash Flow Information                    
Cash payments for income taxes $12,590  $13,390  $12,590  $12,590  $800 



See accompanying notes to financial statements.

F-47F-43


Phoenix Digital Solutions, LLC
Notes to Financial Statements


1. Organization and Business

Phoenix Digital Solutions, LLC (the “Company”) is a Delaware limited liability company organized on June 7, 2005. Through a commercialization agreement dated June 7, 2005, the Company holds the rights to certain patents of its members. The Company receives license fees from license agreements entered into between licensees and a member of the Company and distributes license fee proceeds to its members.

Going Concern and Management’s Plans

The Company’s financial statements have been prepared using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business.

During the years ended May 31, 2011 and 2010, the Company has experienced a decline in license revenues. At August 26, 2011, the Company’s cash and cash equivalents balance was $689,169.  The ability of PDS to continue as a going concern is dependent on its ability to generate or obtain sufficient cash to meet its obligations on a timely basis.  The Company will need to generate proceeds from new license agreements or obtain equity or debt financing to fund its planned operating expenses and working capital requirements for the foreseeable future.  Currently, the Company has no commitments to obtain additional capital from sources outside of that which may be contributed by the members, and there can be no assurance that financing will be available in amounts or on terms acceptable to the Company, if at all.

Because of the uncertain nature of the negotiations that lead to license revenues, pending litigation with companies which the members believe have infringed on their patent portfolio, the possibility of legislative action regarding patent rights, the possible effect of new judicial interpretations of patent laws, and current litigation between the members of PDS, there is no assurance that the Company will receive any future revenues from license agreements, or if it does, that such license revenues in the future will be consistent with amounts received in the past.

In the event the Company is unable to successfully generate proceeds from license agreements at historical levels or obtain additional capital, it is unlikely that the Company will have sufficient cash flows and liquidity to finance its business operations as currently contemplated. Accordingly, in the event new financing is not obtained, the Company will likely reduce general and administrative expenses, including legal fees, litigation activity and other licensing costs, until it is able to obtain sufficient financing to do so.

Management believes that its current sources of funds and current liquid assets will allow the Company to continue as a going concern through at least September 30, 2011. As such, these financial statements do not include any adjustments that might result from the outcome of this uncertainty.

2. Summary of Significant Accounting Policies

Limited Liability Company Operating Agreement
As a limited liability company, each member’s liability is limited to the capital invested. Allocation of profits, losses and distributions is in accordance with the terms as defined in the operating agreement.

The Company is treated as a partnership for federal income tax purposes. Consequently, federal income taxes are not payable by the Company. The Company’s net income or loss is allocated among the members in accordance with the operating agreement of the Company and members are taxed individually on their share of the Company’s earnings. The State of California assesses a limited liability company a fee based on the Company’s income in addition to a flat limited liability company tax.  Accordingly the financial statements reflect a provision for these California taxes.

Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts and disclosures. Accordingly, actual results could differ from those estimates.


F-44


Phoenix Digital Solutions, LLC
Notes to Financial Statements (Continued)

Summary of Significant Accounting Policies (continued)

Revenue Recognition
The Company recognizes revenue when all obligations are satisfied under the license agreement and realization of the revenue is assured, which is generally upon receipt of the license proceeds from the licensee at which time all obligations of the Company have been performed under the license agreements.(see Note 3).

Cash Equivalents
The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents.

Financial Instruments and Concentrations
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.

Credit Risk

TheAt May 31, 2011, the Company’s cash and cash equivalents balance consisting of its checking account balance over the FDIC insurance limit and its money market account not subject to FDIC insurance was $1,645,653.

At May 31, 2010, the Company’s cash maintained with its bank exceeds the Federal Deposit Insurance Corporation’s insured limitand cash equivalents balance consisting of $100,000.money market accounts not subject to FDIC insurance was $779,932.  The Company limits its exposure of loss by maintaining its cash with a financially stable financial institutions.institution.

Legal Fees

For the years ended May 31, 2011 and 2010, one legal service provider accounted for $5,024,404 and $1,038,568, respectively, of legal costs associated with the litigation of the MMP patent portfolio.  These amounts are included in general and administrative expense in the accompanying statements of income.  

Intellectual Property Rights

The Company relies on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect its intellectual property rights. The Company currently has seven U.S. patents, one European patent, and one Japanese patent issued. A successful challenge to its ownership of the technology or the proprietary nature of the intellectual property would materially damage the Company’s business prospects. Any issued patent may be challenged and invalidated.

3. Prepaid Expenses

At May 31, 2011 prepaid expenses consist of the June 1, 2011 $500,000 quarterly amount for supporting efforts to secure licensing agreements by TPL on behalf of PDS of which TPL requested early payment in May 2011 and a $100,000 retainer for the attorney representing TPL in the HTC/Acer/Barco litigation.

At May 31, 2010 prepaid expenses consist of a retainer in the amount of $25,000 for the attorney presenting the Company in the dispute between TPL and PTSC regarding the Commercialization Agreement.

4. Licenses Receivable

The Company generally recognizes revenue upon receipt of the license proceeds from the licensee at which time all obligations of the Company have been performed under the license agreements.

At May 31, 2010, the balance in licenses receivable consists of a license agreement for which partial payment was made in fiscal 2010 and the remaining payment of $2,000,000 was received by the Company during July 2010.


F-48F-45


Phoenix Digital Solutions, LLC
Notes to Financial Statements (Continued)

3.5. Formation and Commercialization Agreement

The Company has two members: Technology Properties Limited Inc. (“TPL”), and Patriot Scientific Corporation (“PTSC”). Each member owns 50% of the membership interests of the Company. Each member has the right to appoint one member of the three member management committee. The two appointees are required to select a mutually acceptable third member of the management committee.

Pursuant to the LLC Agreement, the members agreed to establish a working capital fund for the Company of $4,000,000, of which each member contributed $2,000,000. The working capital fund increases to a maximum of $8,000,000 as license revenues are achieved. The members are obligated to fund future working capital requirements at the discretion of the management committee of the Company in order to maintain working capital of not more than $8,000,000. Neither member is required to contribute more than $2,000,000 in any fiscal year.  During the fiscal year ended May 31, 2010 PTSC and TPL each contributed $580,000 to the Company for working capital requirements.  No such contributions were made during the fiscal year ended May 31, 2011.  Distributable cash and allocation of profits and losses will beare allocated to the members in the priority defined in the LLC Agreement.

On June 7, 2005, the Company entered into a Commercialization Agreement with TPL and PTSC. This Commercialization Agreement allows TPL to commercialize the patent portfolio by entering into settlement and/or license agreements, suing in the name of TPL, PTSC, the Company and Charles Moore, and manage the use of the patent portfolio by third parties.

Under terms of the Commercialization Agreement, the Company is required to pay a quarterly amount ranging between $500,000 and $1,000,000 (based upon a percentage of the working capital fund balance) to TPL for TPL’s supporting efforts to secure licensing agreements for the Company. During the years ended May 31, 2008, 20072011 and 2006,2010, the Company paid $2,952,362, $3,871,602expensed $2,500,000 and $2,500,000,$1,500,000, respectively, to TPL pursuant to the agreement. The Company is also required to reimburse TPL for payment of all legal and third-party expert fess and other related third party costs and expenses. During the years ended May 31, 2008, 20072011 and 2006,2010, the Company paid $12,894,053, $5,914,000expensed $6,833,708 and $1,021,357,$3,684,154, respectively, to TPL pursuant to the agreement.

On August 17, 2009, the Company’s management committee resolved to pay TPL $500,000 per quarter beginning on June 1, 2009 and continuing through May 31, 2010 relating to TPL’s special work and effort regarding the MMP litigation and U.S. Patent Office re-examinations.  In the event that the Company had insufficient funds to make such payments, PTSC was required to advance half of the quarterly amount to the Company.  PTSC’s advances to the Company were to be without interest and were to be repaid to PTSC no later than May 31, 2010.  During the fiscal year ended May 31, 2010, TPL received $1,500,000 from the Company pursuant to this agreement which is included in the fiscal 2010 legal and third-party expenses above.  PTSC did not advance any funds to the Company or TPL under this resolution.  On May 31, 2010, the resolution terminated.  On January 19, 2011, in accordance with PTSC’s settlement agreement with TPL, PDS agreed to pay TPL an additional $750,000 pursuant to this agreement representing reimbursement of special litigation support costs incurred by TPL.

All of the amounts are recorded in general and administrative expense in the accompanying statements of income.

4.During April 2010, PTSC filed two separate actions against TPL in the Superior Courts of San Diego and Santa Clara counties.  PTSC and TPL had been in negotiations to restructure their relationship.  On January 19, 2011, PTSC settled the San Diego Superior Court action.

On July 15, 2010, the Company paid PTSC $1,003,095 consisting of principal and interest through July 15, 2010 on PTSC’s $950,000 secured note with TPL for which the Company was jointly and severally liable.  This amount had been recorded as a note receivable from TPL on the Company’s balance sheet on July 15, 2010.  Due to TPL’s inability to pay the note, it was fully reserved for at July 15, 2010 and the allowance was recorded as “Reserve for loan loss and uncollectable receivable” on the Company’s statement of operations for the six months ended November 30, 2010.  On January 19, 2011, pursuant to PTSC’s settlement agreement with TPL, $1,048,903 consisting of principal and interest through January 2011 was applied against the March 1, 2010 and June 1, 2010 $500,000 quarterly expense amounts payable to TPL in accordance with the LLC Agreement for supporting efforts to secure licensing agreements and a portion of the fiscal 2010 special litigation support payments owed to TPL by the Company.  The Company has paid TPL in cash for the September 1, 2010 and subsequent quarters’ expense amounts pursuant to the LLC Agreement for supporting efforts to secure licensing agreements.

F-46


Phoenix Digital Solutions, LLC
Notes to Financial Statements (Continued)

Formation and Commercialization Agreement (continued)

During June 2010, the Company advanced Alliacense, LLC TPL’s intellectual property licensing enterprise $410,000 to fund payroll and rent obligations.  Due to non-payment by Alliacense, this amount was fully reserved for at August 31, 2010 and the allowance was recorded as “Reserve for loan loss and uncollectable receivable” on the Company’s statement of operations for the six months ended November 30, 2010. On January 19, 2011, pursuant to PTSC’s settlement agreement with TPL, the $410,000 was applied against the fiscal 2010 special litigation support payments owed to TPL by the Company.

On January 19, 2011, pursuant to PTSC’s settlement agreement with TPL, the Company agreed to pay TPL $67,000 per month from September 1, 2010 to April 30, 2011 relating to TPL’s special work and effort regarding internal costs related to litigation support and patent re-examinations.

6. Commitments and Contingencies

Litigation

On April 22, 2010, PTSC filed an action against TPL and Alliacense LLC in Santa Clara Superior Court alleging claims for breach of contract, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and interference with contract, constructive fraud, for preliminary and permanent injunctions and for an accounting.  The Action stemmed from TPL's notification of a license written in April 2010 which included a license of the MMP patents and other patent to use portfolios and technologies co-owned and potentially owned by TPL in the future.  PTSC objected to the amount of license consideration allocated to the MMP patent license as too low relative to the other license components.

On April 26, 2010, the Court granted PTSC's application for a Temporary Restraining Order ("TRO") precluding TPL from executing any license of the MMP patents without providing PTSC five business days' notice of the proposed MMP license and any other proposed license with the licensor, in order to allow PTSC time to seek redress if PTSC is dissatisfied by the proposed licenses.  At that time, TPL filed motions to seal the file and to bar press releases commenting on the contents of the court file, and a motion to compel private arbitration of the dispute.

TPL stipulated on August 3, 2010 that the TRO already in place would become a Preliminary Injunction.  On August 12, 2010, the Court considered defendants’ request to seal the file indefinitely and to compel private arbitration of the dispute and denied both Motions.  On September 30, 2010, the Court agreed to redaction of the court file at TPL’s request for commercially sensitive data such as dollar amounts of licenses, percentage allocation to MMP licenses and other such confidential data.  TPL has appealed the denial of its Motion to Compel Arbitration which appeal stays the Superior Court proceeding.  The appeal is in the briefing stage and expected to be decided in late 2011 or early 2012.  If the Appeal is unsuccessful then the Superior Court action will be activated.  If it is successful, some or all of the case would proceed to arbitration.  Based on the status of this litigation these financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Guarantees and Indemnities

Under the LLC Operating Agreement, the Company indemnifies its members, managers, officers and employees from any damages and liabilities by reason of their management or involvement in the affairs of the Company as long as the indemnitee acted in good faith and in the best interests of the Company.

Under the Commercialization Agreement, the Company and PTSC hold harmless TPL and its representatives with respect to all claims of any nature by or on behalf of the Company and PTSC related to the preparation, execution and delivery of the Commercialization Agreement.


F-47


Phoenix Digital Solutions, LLC
Notes to Financial Statements (Continued)

Commitments and Contingencies (continued)

The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying balance sheets.

5.7. Related Party Transactions

Significant related party transactions between the Company and TPL are described in Note 5 “Formation and Commercialization Agreement.”

During the fiscal year ended May 31, 2010 TPL and PTSC each contributed $580,000 to the Company for working capital obligations.

During the fiscal years ended May 31, 2011 and 2010, the Company expensed $204,498 and $14,677, respectively, for reimbursement of legal and related fees incurred by PTSC due to patent litigation.

At May 31, 2008, PDS2011, the Company had accounts payable balances of approximately $3,197,000$1,754,000 and $7,500$129,400 to TPL and PTSC, respectively.respectively, for direct expenses incurred by TPL and PTSC.

At May 31, 2010, the Company had accounts payable balances of approximately $1,724,000 and $7,000 to TPL and PTSC, respectively, for direct expenses incurred by TPL and PTSC.




F-49F-48


SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrantregistrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATED:  August 14, 200829, 2011
PATRIOT SCIENTIFIC CORPORATION
 
/S/ FREDERICK C. GOERNERCLIFFORD L. FLOWERS

Frederick C. Goerner
PresidentClifford L. Flowers
Interim Chief Executive Officer and Chief ExecutiveFinancial Officer
(Duly Authorized and Principal Financial Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/S/ FREDERICK C. GOERNER
Frederick C. Goerner
President and Chief Executive Officer
August 14, 2008
/S/ CLIFFORD L. FLOWERS
Clifford L. Flowers
Chief Financial Officer and Principal Accounting Officer
August 14, 2008
/S/ CARLTON M. JOHNSON
Carlton M. Johnson
Director
August 14, 2008
/S/ GLORIA H. FELCYN
Gloria H. Felcyn
Director
August 14, 2008
/S/ HELMUT FALK, JR
Helmut Falk, Jr.
Director
August 14, 2008
/S/ HARRY L. TREDENNICK
Harry L. Tredennick
Director
August 14, 2008
/S/ DONALD E. SCHROCK
Donald E. Schrock
Director
August 14, 2008